Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048731 | 0.00000 | 2.48569 | 130 | 244 | 4746 | system development |
| GO:0048856 | 0.00000 | 2.35983 | 161 | 279 | 5871 | anatomical structure development |
| GO:0051179 | 0.00000 | 2.33147 | 164 | 280 | 5950 | localization |
| GO:0032502 | 0.00000 | 2.24367 | 172 | 285 | 6258 | developmental process |
| GO:0007275 | 0.00000 | 2.29239 | 147 | 256 | 5362 | multicellular organism development |
| GO:0007155 | 0.00000 | 3.35861 | 36 | 101 | 1298 | cell adhesion |
| GO:0022610 | 0.00000 | 3.32340 | 36 | 101 | 1310 | biological adhesion |
| GO:0048513 | 0.00000 | 2.42603 | 96 | 188 | 3504 | animal organ development |
| GO:0009888 | 0.00000 | 2.73113 | 54 | 124 | 1956 | tissue development |
| GO:0009653 | 0.00000 | 2.45479 | 75 | 154 | 2744 | anatomical structure morphogenesis |
| GO:0030154 | 0.00000 | 2.18953 | 116 | 205 | 4218 | cell differentiation |
| GO:0048869 | 0.00000 | 2.15728 | 122 | 212 | 4443 | cellular developmental process |
| GO:0032879 | 0.00000 | 2.31846 | 78 | 152 | 2835 | regulation of localization |
| GO:0051234 | 0.00000 | 2.08359 | 125 | 211 | 4538 | establishment of localization |
| GO:0006928 | 0.00000 | 2.52918 | 55 | 120 | 2014 | movement of cell or subcellular component |
| GO:0098609 | 0.00000 | 3.65468 | 20 | 63 | 720 | cell-cell adhesion |
| GO:0006810 | 0.00000 | 2.07521 | 121 | 205 | 4398 | transport |
| GO:0060429 | 0.00000 | 2.99403 | 32 | 84 | 1172 | epithelium development |
| GO:0048870 | 0.00000 | 2.68674 | 44 | 102 | 1595 | cell motility |
| GO:0051674 | 0.00000 | 2.68674 | 44 | 102 | 1595 | localization of cell |
| GO:0040011 | 0.00000 | 2.54650 | 50 | 110 | 1817 | locomotion |
| GO:0051239 | 0.00000 | 2.16762 | 89 | 163 | 3248 | regulation of multicellular organismal process |
| GO:0030155 | 0.00000 | 3.56649 | 19 | 59 | 686 | regulation of cell adhesion |
| GO:0016477 | 0.00000 | 2.67407 | 40 | 93 | 1447 | cell migration |
| GO:0048523 | 0.00000 | 1.98311 | 129 | 210 | 4687 | negative regulation of cellular process |
| GO:0048468 | 0.00000 | 2.28201 | 66 | 130 | 2406 | cell development |
| GO:0030855 | 0.00000 | 3.63497 | 17 | 55 | 626 | epithelial cell differentiation |
| GO:0048518 | 0.00000 | 1.88720 | 170 | 256 | 6171 | positive regulation of biological process |
| GO:0016043 | 0.00000 | 1.88712 | 167 | 253 | 6083 | cellular component organization |
| GO:0065007 | 0.00000 | 1.85081 | 334 | 425 | 12135 | biological regulation |
| GO:0050793 | 0.00000 | 2.13587 | 75 | 138 | 2721 | regulation of developmental process |
| GO:0071840 | 0.00000 | 1.82198 | 172 | 254 | 6266 | cellular component organization or biogenesis |
| GO:2000026 | 0.00000 | 2.22776 | 60 | 117 | 2184 | regulation of multicellular organismal development |
| GO:0045321 | 0.00000 | 2.83787 | 27 | 69 | 994 | leukocyte activation |
| GO:0002376 | 0.00000 | 2.10618 | 73 | 134 | 2664 | immune system process |
| GO:0007010 | 0.00000 | 2.57448 | 36 | 82 | 1305 | cytoskeleton organization |
| GO:0001775 | 0.00000 | 2.71605 | 30 | 73 | 1098 | cell activation |
| GO:0048519 | 0.00000 | 1.83558 | 145 | 221 | 5278 | negative regulation of biological process |
| GO:0002520 | 0.00000 | 2.77443 | 28 | 70 | 1030 | immune system development |
| GO:0000902 | 0.00000 | 2.71051 | 30 | 73 | 1100 | cell morphogenesis |
| GO:0008283 | 0.00000 | 2.23503 | 55 | 108 | 1994 | cell proliferation |
| GO:0032989 | 0.00000 | 2.59477 | 33 | 77 | 1211 | cellular component morphogenesis |
| GO:0035295 | 0.00000 | 2.65095 | 31 | 73 | 1122 | tube development |
| GO:0009987 | 0.00000 | 1.89644 | 434 | 510 | 15803 | cellular process |
| GO:0051240 | 0.00000 | 2.24085 | 53 | 105 | 1929 | positive regulation of multicellular organismal process |
| GO:0048522 | 0.00000 | 1.80019 | 150 | 225 | 5469 | positive regulation of cellular process |
| GO:0002064 | 0.00000 | 5.08315 | 7 | 30 | 247 | epithelial cell development |
| GO:0032501 | 0.00000 | 1.72499 | 226 | 308 | 8233 | multicellular organismal process |
| GO:0009605 | 0.00000 | 2.05759 | 69 | 125 | 2515 | response to external stimulus |
| GO:0030097 | 0.00000 | 2.77284 | 25 | 63 | 921 | hemopoiesis |
| GO:0051049 | 0.00000 | 2.19180 | 53 | 104 | 1946 | regulation of transport |
| GO:0050789 | 0.00000 | 1.70724 | 317 | 398 | 11520 | regulation of biological process |
| GO:0046903 | 0.00000 | 2.47696 | 34 | 75 | 1227 | secretion |
| GO:0042110 | 0.00000 | 3.47217 | 13 | 42 | 491 | T cell activation |
| GO:0048534 | 0.00000 | 2.66024 | 27 | 64 | 972 | hematopoietic or lymphoid organ development |
| GO:0048583 | 0.00000 | 1.84500 | 107 | 170 | 3883 | regulation of response to stimulus |
| GO:0051094 | 0.00000 | 2.29496 | 42 | 87 | 1540 | positive regulation of developmental process |
| GO:0042127 | 0.00000 | 2.24386 | 45 | 91 | 1649 | regulation of cell proliferation |
| GO:0046649 | 0.00000 | 2.78276 | 23 | 58 | 841 | lymphocyte activation |
| GO:0051270 | 0.00000 | 2.59196 | 28 | 66 | 1028 | regulation of cellular component movement |
| GO:0050896 | 0.00000 | 1.65034 | 262 | 339 | 9531 | response to stimulus |
| GO:0035239 | 0.00000 | 2.66911 | 25 | 60 | 905 | tube morphogenesis |
| GO:0007162 | 0.00000 | 4.33550 | 8 | 30 | 284 | negative regulation of cell adhesion |
| GO:0030334 | 0.00000 | 2.65930 | 25 | 59 | 892 | regulation of cell migration |
| GO:2000145 | 0.00000 | 2.61216 | 26 | 61 | 939 | regulation of cell motility |
| GO:0045595 | 0.00000 | 2.10687 | 52 | 99 | 1909 | regulation of cell differentiation |
| GO:0000904 | 0.00000 | 2.74870 | 22 | 55 | 804 | cell morphogenesis involved in differentiation |
| GO:0007399 | 0.00000 | 1.99547 | 64 | 114 | 2333 | nervous system development |
| GO:0002521 | 0.00000 | 3.12287 | 16 | 44 | 567 | leukocyte differentiation |
| GO:0006811 | 0.00000 | 2.19053 | 43 | 85 | 1565 | ion transport |
| GO:0007159 | 0.00000 | 3.95161 | 9 | 31 | 319 | leukocyte cell-cell adhesion |
| GO:0022407 | 0.00000 | 3.58126 | 11 | 35 | 395 | regulation of cell-cell adhesion |
| GO:0030030 | 0.00000 | 2.17950 | 43 | 85 | 1572 | cell projection organization |
| GO:0065009 | 0.00000 | 1.94438 | 68 | 118 | 2477 | regulation of molecular function |
| GO:0006954 | 0.00000 | 2.84174 | 19 | 49 | 691 | inflammatory response |
| GO:0050900 | 0.00000 | 3.81707 | 9 | 32 | 340 | leukocyte migration |
| GO:0002366 | 0.00000 | 4.25323 | 7 | 28 | 269 | leukocyte activation involved in immune response |
| GO:0072359 | 0.00000 | 2.38563 | 31 | 68 | 1143 | circulatory system development |
| GO:0008219 | 0.00000 | 2.02238 | 57 | 103 | 2065 | cell death |
| GO:0002263 | 0.00000 | 4.18304 | 8 | 28 | 273 | cell activation involved in immune response |
| GO:0030029 | 0.00000 | 2.73486 | 21 | 51 | 746 | actin filament-based process |
| GO:0003382 | 0.00000 | 12.70701 | 1 | 12 | 46 | epithelial cell morphogenesis |
| GO:0050790 | 0.00000 | 2.07658 | 50 | 93 | 1807 | regulation of catalytic activity |
| GO:0002682 | 0.00000 | 2.17977 | 40 | 80 | 1473 | regulation of immune system process |
| GO:0042330 | 0.00000 | 2.93312 | 16 | 44 | 600 | taxis |
| GO:0120036 | 0.00000 | 2.15789 | 42 | 82 | 1526 | plasma membrane bounded cell projection organization |
| GO:0040012 | 0.00000 | 2.43381 | 28 | 62 | 1018 | regulation of locomotion |
| GO:0050794 | 0.00000 | 1.59349 | 296 | 368 | 10774 | regulation of cellular process |
| GO:0065008 | 0.00000 | 1.73487 | 111 | 169 | 4051 | regulation of biological quality |
| GO:0045597 | 0.00000 | 2.36769 | 30 | 65 | 1097 | positive regulation of cell differentiation |
| GO:0023051 | 0.00000 | 1.78732 | 92 | 146 | 3360 | regulation of signaling |
| GO:0010646 | 0.00000 | 1.78506 | 92 | 145 | 3338 | regulation of cell communication |
| GO:0012501 | 0.00000 | 2.00324 | 52 | 95 | 1908 | programmed cell death |
| GO:0030036 | 0.00000 | 2.76493 | 18 | 46 | 663 | actin cytoskeleton organization |
| GO:0006935 | 0.00000 | 2.87223 | 16 | 43 | 597 | chemotaxis |
| GO:0046631 | 0.00000 | 5.29965 | 4 | 20 | 157 | alpha-beta T cell activation |
| GO:0051272 | 0.00000 | 2.88612 | 16 | 42 | 580 | positive regulation of cellular component movement |
| GO:0035710 | 0.00000 | 6.88654 | 3 | 16 | 100 | CD4-positive, alpha-beta T cell activation |
| GO:0022603 | 0.00000 | 2.33180 | 30 | 63 | 1076 | regulation of anatomical structure morphogenesis |
| GO:2000147 | 0.00000 | 2.91242 | 15 | 41 | 561 | positive regulation of cell motility |
| GO:0030098 | 0.00000 | 3.34656 | 11 | 33 | 395 | lymphocyte differentiation |
| GO:0007154 | 0.00000 | 1.59591 | 183 | 247 | 6648 | cell communication |
| GO:0030001 | 0.00000 | 2.51116 | 23 | 53 | 839 | metal ion transport |
| GO:0045216 | 0.00000 | 5.46804 | 4 | 19 | 145 | cell-cell junction organization |
| GO:0046634 | 0.00000 | 6.57235 | 3 | 16 | 104 | regulation of alpha-beta T cell activation |
| GO:0044093 | 0.00000 | 2.12082 | 39 | 76 | 1429 | positive regulation of molecular function |
| GO:0040017 | 0.00000 | 2.81636 | 16 | 42 | 593 | positive regulation of locomotion |
| GO:0032940 | 0.00000 | 2.30270 | 29 | 62 | 1070 | secretion by cell |
| GO:0050863 | 0.00000 | 3.70805 | 8 | 28 | 304 | regulation of T cell activation |
| GO:0009966 | 0.00000 | 1.80898 | 76 | 124 | 2780 | regulation of signal transduction |
| GO:0030217 | 0.00000 | 3.90378 | 7 | 26 | 269 | T cell differentiation |
| GO:0009893 | 0.00000 | 1.72451 | 96 | 147 | 3486 | positive regulation of metabolic process |
| GO:0010941 | 0.00000 | 2.01472 | 46 | 85 | 1685 | regulation of cell death |
| GO:0045785 | 0.00000 | 3.20260 | 11 | 33 | 411 | positive regulation of cell adhesion |
| GO:0030335 | 0.00000 | 2.87415 | 15 | 39 | 539 | positive regulation of cell migration |
| GO:0022008 | 0.00000 | 1.97699 | 49 | 88 | 1778 | neurogenesis |
| GO:0008285 | 0.00000 | 2.61733 | 19 | 45 | 681 | negative regulation of cell proliferation |
| GO:0042221 | 0.00000 | 1.66187 | 114 | 167 | 4136 | response to chemical |
| GO:0010604 | 0.00000 | 1.73383 | 88 | 137 | 3212 | positive regulation of macromolecule metabolic process |
| GO:0023052 | 0.00000 | 1.56563 | 181 | 242 | 6579 | signaling |
| GO:0050670 | 0.00000 | 4.14159 | 6 | 23 | 225 | regulation of lymphocyte proliferation |
| GO:0043085 | 0.00000 | 2.26059 | 29 | 60 | 1051 | positive regulation of catalytic activity |
| GO:0009991 | 0.00000 | 3.17733 | 11 | 32 | 401 | response to extracellular stimulus |
| GO:0032944 | 0.00000 | 4.10062 | 6 | 23 | 227 | regulation of mononuclear cell proliferation |
| GO:0002285 | 0.00000 | 4.43255 | 5 | 21 | 193 | lymphocyte activation involved in immune response |
| GO:0033036 | 0.00000 | 1.75565 | 80 | 126 | 2901 | macromolecule localization |
| GO:0001578 | 0.00000 | 6.36965 | 3 | 15 | 100 | microtubule bundle formation |
| GO:0006915 | 0.00000 | 1.92191 | 51 | 90 | 1867 | apoptotic process |
| GO:0051128 | 0.00000 | 1.79173 | 70 | 114 | 2558 | regulation of cellular component organization |
| GO:0048568 | 0.00000 | 2.89385 | 14 | 36 | 493 | embryonic organ development |
| GO:0002250 | 0.00000 | 2.71365 | 16 | 40 | 583 | adaptive immune response |
| GO:2000514 | 0.00000 | 8.30179 | 2 | 12 | 64 | regulation of CD4-positive, alpha-beta T cell activation |
| GO:0070661 | 0.00000 | 3.37354 | 9 | 28 | 331 | leukocyte proliferation |
| GO:0034113 | 0.00000 | 9.41103 | 1 | 11 | 53 | heterotypic cell-cell adhesion |
| GO:0006812 | 0.00000 | 2.18879 | 30 | 61 | 1101 | cation transport |
| GO:0034330 | 0.00000 | 3.78036 | 7 | 24 | 255 | cell junction organization |
| GO:0030031 | 0.00000 | 2.84304 | 14 | 36 | 501 | cell projection assembly |
| GO:1902105 | 0.00000 | 3.53566 | 8 | 26 | 294 | regulation of leukocyte differentiation |
| GO:0048646 | 0.00000 | 2.15104 | 32 | 63 | 1157 | anatomical structure formation involved in morphogenesis |
| GO:0070663 | 0.00000 | 3.88891 | 7 | 23 | 238 | regulation of leukocyte proliferation |
| GO:0007166 | 0.00000 | 1.78194 | 69 | 111 | 2497 | cell surface receptor signaling pathway |
| GO:0031668 | 0.00000 | 3.97495 | 6 | 22 | 223 | cellular response to extracellular stimulus |
| GO:0009887 | 0.00000 | 2.17106 | 30 | 60 | 1090 | animal organ morphogenesis |
| GO:0031325 | 0.00000 | 1.69086 | 88 | 134 | 3201 | positive regulation of cellular metabolic process |
| GO:0035082 | 0.00000 | 7.70744 | 2 | 12 | 68 | axoneme assembly |
| GO:0070887 | 0.00000 | 1.70589 | 83 | 128 | 3023 | cellular response to chemical stimulus |
| GO:0097529 | 0.00000 | 4.09636 | 6 | 21 | 207 | myeloid leukocyte migration |
| GO:1903706 | 0.00000 | 3.01481 | 11 | 31 | 407 | regulation of hemopoiesis |
| GO:0001944 | 0.00000 | 2.40658 | 21 | 46 | 752 | vasculature development |
| GO:0030595 | 0.00000 | 4.00940 | 6 | 21 | 211 | leukocyte chemotaxis |
| GO:0051241 | 0.00000 | 2.02724 | 37 | 69 | 1343 | negative regulation of multicellular organismal process |
| GO:0046632 | 0.00000 | 5.57868 | 3 | 15 | 112 | alpha-beta T cell differentiation |
| GO:0046651 | 0.00000 | 3.35802 | 8 | 26 | 308 | lymphocyte proliferation |
| GO:0043067 | 0.00000 | 1.95405 | 42 | 76 | 1537 | regulation of programmed cell death |
| GO:0022607 | 0.00000 | 1.71439 | 77 | 120 | 2807 | cellular component assembly |
| GO:0032943 | 0.00000 | 3.33407 | 9 | 26 | 310 | mononuclear cell proliferation |
| GO:0031323 | 0.00000 | 1.54817 | 148 | 202 | 5401 | regulation of cellular metabolic process |
| GO:0072358 | 0.00000 | 2.36167 | 21 | 46 | 765 | cardiovascular system development |
| GO:0050865 | 0.00000 | 2.43735 | 19 | 43 | 693 | regulation of cell activation |
| GO:0051716 | 0.00000 | 1.49202 | 215 | 273 | 7810 | cellular response to stimulus |
| GO:0051093 | 0.00000 | 2.13043 | 29 | 58 | 1070 | negative regulation of developmental process |
| GO:0002684 | 0.00000 | 2.12604 | 29 | 58 | 1072 | positive regulation of immune system process |
| GO:0120031 | 0.00000 | 2.74241 | 13 | 34 | 488 | plasma membrane bounded cell projection assembly |
| GO:0048699 | 0.00000 | 1.88938 | 46 | 80 | 1672 | generation of neurons |
| GO:0002694 | 0.00000 | 2.46843 | 18 | 41 | 652 | regulation of leukocyte activation |
| GO:0002790 | 0.00000 | 2.46843 | 18 | 41 | 652 | peptide secretion |
| GO:0006950 | 0.00000 | 1.62031 | 100 | 146 | 3640 | response to stress |
| GO:0061138 | 0.00000 | 3.80723 | 6 | 21 | 221 | morphogenesis of a branching epithelium |
| GO:0001763 | 0.00000 | 3.66219 | 7 | 22 | 240 | morphogenesis of a branching structure |
| GO:0048729 | 0.00000 | 2.43448 | 19 | 42 | 677 | tissue morphogenesis |
| GO:0060326 | 0.00000 | 3.31891 | 8 | 25 | 299 | cell chemotaxis |
| GO:0051050 | 0.00000 | 2.10645 | 30 | 58 | 1081 | positive regulation of transport |
| GO:0051173 | 0.00000 | 1.66349 | 84 | 127 | 3061 | positive regulation of nitrogen compound metabolic process |
| GO:0022409 | 0.00000 | 3.62857 | 7 | 22 | 242 | positive regulation of cell-cell adhesion |
| GO:0042093 | 0.00000 | 7.59784 | 2 | 11 | 63 | T-helper cell differentiation |
| GO:0034220 | 0.00000 | 2.23307 | 24 | 50 | 878 | ion transmembrane transport |
| GO:0002252 | 0.00000 | 2.23027 | 24 | 50 | 879 | immune effector process |
| GO:0002294 | 0.00000 | 7.45415 | 2 | 11 | 64 | CD4-positive, alpha-beta T cell differentiation involved in immune response |
| GO:0051336 | 0.00000 | 2.14936 | 27 | 54 | 985 | regulation of hydrolase activity |
| GO:0002822 | 0.00000 | 4.04484 | 5 | 19 | 189 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0071496 | 0.00000 | 3.34135 | 8 | 24 | 285 | cellular response to external stimulus |
| GO:0002293 | 0.00000 | 7.31579 | 2 | 11 | 65 | alpha-beta T cell differentiation involved in immune response |
| GO:0071621 | 0.00000 | 5.00803 | 3 | 15 | 123 | granulocyte chemotaxis |
| GO:0098655 | 0.00000 | 2.38423 | 19 | 42 | 690 | cation transmembrane transport |
| GO:1903037 | 0.00000 | 3.31564 | 8 | 24 | 287 | regulation of leukocyte cell-cell adhesion |
| GO:0002287 | 0.00000 | 7.18246 | 2 | 11 | 66 | alpha-beta T cell activation involved in immune response |
| GO:0035556 | 0.00000 | 1.69336 | 72 | 111 | 2608 | intracellular signal transduction |
| GO:0048514 | 0.00000 | 2.45570 | 17 | 39 | 622 | blood vessel morphogenesis |
| GO:0001568 | 0.00000 | 2.34083 | 20 | 43 | 719 | blood vessel development |
| GO:0002009 | 0.00000 | 2.55107 | 15 | 36 | 553 | morphogenesis of an epithelium |
| GO:0007169 | 0.00000 | 2.55107 | 15 | 36 | 553 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0002460 | 0.00000 | 2.76057 | 12 | 31 | 441 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0043367 | 0.00000 | 6.25170 | 2 | 12 | 81 | CD4-positive, alpha-beta T cell differentiation |
| GO:0006952 | 0.00000 | 1.86637 | 44 | 76 | 1601 | defense response |
| GO:0042592 | 0.00000 | 1.79681 | 52 | 86 | 1887 | homeostatic process |
| GO:0048585 | 0.00000 | 1.87007 | 43 | 75 | 1576 | negative regulation of response to stimulus |
| GO:0030099 | 0.00000 | 2.84178 | 11 | 29 | 401 | myeloid cell differentiation |
| GO:0060100 | 0.00000 | 21.41962 | 0 | 6 | 16 | positive regulation of phagocytosis, engulfment |
| GO:1905155 | 0.00000 | 21.41962 | 0 | 6 | 16 | positive regulation of membrane invagination |
| GO:0002286 | 0.00000 | 5.09295 | 3 | 14 | 113 | T cell activation involved in immune response |
| GO:0031589 | 0.00000 | 3.02123 | 9 | 26 | 339 | cell-substrate adhesion |
| GO:0008104 | 0.00000 | 1.67769 | 71 | 109 | 2578 | protein localization |
| GO:0003341 | 0.00000 | 6.69432 | 2 | 11 | 70 | cilium movement |
| GO:0120192 | 0.00000 | 8.95707 | 1 | 9 | 45 | tight junction assembly |
| GO:0098662 | 0.00000 | 2.42286 | 17 | 38 | 613 | inorganic cation transmembrane transport |
| GO:0032945 | 0.00000 | 5.99042 | 2 | 12 | 84 | negative regulation of mononuclear cell proliferation |
| GO:0050672 | 0.00000 | 5.99042 | 2 | 12 | 84 | negative regulation of lymphocyte proliferation |
| GO:0002683 | 0.00000 | 2.64996 | 13 | 32 | 473 | negative regulation of immune system process |
| GO:0002292 | 0.00000 | 6.58246 | 2 | 11 | 71 | T cell differentiation involved in immune response |
| GO:0030593 | 0.00000 | 5.37572 | 3 | 13 | 100 | neutrophil chemotaxis |
| GO:0006955 | 0.00000 | 1.82980 | 45 | 77 | 1652 | immune response |
| GO:0008284 | 0.00000 | 2.08841 | 27 | 52 | 972 | positive regulation of cell proliferation |
| GO:0055085 | 0.00000 | 1.94622 | 35 | 63 | 1266 | transmembrane transport |
| GO:0045580 | 0.00000 | 4.30734 | 4 | 16 | 150 | regulation of T cell differentiation |
| GO:0042981 | 0.00000 | 1.86126 | 42 | 72 | 1516 | regulation of apoptotic process |
| GO:0002819 | 0.00000 | 3.69425 | 6 | 19 | 205 | regulation of adaptive immune response |
| GO:0042098 | 0.00000 | 3.69425 | 6 | 19 | 205 | T cell proliferation |
| GO:0010942 | 0.00000 | 2.30162 | 19 | 41 | 695 | positive regulation of cell death |
| GO:0032101 | 0.00000 | 2.22896 | 21 | 44 | 770 | regulation of response to external stimulus |
| GO:0022408 | 0.00000 | 3.84858 | 5 | 18 | 187 | negative regulation of cell-cell adhesion |
| GO:0032970 | 0.00000 | 2.79271 | 11 | 28 | 393 | regulation of actin filament-based process |
| GO:0070664 | 0.00001 | 5.67412 | 2 | 12 | 88 | negative regulation of leukocyte proliferation |
| GO:0051249 | 0.00001 | 2.46147 | 15 | 35 | 555 | regulation of lymphocyte activation |
| GO:0016192 | 0.00001 | 1.85134 | 41 | 71 | 1501 | vesicle-mediated transport |
| GO:0044085 | 0.00001 | 1.60866 | 84 | 123 | 3041 | cellular component biogenesis |
| GO:0051345 | 0.00001 | 2.52659 | 14 | 33 | 510 | positive regulation of hydrolase activity |
| GO:0001817 | 0.00001 | 2.29592 | 19 | 40 | 679 | regulation of cytokine production |
| GO:0019222 | 0.00001 | 1.46965 | 164 | 213 | 5953 | regulation of metabolic process |
| GO:0001816 | 0.00001 | 2.21882 | 21 | 43 | 755 | cytokine production |
| GO:0051046 | 0.00001 | 2.09524 | 25 | 49 | 911 | regulation of secretion |
| GO:0007165 | 0.00001 | 1.46537 | 166 | 215 | 6028 | signal transduction |
| GO:0010720 | 0.00001 | 2.30526 | 18 | 39 | 659 | positive regulation of cell development |
| GO:0071702 | 0.00001 | 1.65577 | 69 | 105 | 2505 | organic substance transport |
| GO:0051246 | 0.00001 | 1.63497 | 74 | 111 | 2687 | regulation of protein metabolic process |
| GO:0030100 | 0.00001 | 3.08911 | 8 | 23 | 293 | regulation of endocytosis |
| GO:0051130 | 0.00001 | 1.90601 | 35 | 63 | 1290 | positive regulation of cellular component organization |
| GO:0120193 | 0.00001 | 7.86300 | 1 | 9 | 50 | tight junction organization |
| GO:0050731 | 0.00001 | 3.67332 | 5 | 18 | 195 | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0072539 | 0.00001 | 11.91284 | 1 | 7 | 28 | T-helper 17 cell differentiation |
| GO:0080090 | 0.00001 | 1.47994 | 144 | 191 | 5248 | regulation of primary metabolic process |
| GO:0032656 | 0.00001 | 16.47444 | 1 | 6 | 19 | regulation of interleukin-13 production |
| GO:0060099 | 0.00001 | 16.47444 | 1 | 6 | 19 | regulation of phagocytosis, engulfment |
| GO:0002274 | 0.00001 | 3.50420 | 6 | 19 | 215 | myeloid leukocyte activation |
| GO:0006996 | 0.00001 | 1.55509 | 98 | 139 | 3568 | organelle organization |
| GO:0060627 | 0.00001 | 2.40002 | 16 | 35 | 568 | regulation of vesicle-mediated transport |
| GO:0018108 | 0.00001 | 2.95174 | 9 | 24 | 319 | peptidyl-tyrosine phosphorylation |
| GO:0018212 | 0.00001 | 2.92163 | 9 | 24 | 322 | peptidyl-tyrosine modification |
| GO:1905153 | 0.00001 | 15.29702 | 1 | 6 | 20 | regulation of membrane invagination |
| GO:0045619 | 0.00001 | 3.71755 | 5 | 17 | 182 | regulation of lymphocyte differentiation |
| GO:0060284 | 0.00001 | 1.95714 | 30 | 55 | 1093 | regulation of cell development |
| GO:0097530 | 0.00001 | 4.12453 | 4 | 15 | 146 | granulocyte migration |
| GO:0002443 | 0.00001 | 2.45650 | 14 | 32 | 507 | leukocyte mediated immunity |
| GO:0009306 | 0.00001 | 2.31247 | 17 | 36 | 605 | protein secretion |
| GO:1903039 | 0.00001 | 3.51322 | 6 | 18 | 203 | positive regulation of leukocyte cell-cell adhesion |
| GO:0031667 | 0.00001 | 2.73706 | 10 | 26 | 371 | response to nutrient levels |
| GO:0098660 | 0.00001 | 2.24987 | 18 | 38 | 656 | inorganic ion transmembrane transport |
| GO:0050663 | 0.00002 | 3.22873 | 7 | 20 | 244 | cytokine secretion |
| GO:0051091 | 0.00002 | 3.22873 | 7 | 20 | 244 | positive regulation of DNA-binding transcription factor activity |
| GO:0046637 | 0.00002 | 6.18109 | 2 | 10 | 68 | regulation of alpha-beta T cell differentiation |
| GO:0030183 | 0.00002 | 4.03165 | 4 | 15 | 149 | B cell differentiation |
| GO:0007167 | 0.00002 | 2.04985 | 24 | 47 | 890 | enzyme linked receptor protein signaling pathway |
| GO:0006793 | 0.00002 | 1.57854 | 81 | 118 | 2955 | phosphorus metabolic process |
| GO:0050870 | 0.00002 | 3.60741 | 5 | 17 | 187 | positive regulation of T cell activation |
| GO:0051247 | 0.00002 | 1.76117 | 45 | 74 | 1639 | positive regulation of protein metabolic process |
| GO:0030888 | 0.00002 | 6.07606 | 2 | 10 | 69 | regulation of B cell proliferation |
| GO:0046635 | 0.00002 | 6.07606 | 2 | 10 | 69 | positive regulation of alpha-beta T cell activation |
| GO:0006796 | 0.00002 | 1.57549 | 81 | 117 | 2933 | phosphate-containing compound metabolic process |
| GO:0042129 | 0.00002 | 3.74460 | 5 | 16 | 170 | regulation of T cell proliferation |
| GO:0060255 | 0.00002 | 1.44868 | 151 | 196 | 5486 | regulation of macromolecule metabolic process |
| GO:0010562 | 0.00002 | 1.92026 | 31 | 55 | 1112 | positive regulation of phosphorus metabolic process |
| GO:0045937 | 0.00002 | 1.92026 | 31 | 55 | 1112 | positive regulation of phosphate metabolic process |
| GO:0098657 | 0.00002 | 2.04567 | 24 | 46 | 872 | import into cell |
| GO:1904158 | 0.00002 | Inf | 0 | 3 | 3 | axonemal central apparatus assembly |
| GO:0072538 | 0.00002 | 10.00501 | 1 | 7 | 32 | T-helper 17 type immune response |
| GO:0032616 | 0.00002 | 13.38370 | 1 | 6 | 22 | interleukin-13 production |
| GO:0070830 | 0.00002 | 7.94921 | 1 | 8 | 44 | bicellular tight junction assembly |
| GO:0006814 | 0.00002 | 3.36639 | 6 | 18 | 211 | sodium ion transport |
| GO:0072511 | 0.00002 | 2.45347 | 13 | 30 | 475 | divalent inorganic cation transport |
| GO:0006629 | 0.00002 | 1.85205 | 35 | 60 | 1258 | lipid metabolic process |
| GO:1990266 | 0.00002 | 4.40842 | 3 | 13 | 119 | neutrophil migration |
| GO:0009790 | 0.00002 | 1.86063 | 34 | 59 | 1231 | embryo development |
| GO:0021591 | 0.00003 | 9.61977 | 1 | 7 | 33 | ventricular system development |
| GO:0050920 | 0.00003 | 3.33156 | 6 | 18 | 213 | regulation of chemotaxis |
| GO:0040007 | 0.00003 | 1.90862 | 30 | 54 | 1097 | growth |
| GO:0030010 | 0.00003 | 4.06162 | 4 | 14 | 138 | establishment of cell polarity |
| GO:0051641 | 0.00003 | 1.59096 | 71 | 105 | 2592 | cellular localization |
| GO:0002706 | 0.00003 | 3.44405 | 5 | 17 | 195 | regulation of lymphocyte mediated immunity |
| GO:0030182 | 0.00003 | 1.76906 | 41 | 68 | 1494 | neuron differentiation |
| GO:0038127 | 0.00003 | 4.63341 | 3 | 12 | 105 | ERBB signaling pathway |
| GO:0032956 | 0.00003 | 2.71808 | 9 | 24 | 344 | regulation of actin cytoskeleton organization |
| GO:0050867 | 0.00003 | 2.44048 | 13 | 29 | 461 | positive regulation of cell activation |
| GO:0051171 | 0.00004 | 1.44263 | 140 | 183 | 5104 | regulation of nitrogen compound metabolic process |
| GO:0048589 | 0.00004 | 2.06462 | 22 | 42 | 787 | developmental growth |
| GO:0006978 | 0.00004 | 17.82148 | 0 | 5 | 15 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
| GO:0043129 | 0.00004 | 17.82148 | 0 | 5 | 15 | surfactant homeostasis |
| GO:0032878 | 0.00004 | 11.89557 | 1 | 6 | 24 | regulation of establishment or maintenance of cell polarity |
| GO:0048017 | 0.00004 | 3.72397 | 4 | 15 | 160 | inositol lipid-mediated signaling |
| GO:0031175 | 0.00004 | 1.89482 | 30 | 53 | 1083 | neuron projection development |
| GO:0010648 | 0.00004 | 1.81098 | 36 | 61 | 1306 | negative regulation of cell communication |
| GO:0007043 | 0.00004 | 4.53546 | 3 | 12 | 107 | cell-cell junction assembly |
| GO:0023057 | 0.00004 | 1.80484 | 36 | 61 | 1310 | negative regulation of signaling |
| GO:0006897 | 0.00004 | 2.08694 | 20 | 40 | 741 | endocytosis |
| GO:0051090 | 0.00004 | 2.54925 | 11 | 26 | 396 | regulation of DNA-binding transcription factor activity |
| GO:0002685 | 0.00004 | 3.33085 | 6 | 17 | 201 | regulation of leukocyte migration |
| GO:0010628 | 0.00004 | 1.65252 | 54 | 84 | 1981 | positive regulation of gene expression |
| GO:0050730 | 0.00004 | 2.97375 | 7 | 20 | 263 | regulation of peptidyl-tyrosine phosphorylation |
| GO:0002687 | 0.00005 | 3.87313 | 4 | 14 | 144 | positive regulation of leukocyte migration |
| GO:0002695 | 0.00005 | 3.47205 | 5 | 16 | 182 | negative regulation of leukocyte activation |
| GO:0042035 | 0.00005 | 4.44155 | 3 | 12 | 109 | regulation of cytokine biosynthetic process |
| GO:0070925 | 0.00005 | 2.03914 | 22 | 42 | 796 | organelle assembly |
| GO:0090023 | 0.00005 | 11.26899 | 1 | 6 | 25 | positive regulation of neutrophil chemotaxis |
| GO:2000516 | 0.00005 | 8.62348 | 1 | 7 | 36 | positive regulation of CD4-positive, alpha-beta T cell activation |
| GO:0016310 | 0.00005 | 1.62145 | 60 | 90 | 2166 | phosphorylation |
| GO:0050776 | 0.00005 | 1.96886 | 25 | 46 | 903 | regulation of immune response |
| GO:0002696 | 0.00005 | 2.43279 | 12 | 28 | 446 | positive regulation of leukocyte activation |
| GO:0050866 | 0.00005 | 3.29474 | 6 | 17 | 203 | negative regulation of cell activation |
| GO:0006816 | 0.00005 | 2.47463 | 12 | 27 | 423 | calcium ion transport |
| GO:0042772 | 0.00005 | 16.20063 | 0 | 5 | 16 | DNA damage response, signal transduction resulting in transcription |
| GO:0046629 | 0.00005 | 16.20063 | 0 | 5 | 16 | gamma-delta T cell activation |
| GO:0070838 | 0.00005 | 2.37870 | 13 | 29 | 472 | divalent metal ion transport |
| GO:0042327 | 0.00005 | 1.89004 | 29 | 51 | 1043 | positive regulation of phosphorylation |
| GO:0051960 | 0.00005 | 1.87689 | 29 | 52 | 1071 | regulation of nervous system development |
| GO:0048878 | 0.00005 | 1.83262 | 32 | 56 | 1182 | chemical homeostasis |
| GO:2000116 | 0.00006 | 3.12153 | 6 | 18 | 226 | regulation of cysteine-type endopeptidase activity |
| GO:0022604 | 0.00006 | 2.29196 | 14 | 31 | 523 | regulation of cell morphogenesis |
| GO:0032103 | 0.00006 | 2.74409 | 9 | 22 | 312 | positive regulation of response to external stimulus |
| GO:0060562 | 0.00006 | 2.55233 | 10 | 25 | 380 | epithelial tube morphogenesis |
| GO:0034329 | 0.00006 | 3.24201 | 6 | 17 | 206 | cell junction assembly |
| GO:1903530 | 0.00006 | 1.99785 | 23 | 43 | 831 | regulation of secretion by cell |
| GO:0007173 | 0.00006 | 4.69674 | 3 | 11 | 95 | epidermal growth factor receptor signaling pathway |
| GO:0043370 | 0.00006 | 6.81179 | 1 | 8 | 50 | regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0098901 | 0.00006 | 10.70506 | 1 | 6 | 26 | regulation of cardiac muscle cell action potential |
| GO:0060560 | 0.00006 | 2.88958 | 7 | 20 | 270 | developmental growth involved in morphogenesis |
| GO:0002703 | 0.00007 | 2.96861 | 7 | 19 | 250 | regulation of leukocyte mediated immunity |
| GO:0051271 | 0.00007 | 2.70627 | 9 | 22 | 316 | negative regulation of cellular component movement |
| GO:0002791 | 0.00007 | 2.26373 | 15 | 31 | 529 | regulation of peptide secretion |
| GO:0060541 | 0.00007 | 2.95568 | 7 | 19 | 251 | respiratory system development |
| GO:0048875 | 0.00007 | 14.84992 | 0 | 5 | 17 | chemical homeostasis within a tissue |
| GO:0050769 | 0.00007 | 2.19628 | 16 | 33 | 580 | positive regulation of neurogenesis |
| GO:0071624 | 0.00008 | 10.19485 | 1 | 6 | 27 | positive regulation of granulocyte chemotaxis |
| GO:0002835 | 0.00008 | 106.63465 | 0 | 3 | 4 | negative regulation of response to tumor cell |
| GO:0002838 | 0.00008 | 106.63465 | 0 | 3 | 4 | negative regulation of immune response to tumor cell |
| GO:0051250 | 0.00008 | 3.64730 | 4 | 14 | 152 | negative regulation of lymphocyte activation |
| GO:0044092 | 0.00008 | 1.87899 | 28 | 49 | 1006 | negative regulation of molecular function |
| GO:0044089 | 0.00009 | 2.24072 | 15 | 31 | 534 | positive regulation of cellular component biogenesis |
| GO:0031324 | 0.00009 | 1.56093 | 67 | 98 | 2449 | negative regulation of cellular metabolic process |
| GO:0045860 | 0.00009 | 2.38270 | 12 | 27 | 438 | positive regulation of protein kinase activity |
| GO:0043068 | 0.00009 | 2.11828 | 18 | 35 | 637 | positive regulation of programmed cell death |
| GO:0050767 | 0.00009 | 1.89524 | 26 | 47 | 956 | regulation of neurogenesis |
| GO:0016049 | 0.00010 | 2.25656 | 14 | 30 | 513 | cell growth |
| GO:0031669 | 0.00010 | 3.23624 | 5 | 16 | 194 | cellular response to nutrient levels |
| GO:0032674 | 0.00010 | 13.70701 | 0 | 5 | 18 | regulation of interleukin-5 production |
| GO:0035089 | 0.00010 | 13.70701 | 0 | 5 | 18 | establishment of apical/basal cell polarity |
| GO:0050671 | 0.00010 | 3.79625 | 4 | 13 | 136 | positive regulation of lymphocyte proliferation |
| GO:0043009 | 0.00010 | 1.96360 | 23 | 42 | 824 | chordate embryonic development |
| GO:0044255 | 0.00010 | 1.90187 | 26 | 46 | 932 | cellular lipid metabolic process |
| GO:0051251 | 0.00010 | 2.45395 | 11 | 25 | 394 | positive regulation of lymphocyte activation |
| GO:0030853 | 0.00010 | 23.72871 | 0 | 4 | 10 | negative regulation of granulocyte differentiation |
| GO:0098771 | 0.00011 | 2.01358 | 21 | 39 | 746 | inorganic ion homeostasis |
| GO:0045596 | 0.00011 | 1.97640 | 22 | 41 | 799 | negative regulation of cell differentiation |
| GO:0043297 | 0.00011 | 6.21836 | 1 | 8 | 54 | apical junction assembly |
| GO:0001818 | 0.00011 | 2.85614 | 7 | 19 | 259 | negative regulation of cytokine production |
| GO:0032268 | 0.00011 | 1.54738 | 69 | 99 | 2494 | regulation of cellular protein metabolic process |
| GO:0032270 | 0.00011 | 1.69055 | 42 | 67 | 1532 | positive regulation of cellular protein metabolic process |
| GO:0019218 | 0.00011 | 4.33410 | 3 | 11 | 102 | regulation of steroid metabolic process |
| GO:0048588 | 0.00012 | 2.84416 | 7 | 19 | 260 | developmental cell growth |
| GO:0048015 | 0.00012 | 3.51898 | 4 | 14 | 157 | phosphatidylinositol-mediated signaling |
| GO:0032946 | 0.00012 | 3.73518 | 4 | 13 | 138 | positive regulation of mononuclear cell proliferation |
| GO:0060548 | 0.00012 | 1.83628 | 29 | 50 | 1049 | negative regulation of cell death |
| GO:0042130 | 0.00012 | 5.28028 | 2 | 9 | 70 | negative regulation of T cell proliferation |
| GO:0006887 | 0.00012 | 2.47457 | 10 | 24 | 375 | exocytosis |
| GO:0042089 | 0.00013 | 3.95046 | 3 | 12 | 121 | cytokine biosynthetic process |
| GO:0030852 | 0.00013 | 12.72738 | 1 | 5 | 19 | regulation of granulocyte differentiation |
| GO:0032634 | 0.00013 | 12.72738 | 1 | 5 | 19 | interleukin-5 production |
| GO:2000114 | 0.00013 | 12.72738 | 1 | 5 | 19 | regulation of establishment of cell polarity |
| GO:0048666 | 0.00013 | 1.76645 | 34 | 56 | 1222 | neuron development |
| GO:0002449 | 0.00014 | 2.36088 | 12 | 26 | 425 | lymphocyte mediated immunity |
| GO:0002793 | 0.00014 | 2.57316 | 9 | 22 | 331 | positive regulation of peptide secretion |
| GO:0051962 | 0.00014 | 2.06882 | 18 | 35 | 651 | positive regulation of nervous system development |
| GO:0048584 | 0.00014 | 1.55872 | 63 | 92 | 2294 | positive regulation of response to stimulus |
| GO:0043372 | 0.00014 | 8.91930 | 1 | 6 | 30 | positive regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0040013 | 0.00014 | 2.56475 | 9 | 22 | 332 | negative regulation of locomotion |
| GO:0043269 | 0.00015 | 1.99655 | 20 | 38 | 732 | regulation of ion transport |
| GO:0033674 | 0.00015 | 2.26680 | 13 | 28 | 476 | positive regulation of kinase activity |
| GO:0044087 | 0.00015 | 1.86676 | 26 | 46 | 948 | regulation of cellular component biogenesis |
| GO:0050764 | 0.00015 | 4.19522 | 3 | 11 | 105 | regulation of phagocytosis |
| GO:0070232 | 0.00016 | 6.94453 | 1 | 7 | 43 | regulation of T cell apoptotic process |
| GO:0098742 | 0.00016 | 3.09594 | 6 | 16 | 202 | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:0009792 | 0.00016 | 1.92032 | 23 | 42 | 841 | embryo development ending in birth or egg hatching |
| GO:0042113 | 0.00016 | 2.38173 | 11 | 25 | 405 | B cell activation |
| GO:0090043 | 0.00016 | 20.33799 | 0 | 4 | 11 | regulation of tubulin deacetylation |
| GO:0015672 | 0.00017 | 2.28631 | 13 | 27 | 455 | monovalent inorganic cation transport |
| GO:0061162 | 0.00017 | 11.87836 | 1 | 5 | 20 | establishment of monopolar cell polarity |
| GO:0070633 | 0.00017 | 11.87836 | 1 | 5 | 20 | transepithelial transport |
| GO:0043065 | 0.00017 | 2.06847 | 17 | 34 | 632 | positive regulation of apoptotic process |
| GO:0090022 | 0.00017 | 8.56215 | 1 | 6 | 31 | regulation of neutrophil chemotaxis |
| GO:0042107 | 0.00018 | 3.80995 | 3 | 12 | 125 | cytokine metabolic process |
| GO:0038061 | 0.00018 | 4.10746 | 3 | 11 | 107 | NIK/NF-kappaB signaling |
| GO:0032663 | 0.00018 | 5.71987 | 2 | 8 | 58 | regulation of interleukin-2 production |
| GO:0052548 | 0.00018 | 2.52347 | 9 | 22 | 337 | regulation of endopeptidase activity |
| GO:0061098 | 0.00018 | 6.75654 | 1 | 7 | 44 | positive regulation of protein tyrosine kinase activity |
| GO:0048754 | 0.00018 | 3.19170 | 5 | 15 | 184 | branching morphogenesis of an epithelial tube |
| GO:0019216 | 0.00019 | 2.51537 | 9 | 22 | 338 | regulation of lipid metabolic process |
| GO:0045184 | 0.00019 | 1.60424 | 51 | 77 | 1856 | establishment of protein localization |
| GO:0070665 | 0.00019 | 3.53600 | 4 | 13 | 145 | positive regulation of leukocyte proliferation |
| GO:0015833 | 0.00019 | 1.61297 | 49 | 75 | 1797 | peptide transport |
| GO:0045621 | 0.00019 | 4.06493 | 3 | 11 | 108 | positive regulation of lymphocyte differentiation |
| GO:0060298 | 0.00020 | 53.31496 | 0 | 3 | 5 | positive regulation of sarcomere organization |
| GO:0060711 | 0.00020 | 5.60747 | 2 | 8 | 59 | labyrinthine layer development |
| GO:0001934 | 0.00020 | 1.82606 | 27 | 47 | 989 | positive regulation of protein phosphorylation |
| GO:0048871 | 0.00021 | 2.21631 | 13 | 28 | 486 | multicellular organismal homeostasis |
| GO:0030890 | 0.00021 | 6.57845 | 1 | 7 | 45 | positive regulation of B cell proliferation |
| GO:0061097 | 0.00021 | 4.87917 | 2 | 9 | 75 | regulation of protein tyrosine kinase activity |
| GO:0061339 | 0.00022 | 11.13547 | 1 | 5 | 21 | establishment or maintenance of monopolar cell polarity |
| GO:0043069 | 0.00023 | 1.84009 | 26 | 45 | 939 | negative regulation of programmed cell death |
| GO:0032754 | 0.00023 | 17.79495 | 0 | 4 | 12 | positive regulation of interleukin-5 production |
| GO:1902107 | 0.00024 | 3.26603 | 5 | 14 | 168 | positive regulation of leukocyte differentiation |
| GO:0050708 | 0.00024 | 2.19672 | 13 | 28 | 490 | regulation of protein secretion |
| GO:0002707 | 0.00024 | 6.40948 | 1 | 7 | 46 | negative regulation of lymphocyte mediated immunity |
| GO:0060271 | 0.00025 | 2.58586 | 8 | 20 | 299 | cilium assembly |
| GO:0006468 | 0.00026 | 1.59490 | 50 | 75 | 1815 | protein phosphorylation |
| GO:0010810 | 0.00026 | 2.95187 | 6 | 16 | 211 | regulation of cell-substrate adhesion |
| GO:0050766 | 0.00026 | 4.73525 | 2 | 9 | 77 | positive regulation of phagocytosis |
| GO:0042063 | 0.00026 | 2.50985 | 9 | 21 | 323 | gliogenesis |
| GO:0001892 | 0.00026 | 3.90325 | 3 | 11 | 112 | embryonic placenta development |
| GO:0042886 | 0.00026 | 1.59292 | 50 | 75 | 1817 | amide transport |
| GO:0008360 | 0.00027 | 3.40619 | 4 | 13 | 150 | regulation of cell shape |
| GO:0022612 | 0.00027 | 3.40619 | 4 | 13 | 150 | gland morphogenesis |
| GO:0050715 | 0.00027 | 3.40619 | 4 | 13 | 150 | positive regulation of cytokine secretion |
| GO:0045624 | 0.00028 | 10.47997 | 1 | 5 | 22 | positive regulation of T-helper cell differentiation |
| GO:0046486 | 0.00028 | 2.49311 | 9 | 21 | 325 | glycerolipid metabolic process |
| GO:1904019 | 0.00029 | 3.86481 | 3 | 11 | 113 | epithelial cell apoptotic process |
| GO:0009913 | 0.00029 | 2.92164 | 6 | 16 | 213 | epidermal cell differentiation |
| GO:0050707 | 0.00029 | 2.92164 | 6 | 16 | 213 | regulation of cytokine secretion |
| GO:0050714 | 0.00029 | 2.55801 | 8 | 20 | 302 | positive regulation of protein secretion |
| GO:0072507 | 0.00029 | 2.13705 | 14 | 29 | 521 | divalent inorganic cation homeostasis |
| GO:0048812 | 0.00029 | 1.98269 | 19 | 35 | 677 | neuron projection morphogenesis |
| GO:1902624 | 0.00029 | 7.64376 | 1 | 6 | 34 | positive regulation of neutrophil migration |
| GO:0050801 | 0.00030 | 1.88885 | 22 | 40 | 812 | ion homeostasis |
| GO:1903532 | 0.00030 | 2.19728 | 13 | 27 | 472 | positive regulation of secretion by cell |
| GO:0048771 | 0.00031 | 3.02911 | 5 | 15 | 193 | tissue remodeling |
| GO:0044782 | 0.00031 | 2.47659 | 9 | 21 | 327 | cilium organization |
| GO:0002762 | 0.00032 | 6.09629 | 1 | 7 | 48 | negative regulation of myeloid leukocyte differentiation |
| GO:0050873 | 0.00032 | 6.09629 | 1 | 7 | 48 | brown fat cell differentiation |
| GO:0045637 | 0.00032 | 2.89202 | 6 | 16 | 215 | regulation of myeloid cell differentiation |
| GO:0010950 | 0.00032 | 3.33275 | 4 | 13 | 153 | positive regulation of endopeptidase activity |
| GO:0032675 | 0.00032 | 3.33275 | 4 | 13 | 153 | regulation of interleukin-6 production |
| GO:0007507 | 0.00032 | 2.01470 | 17 | 33 | 628 | heart development |
| GO:0048667 | 0.00032 | 2.01470 | 17 | 33 | 628 | cell morphogenesis involved in neuron differentiation |
| GO:0010557 | 0.00032 | 1.58565 | 49 | 74 | 1799 | positive regulation of macromolecule biosynthetic process |
| GO:0001819 | 0.00032 | 2.22452 | 12 | 26 | 449 | positive regulation of cytokine production |
| GO:0097435 | 0.00032 | 1.97005 | 19 | 35 | 681 | supramolecular fiber organization |
| GO:0032880 | 0.00032 | 1.77356 | 29 | 48 | 1038 | regulation of protein localization |
| GO:0007015 | 0.00033 | 2.30744 | 11 | 24 | 400 | actin filament organization |
| GO:1902531 | 0.00033 | 1.59929 | 47 | 71 | 1710 | regulation of intracellular signal transduction |
| GO:0050673 | 0.00033 | 2.26060 | 12 | 25 | 425 | epithelial cell proliferation |
| GO:0051347 | 0.00033 | 2.08837 | 15 | 30 | 551 | positive regulation of transferase activity |
| GO:0042492 | 0.00033 | 15.81703 | 0 | 4 | 13 | gamma-delta T cell differentiation |
| GO:0060670 | 0.00033 | 15.81703 | 0 | 4 | 13 | branching involved in labyrinthine layer morphogenesis |
| GO:0090042 | 0.00033 | 15.81703 | 0 | 4 | 13 | tubulin deacetylation |
| GO:0002573 | 0.00033 | 2.87743 | 6 | 16 | 216 | myeloid leukocyte differentiation |
| GO:0007163 | 0.00033 | 2.87743 | 6 | 16 | 216 | establishment or maintenance of cell polarity |
| GO:0042325 | 0.00034 | 1.63079 | 42 | 65 | 1533 | regulation of phosphorylation |
| GO:0006937 | 0.00034 | 3.30897 | 4 | 13 | 154 | regulation of muscle contraction |
| GO:0001911 | 0.00034 | 9.89731 | 1 | 5 | 23 | negative regulation of leukocyte mediated cytotoxicity |
| GO:0099149 | 0.00034 | 9.89731 | 1 | 5 | 23 | regulation of postsynaptic neurotransmitter receptor internalization |
| GO:0050808 | 0.00035 | 2.21385 | 12 | 26 | 451 | synapse organization |
| GO:0060292 | 0.00035 | 7.37986 | 1 | 6 | 35 | long-term synaptic depression |
| GO:0051047 | 0.00035 | 2.11073 | 14 | 29 | 527 | positive regulation of secretion |
| GO:0045765 | 0.00035 | 2.51288 | 8 | 20 | 307 | regulation of angiogenesis |
| GO:0045807 | 0.00036 | 3.12305 | 5 | 14 | 175 | positive regulation of endocytosis |
| GO:0072331 | 0.00036 | 3.49864 | 4 | 12 | 135 | signal transduction by p53 class mediator |
| GO:0046638 | 0.00036 | 5.95087 | 1 | 7 | 49 | positive regulation of alpha-beta T cell differentiation |
| GO:1904428 | 0.00039 | 35.54173 | 0 | 3 | 6 | negative regulation of tubulin deacetylation |
| GO:2000321 | 0.00039 | 35.54173 | 0 | 3 | 6 | positive regulation of T-helper 17 cell differentiation |
| GO:2000664 | 0.00039 | 35.54173 | 0 | 3 | 6 | positive regulation of interleukin-5 secretion |
| GO:0033627 | 0.00040 | 5.01587 | 2 | 8 | 65 | cell adhesion mediated by integrin |
| GO:0019220 | 0.00040 | 1.59178 | 47 | 70 | 1692 | regulation of phosphate metabolic process |
| GO:0051174 | 0.00041 | 1.59072 | 47 | 70 | 1693 | regulation of phosphorus metabolic process |
| GO:0032715 | 0.00041 | 5.81222 | 1 | 7 | 50 | negative regulation of interleukin-6 production |
| GO:0040008 | 0.00041 | 1.92231 | 20 | 36 | 717 | regulation of growth |
| GO:0055065 | 0.00042 | 1.96055 | 18 | 34 | 664 | metal ion homeostasis |
| GO:0120039 | 0.00042 | 1.93914 | 19 | 35 | 691 | plasma membrane bounded cell projection morphogenesis |
| GO:0032990 | 0.00042 | 1.91941 | 20 | 36 | 718 | cell part morphogenesis |
| GO:0007205 | 0.00043 | 9.37599 | 1 | 5 | 24 | protein kinase C-activating G protein-coupled receptor signaling pathway |
| GO:0071310 | 0.00043 | 1.49472 | 67 | 94 | 2433 | cellular response to organic substance |
| GO:0007584 | 0.00043 | 3.97771 | 3 | 10 | 100 | response to nutrient |
| GO:0032623 | 0.00044 | 4.92917 | 2 | 8 | 66 | interleukin-2 production |
| GO:1901184 | 0.00044 | 4.92917 | 2 | 8 | 66 | regulation of ERBB signaling pathway |
| GO:0050868 | 0.00045 | 3.64912 | 3 | 11 | 119 | negative regulation of T cell activation |
| GO:0010033 | 0.00045 | 1.44371 | 84 | 114 | 3070 | response to organic substance |
| GO:0032736 | 0.00045 | 14.23470 | 0 | 4 | 14 | positive regulation of interleukin-13 production |
| GO:0098911 | 0.00045 | 14.23470 | 0 | 4 | 14 | regulation of ventricular cardiac muscle cell action potential |
| GO:0031399 | 0.00046 | 1.57383 | 48 | 72 | 1760 | regulation of protein modification process |
| GO:0007264 | 0.00046 | 2.13366 | 13 | 27 | 485 | small GTPase mediated signal transduction |
| GO:0051222 | 0.00047 | 2.20447 | 12 | 25 | 435 | positive regulation of protein transport |
| GO:1901222 | 0.00047 | 3.93382 | 3 | 10 | 101 | regulation of NIK/NF-kappaB signaling |
| GO:0043281 | 0.00047 | 2.89779 | 6 | 15 | 201 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0042554 | 0.00047 | 6.90312 | 1 | 6 | 37 | superoxide anion generation |
| GO:0052547 | 0.00048 | 2.24074 | 11 | 24 | 411 | regulation of peptidase activity |
| GO:0030336 | 0.00048 | 2.59223 | 7 | 18 | 268 | negative regulation of cell migration |
| GO:0048858 | 0.00048 | 1.92403 | 19 | 35 | 696 | cell projection morphogenesis |
| GO:0001701 | 0.00049 | 2.06408 | 15 | 29 | 538 | in utero embryonic development |
| GO:0051493 | 0.00049 | 2.06408 | 15 | 29 | 538 | regulation of cytoskeleton organization |
| GO:0043113 | 0.00049 | 4.84541 | 2 | 8 | 67 | receptor clustering |
| GO:0034103 | 0.00050 | 4.29196 | 2 | 9 | 84 | regulation of tissue remodeling |
| GO:0001525 | 0.00050 | 2.09037 | 14 | 28 | 513 | angiogenesis |
| GO:0002824 | 0.00050 | 3.36122 | 4 | 12 | 140 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0050921 | 0.00050 | 3.36122 | 4 | 12 | 140 | positive regulation of chemotaxis |
| GO:1902106 | 0.00051 | 3.89089 | 3 | 10 | 102 | negative regulation of leukocyte differentiation |
| GO:0010468 | 0.00052 | 1.39780 | 106 | 138 | 3860 | regulation of gene expression |
| GO:0009968 | 0.00052 | 1.69486 | 32 | 52 | 1175 | negative regulation of signal transduction |
| GO:0003351 | 0.00052 | 8.90679 | 1 | 5 | 25 | epithelial cilium movement |
| GO:0031529 | 0.00052 | 5.55341 | 1 | 7 | 52 | ruffle organization |
| GO:0031326 | 0.00053 | 1.41504 | 95 | 126 | 3470 | regulation of cellular biosynthetic process |
| GO:0031344 | 0.00053 | 1.86070 | 21 | 38 | 781 | regulation of cell projection organization |
| GO:0021700 | 0.00053 | 2.42718 | 9 | 20 | 317 | developmental maturation |
| GO:0042391 | 0.00053 | 2.18278 | 12 | 25 | 439 | regulation of membrane potential |
| GO:1901342 | 0.00054 | 2.36675 | 9 | 21 | 341 | regulation of vasculature development |
| GO:0002275 | 0.00054 | 4.23529 | 2 | 9 | 85 | myeloid cell activation involved in immune response |
| GO:0043549 | 0.00055 | 1.89081 | 20 | 36 | 728 | regulation of kinase activity |
| GO:0000226 | 0.00055 | 2.02083 | 16 | 30 | 568 | microtubule cytoskeleton organization |
| GO:0007160 | 0.00055 | 2.85141 | 6 | 15 | 204 | cell-matrix adhesion |
| GO:0030851 | 0.00055 | 6.68710 | 1 | 6 | 38 | granulocyte differentiation |
| GO:0045622 | 0.00055 | 6.68710 | 1 | 6 | 38 | regulation of T-helper cell differentiation |
| GO:0010952 | 0.00056 | 3.13019 | 4 | 13 | 162 | positive regulation of peptidase activity |
| GO:0032635 | 0.00056 | 3.13019 | 4 | 13 | 162 | interleukin-6 production |
| GO:0072657 | 0.00056 | 2.04354 | 15 | 29 | 543 | protein localization to membrane |
| GO:0009889 | 0.00057 | 1.40840 | 97 | 128 | 3542 | regulation of biosynthetic process |
| GO:0048732 | 0.00058 | 2.13199 | 13 | 26 | 467 | gland development |
| GO:0055010 | 0.00059 | 5.43244 | 1 | 7 | 53 | ventricular cardiac muscle tissue morphogenesis |
| GO:0010035 | 0.00059 | 2.09627 | 14 | 27 | 493 | response to inorganic substance |
| GO:0007017 | 0.00060 | 1.86312 | 21 | 37 | 759 | microtubule-based process |
| GO:0055080 | 0.00060 | 1.87960 | 20 | 36 | 732 | cation homeostasis |
| GO:0051668 | 0.00062 | 2.93910 | 5 | 14 | 185 | localization within membrane |
| GO:0032528 | 0.00063 | 8.48228 | 1 | 5 | 26 | microvillus organization |
| GO:0070168 | 0.00063 | 8.48228 | 1 | 5 | 26 | negative regulation of biomineral tissue development |
| GO:0002065 | 0.00064 | 3.25879 | 4 | 12 | 144 | columnar/cuboidal epithelial cell differentiation |
| GO:0032350 | 0.00066 | 5.31662 | 1 | 7 | 54 | regulation of hormone metabolic process |
| GO:0034154 | 0.00067 | 26.65512 | 0 | 3 | 7 | toll-like receptor 7 signaling pathway |
| GO:0045409 | 0.00067 | 26.65512 | 0 | 3 | 7 | negative regulation of interleukin-6 biosynthetic process |
| GO:0072603 | 0.00067 | 26.65512 | 0 | 3 | 7 | interleukin-5 secretion |
| GO:0086042 | 0.00067 | 26.65512 | 0 | 3 | 7 | cardiac muscle cell-cardiac muscle cell adhesion |
| GO:2000662 | 0.00067 | 26.65512 | 0 | 3 | 7 | regulation of interleukin-5 secretion |
| GO:2000665 | 0.00067 | 26.65512 | 0 | 3 | 7 | regulation of interleukin-13 secretion |
| GO:0002761 | 0.00068 | 3.45614 | 3 | 11 | 125 | regulation of myeloid leukocyte differentiation |
| GO:0045446 | 0.00069 | 3.72811 | 3 | 10 | 106 | endothelial cell differentiation |
| GO:0032535 | 0.00070 | 2.21970 | 11 | 23 | 397 | regulation of cellular component size |
| GO:0006644 | 0.00070 | 2.31536 | 10 | 21 | 348 | phospholipid metabolic process |
| GO:1904062 | 0.00072 | 2.30820 | 10 | 21 | 349 | regulation of cation transmembrane transport |
| GO:0002369 | 0.00073 | 6.29319 | 1 | 6 | 40 | T cell cytokine production |
| GO:0046456 | 0.00073 | 6.29319 | 1 | 6 | 40 | icosanoid biosynthetic process |
| GO:0001894 | 0.00073 | 2.66238 | 6 | 16 | 232 | tissue homeostasis |
| GO:0048608 | 0.00074 | 2.13034 | 12 | 25 | 449 | reproductive structure development |
| GO:0007423 | 0.00075 | 1.95375 | 17 | 31 | 606 | sensory organ development |
| GO:0002380 | 0.00075 | Inf | 0 | 2 | 2 | immunoglobulin secretion involved in immune response |
| GO:0003366 | 0.00075 | Inf | 0 | 2 | 2 | cell-matrix adhesion involved in ameboidal cell migration |
| GO:0015882 | 0.00075 | Inf | 0 | 2 | 2 | L-ascorbic acid transmembrane transport |
| GO:0070904 | 0.00075 | Inf | 0 | 2 | 2 | transepithelial L-ascorbic acid transport |
| GO:0071460 | 0.00075 | Inf | 0 | 2 | 2 | cellular response to cell-matrix adhesion |
| GO:1905397 | 0.00075 | Inf | 0 | 2 | 2 | activated CD8-positive, alpha-beta T cell apoptotic process |
| GO:1905402 | 0.00075 | Inf | 0 | 2 | 2 | regulation of activated CD8-positive, alpha-beta T cell apoptotic process |
| GO:1905704 | 0.00075 | Inf | 0 | 2 | 2 | positive regulation of inhibitory synapse assembly |
| GO:0002347 | 0.00075 | 8.09637 | 1 | 5 | 27 | response to tumor cell |
| GO:0031342 | 0.00075 | 8.09637 | 1 | 5 | 27 | negative regulation of cell killing |
| GO:0045408 | 0.00075 | 8.09637 | 1 | 5 | 27 | regulation of interleukin-6 biosynthetic process |
| GO:0060713 | 0.00075 | 8.09637 | 1 | 5 | 27 | labyrinthine layer morphogenesis |
| GO:0002821 | 0.00077 | 3.18594 | 4 | 12 | 147 | positive regulation of adaptive immune response |
| GO:0071705 | 0.00077 | 1.49710 | 59 | 83 | 2133 | nitrogen compound transport |
| GO:0048640 | 0.00078 | 3.39625 | 3 | 11 | 127 | negative regulation of developmental growth |
| GO:0060322 | 0.00078 | 1.88654 | 19 | 34 | 688 | head development |
| GO:0010556 | 0.00079 | 1.40702 | 91 | 120 | 3311 | regulation of macromolecule biosynthetic process |
| GO:0035725 | 0.00079 | 3.65170 | 3 | 10 | 108 | sodium ion transmembrane transport |
| GO:0048638 | 0.00080 | 2.19582 | 11 | 23 | 401 | regulation of developmental growth |
| GO:0070588 | 0.00080 | 2.47217 | 8 | 18 | 280 | calcium ion transmembrane transport |
| GO:0045859 | 0.00080 | 1.90285 | 18 | 33 | 662 | regulation of protein kinase activity |
| GO:0120035 | 0.00082 | 1.82908 | 21 | 37 | 772 | regulation of plasma membrane bounded cell projection organization |
| GO:0034765 | 0.00082 | 2.07907 | 13 | 26 | 478 | regulation of ion transmembrane transport |
| GO:0042770 | 0.00083 | 3.97297 | 2 | 9 | 90 | signal transduction in response to DNA damage |
| GO:0002704 | 0.00083 | 5.09916 | 2 | 7 | 56 | negative regulation of leukocyte mediated immunity |
| GO:0051092 | 0.00083 | 3.36707 | 4 | 11 | 128 | positive regulation of NF-kappaB transcription factor activity |
| GO:2000146 | 0.00083 | 2.46266 | 8 | 18 | 281 | negative regulation of cell motility |
| GO:0061458 | 0.00084 | 2.11005 | 12 | 25 | 453 | reproductive system development |
| GO:0045926 | 0.00084 | 2.53658 | 7 | 17 | 258 | negative regulation of growth |
| GO:1904951 | 0.00086 | 2.10503 | 12 | 25 | 454 | positive regulation of establishment of protein localization |
| GO:0090132 | 0.00087 | 2.45323 | 8 | 18 | 282 | epithelium migration |
| GO:0016042 | 0.00088 | 2.38338 | 8 | 19 | 306 | lipid catabolic process |
| GO:0051056 | 0.00088 | 2.52598 | 7 | 17 | 259 | regulation of small GTPase mediated signal transduction |
| GO:1901615 | 0.00090 | 2.06508 | 13 | 26 | 481 | organic hydroxy compound metabolic process |
| GO:0042226 | 0.00090 | 7.74401 | 1 | 5 | 28 | interleukin-6 biosynthetic process |
| GO:0045671 | 0.00090 | 7.74401 | 1 | 5 | 28 | negative regulation of osteoclast differentiation |
| GO:0090087 | 0.00091 | 1.83336 | 21 | 36 | 749 | regulation of peptide transport |
| GO:0051172 | 0.00093 | 1.47397 | 62 | 87 | 2271 | negative regulation of nitrogen compound metabolic process |
| GO:0001667 | 0.00094 | 2.16666 | 11 | 23 | 406 | ameboidal-type cell migration |
| GO:0045165 | 0.00094 | 2.43456 | 8 | 18 | 284 | cell fate commitment |
| GO:0090130 | 0.00094 | 2.43456 | 8 | 18 | 284 | tissue migration |
| GO:0009892 | 0.00094 | 1.42705 | 78 | 105 | 2843 | negative regulation of metabolic process |
| GO:1990138 | 0.00095 | 2.80674 | 5 | 14 | 193 | neuron projection extension |
| GO:0002823 | 0.00095 | 5.94304 | 1 | 6 | 42 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0097178 | 0.00095 | 5.94304 | 1 | 6 | 42 | ruffle assembly |
| GO:1902622 | 0.00095 | 5.94304 | 1 | 6 | 42 | regulation of neutrophil migration |
| GO:0042108 | 0.00095 | 4.33016 | 2 | 8 | 74 | positive regulation of cytokine biosynthetic process |
| GO:0045453 | 0.00095 | 4.33016 | 2 | 8 | 74 | bone resorption |
| GO:1901224 | 0.00095 | 4.33016 | 2 | 8 | 74 | positive regulation of NIK/NF-kappaB signaling |
| GO:0045893 | 0.00098 | 1.56939 | 42 | 63 | 1536 | positive regulation of transcription, DNA-templated |
| GO:0002688 | 0.00098 | 3.54276 | 3 | 10 | 111 | regulation of leukocyte chemotaxis |
| GO:0031328 | 0.00099 | 1.51171 | 52 | 75 | 1903 | positive regulation of cellular biosynthetic process |
| GO:0031401 | 0.00100 | 1.64095 | 33 | 52 | 1210 | positive regulation of protein modification process |
| GO:1903038 | 0.00100 | 3.28246 | 4 | 11 | 131 | negative regulation of leukocyte cell-cell adhesion |
| GO:0010001 | 0.00100 | 2.57800 | 7 | 16 | 239 | glial cell differentiation |
| GO:0030033 | 0.00101 | 10.94831 | 0 | 4 | 17 | microvillus assembly |
| GO:0070231 | 0.00102 | 4.89876 | 2 | 7 | 58 | T cell apoptotic process |
| GO:0051649 | 0.00104 | 1.50902 | 52 | 75 | 1906 | establishment of localization in cell |
| GO:1903508 | 0.00104 | 1.56485 | 42 | 63 | 1540 | positive regulation of nucleic acid-templated transcription |
| GO:0072611 | 0.00104 | 21.32315 | 0 | 3 | 8 | interleukin-13 secretion |
| GO:0051817 | 0.00105 | 3.83057 | 3 | 9 | 93 | modification of morphology or physiology of other organism involved in symbiotic interaction |
| GO:0042100 | 0.00105 | 3.50787 | 3 | 10 | 112 | B cell proliferation |
| GO:1902680 | 0.00106 | 1.56371 | 42 | 63 | 1541 | positive regulation of RNA biosynthetic process |
| GO:1900027 | 0.00106 | 7.42101 | 1 | 5 | 29 | regulation of ruffle assembly |
| GO:0042771 | 0.00108 | 5.78216 | 1 | 6 | 43 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| GO:0009891 | 0.00113 | 1.49971 | 53 | 76 | 1943 | positive regulation of biosynthetic process |
| GO:0030324 | 0.00113 | 2.63998 | 6 | 15 | 219 | lung development |
| GO:0034762 | 0.00114 | 1.94655 | 16 | 29 | 568 | regulation of transmembrane transport |
| GO:0055074 | 0.00114 | 2.02866 | 13 | 26 | 489 | calcium ion homeostasis |
| GO:0055008 | 0.00114 | 4.20243 | 2 | 8 | 76 | cardiac muscle tissue morphogenesis |
| GO:0006066 | 0.00119 | 2.31792 | 9 | 19 | 314 | alcohol metabolic process |
| GO:0048469 | 0.00121 | 2.72986 | 5 | 14 | 198 | cell maturation |
| GO:0007265 | 0.00122 | 2.12157 | 11 | 23 | 414 | Ras protein signal transduction |
| GO:0045582 | 0.00122 | 3.74115 | 3 | 9 | 95 | positive regulation of T cell differentiation |
| GO:0031346 | 0.00124 | 2.04664 | 13 | 25 | 466 | positive regulation of cell projection organization |
| GO:0002724 | 0.00125 | 7.12385 | 1 | 5 | 30 | regulation of T cell cytokine production |
| GO:0032673 | 0.00125 | 7.12385 | 1 | 5 | 30 | regulation of interleukin-4 production |
| GO:0046850 | 0.00125 | 4.71348 | 2 | 7 | 60 | regulation of bone remodeling |
| GO:2000319 | 0.00127 | 10.16584 | 0 | 4 | 18 | regulation of T-helper 17 cell differentiation |
| GO:0035023 | 0.00128 | 3.17600 | 4 | 11 | 135 | regulation of Rho protein signal transduction |
| GO:0006898 | 0.00130 | 2.60137 | 6 | 15 | 222 | receptor-mediated endocytosis |
| GO:0030323 | 0.00130 | 2.60137 | 6 | 15 | 222 | respiratory tube development |
| GO:0034613 | 0.00130 | 1.52875 | 46 | 67 | 1676 | cellular protein localization |
| GO:0030279 | 0.00131 | 3.69799 | 3 | 9 | 96 | negative regulation of ossification |
| GO:0010038 | 0.00133 | 2.42466 | 7 | 17 | 269 | response to metal ion |
| GO:0060249 | 0.00135 | 2.14305 | 11 | 22 | 392 | anatomical structure homeostasis |
| GO:2001056 | 0.00136 | 3.15046 | 4 | 11 | 136 | positive regulation of cysteine-type endopeptidase activity |
| GO:0042058 | 0.00138 | 4.62599 | 2 | 7 | 61 | regulation of epidermal growth factor receptor signaling pathway |
| GO:0010769 | 0.00140 | 2.22920 | 9 | 20 | 343 | regulation of cell morphogenesis involved in differentiation |
| GO:0002444 | 0.00141 | 3.65580 | 3 | 9 | 97 | myeloid leukocyte mediated immunity |
| GO:0070167 | 0.00141 | 3.65580 | 3 | 9 | 97 | regulation of biomineral tissue development |
| GO:0072503 | 0.00143 | 1.99348 | 14 | 26 | 497 | cellular divalent inorganic cation homeostasis |
| GO:0043087 | 0.00144 | 2.33673 | 8 | 18 | 295 | regulation of GTPase activity |
| GO:0002244 | 0.00145 | 2.94446 | 4 | 12 | 158 | hematopoietic progenitor cell differentiation |
| GO:0050777 | 0.00145 | 2.94446 | 4 | 12 | 158 | negative regulation of immune response |
| GO:0001932 | 0.00145 | 1.56953 | 39 | 58 | 1410 | regulation of protein phosphorylation |
| GO:0045932 | 0.00145 | 6.84956 | 1 | 5 | 31 | negative regulation of muscle contraction |
| GO:0098884 | 0.00145 | 6.84956 | 1 | 5 | 31 | postsynaptic neurotransmitter receptor internalization |
| GO:0140239 | 0.00145 | 6.84956 | 1 | 5 | 31 | postsynaptic endocytosis |
| GO:0003208 | 0.00146 | 4.02432 | 2 | 8 | 79 | cardiac ventricle morphogenesis |
| GO:0002697 | 0.00147 | 2.08894 | 12 | 23 | 420 | regulation of immune effector process |
| GO:0006650 | 0.00148 | 2.56386 | 6 | 15 | 225 | glycerophospholipid metabolic process |
| GO:0010632 | 0.00148 | 2.56386 | 6 | 15 | 225 | regulation of epithelial cell migration |
| GO:0032409 | 0.00150 | 2.39581 | 7 | 17 | 272 | regulation of transporter activity |
| GO:0060485 | 0.00150 | 2.39581 | 7 | 17 | 272 | mesenchyme development |
| GO:0010959 | 0.00151 | 2.08360 | 12 | 23 | 421 | regulation of metal ion transport |
| GO:0070727 | 0.00151 | 1.51858 | 46 | 67 | 1686 | cellular macromolecule localization |
| GO:0042102 | 0.00152 | 3.61457 | 3 | 9 | 98 | positive regulation of T cell proliferation |
| GO:0003229 | 0.00152 | 4.54168 | 2 | 7 | 62 | ventricular cardiac muscle tissue development |
| GO:0009967 | 0.00153 | 1.54798 | 41 | 61 | 1504 | positive regulation of signal transduction |
| GO:0001767 | 0.00153 | 17.76850 | 0 | 3 | 9 | establishment of lymphocyte polarity |
| GO:0001768 | 0.00153 | 17.76850 | 0 | 3 | 9 | establishment of T cell polarity |
| GO:0008354 | 0.00153 | 17.76850 | 0 | 3 | 9 | germ cell migration |
| GO:0032836 | 0.00153 | 17.76850 | 0 | 3 | 9 | glomerular basement membrane development |
| GO:0045586 | 0.00153 | 17.76850 | 0 | 3 | 9 | regulation of gamma-delta T cell differentiation |
| GO:0046643 | 0.00153 | 17.76850 | 0 | 3 | 9 | regulation of gamma-delta T cell activation |
| GO:0019751 | 0.00156 | 3.31210 | 3 | 10 | 118 | polyol metabolic process |
| GO:0002726 | 0.00158 | 9.48770 | 1 | 4 | 19 | positive regulation of T cell cytokine production |
| GO:0030502 | 0.00158 | 9.48770 | 1 | 4 | 19 | negative regulation of bone mineralization |
| GO:0045076 | 0.00158 | 9.48770 | 1 | 4 | 19 | regulation of interleukin-2 biosynthetic process |
| GO:0060088 | 0.00158 | 9.48770 | 1 | 4 | 19 | auditory receptor cell stereocilium organization |
| GO:0031214 | 0.00161 | 2.90441 | 4 | 12 | 160 | biomineral tissue development |
| GO:0009607 | 0.00162 | 1.60811 | 33 | 51 | 1208 | response to biotic stimulus |
| GO:0016331 | 0.00163 | 2.75729 | 5 | 13 | 182 | morphogenesis of embryonic epithelium |
| GO:0007417 | 0.00163 | 1.71357 | 24 | 40 | 888 | central nervous system development |
| GO:0051338 | 0.00166 | 1.73712 | 23 | 38 | 832 | regulation of transferase activity |
| GO:0048598 | 0.00166 | 1.85119 | 18 | 31 | 637 | embryonic morphogenesis |
| GO:0003158 | 0.00167 | 3.28157 | 3 | 10 | 119 | endothelium development |
| GO:0031929 | 0.00167 | 3.28157 | 3 | 10 | 119 | TOR signaling |
| GO:0002712 | 0.00167 | 4.46038 | 2 | 7 | 63 | regulation of B cell mediated immunity |
| GO:0002889 | 0.00167 | 4.46038 | 2 | 7 | 63 | regulation of immunoglobulin mediated immune response |
| GO:0030330 | 0.00167 | 4.46038 | 2 | 7 | 63 | DNA damage response, signal transduction by p53 class mediator |
| GO:0032722 | 0.00167 | 4.46038 | 2 | 7 | 63 | positive regulation of chemokine production |
| GO:0032689 | 0.00168 | 6.59558 | 1 | 5 | 32 | negative regulation of interferon-gamma production |
| GO:0060561 | 0.00168 | 6.59558 | 1 | 5 | 32 | apoptotic process involved in morphogenesis |
| GO:0060669 | 0.00168 | 6.59558 | 1 | 5 | 32 | embryonic placenta morphogenesis |
| GO:0007018 | 0.00168 | 2.36764 | 8 | 17 | 275 | microtubule-based movement |
| GO:0002820 | 0.00174 | 5.21712 | 1 | 6 | 47 | negative regulation of adaptive immune response |
| GO:0002702 | 0.00175 | 3.53481 | 3 | 9 | 100 | positive regulation of production of molecular mediator of immune response |
| GO:0032006 | 0.00175 | 3.53481 | 3 | 9 | 100 | regulation of TOR signaling |
| GO:2001141 | 0.00177 | 1.40119 | 77 | 102 | 2801 | regulation of RNA biosynthetic process |
| GO:0043066 | 0.00178 | 1.69288 | 25 | 41 | 921 | negative regulation of apoptotic process |
| GO:0001909 | 0.00182 | 3.02861 | 4 | 11 | 141 | leukocyte mediated cytotoxicity |
| GO:0031532 | 0.00187 | 3.49623 | 3 | 9 | 101 | actin cytoskeleton reorganization |
| GO:0034446 | 0.00187 | 3.49623 | 3 | 9 | 101 | substrate adhesion-dependent cell spreading |
| GO:0032412 | 0.00188 | 2.41390 | 7 | 16 | 254 | regulation of ion transmembrane transporter activity |
| GO:0001764 | 0.00189 | 2.70884 | 5 | 13 | 185 | neuron migration |
| GO:0090066 | 0.00191 | 1.89799 | 15 | 28 | 561 | regulation of anatomical structure size |
| GO:1903708 | 0.00192 | 2.58799 | 6 | 14 | 208 | positive regulation of hemopoiesis |
| GO:0060487 | 0.00194 | 6.35974 | 1 | 5 | 33 | lung epithelial cell differentiation |
| GO:0071902 | 0.00196 | 2.33107 | 8 | 17 | 279 | positive regulation of protein serine/threonine kinase activity |
| GO:0072659 | 0.00196 | 2.33107 | 8 | 17 | 279 | protein localization to plasma membrane |
| GO:0045862 | 0.00196 | 2.21151 | 9 | 19 | 328 | positive regulation of proteolysis |
| GO:0046849 | 0.00200 | 3.45849 | 3 | 9 | 102 | bone remodeling |
| GO:0002381 | 0.00201 | 4.30619 | 2 | 7 | 65 | immunoglobulin production involved in immunoglobulin mediated immune response |
| GO:0008544 | 0.00203 | 2.20427 | 9 | 19 | 329 | epidermis development |
| GO:0010631 | 0.00204 | 2.32210 | 8 | 17 | 280 | epithelial cell migration |
| GO:0001558 | 0.00204 | 2.03161 | 12 | 23 | 431 | regulation of cell growth |
| GO:0006355 | 0.00211 | 1.39425 | 77 | 101 | 2784 | regulation of transcription, DNA-templated |
| GO:0002934 | 0.00215 | 15.22947 | 0 | 3 | 10 | desmosome organization |
| GO:0010692 | 0.00215 | 15.22947 | 0 | 3 | 10 | regulation of alkaline phosphatase activity |
| GO:0060297 | 0.00215 | 15.22947 | 0 | 3 | 10 | regulation of sarcomere organization |
| GO:1903011 | 0.00215 | 15.22947 | 0 | 3 | 10 | negative regulation of bone development |
| GO:1905522 | 0.00215 | 15.22947 | 0 | 3 | 10 | negative regulation of macrophage migration |
| GO:2000318 | 0.00215 | 15.22947 | 0 | 3 | 10 | positive regulation of T-helper 17 type immune response |
| GO:0035088 | 0.00216 | 4.97402 | 1 | 6 | 49 | establishment or maintenance of apical/basal cell polarity |
| GO:0061245 | 0.00216 | 4.97402 | 1 | 6 | 49 | establishment or maintenance of bipolar cell polarity |
| GO:0006970 | 0.00217 | 3.75873 | 2 | 8 | 84 | response to osmotic stress |
| GO:0018193 | 0.00221 | 1.60493 | 31 | 48 | 1137 | peptidyl-amino acid modification |
| GO:0060479 | 0.00222 | 6.14016 | 1 | 5 | 34 | lung cell differentiation |
| GO:0002652 | 0.00222 | 70.97799 | 0 | 2 | 3 | regulation of tolerance induction dependent upon immune response |
| GO:0002856 | 0.00222 | 70.97799 | 0 | 2 | 3 | negative regulation of natural killer cell mediated immune response to tumor cell |
| GO:0002859 | 0.00222 | 70.97799 | 0 | 2 | 3 | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
| GO:0010979 | 0.00222 | 70.97799 | 0 | 2 | 3 | regulation of vitamin D 24-hydroxylase activity |
| GO:0010980 | 0.00222 | 70.97799 | 0 | 2 | 3 | positive regulation of vitamin D 24-hydroxylase activity |
| GO:0036151 | 0.00222 | 70.97799 | 0 | 2 | 3 | phosphatidylcholine acyl-chain remodeling |
| GO:0045658 | 0.00222 | 70.97799 | 0 | 2 | 3 | regulation of neutrophil differentiation |
| GO:0060671 | 0.00222 | 70.97799 | 0 | 2 | 3 | epithelial cell differentiation involved in embryonic placenta development |
| GO:0060672 | 0.00222 | 70.97799 | 0 | 2 | 3 | epithelial cell morphogenesis involved in placental branching |
| GO:0070488 | 0.00222 | 70.97799 | 0 | 2 | 3 | neutrophil aggregation |
| GO:1905702 | 0.00222 | 70.97799 | 0 | 2 | 3 | regulation of inhibitory synapse assembly |
| GO:2000182 | 0.00222 | 70.97799 | 0 | 2 | 3 | regulation of progesterone biosynthetic process |
| GO:0051252 | 0.00224 | 1.37590 | 84 | 109 | 3049 | regulation of RNA metabolic process |
| GO:0045666 | 0.00228 | 1.97989 | 13 | 24 | 461 | positive regulation of neuron differentiation |
| GO:0007009 | 0.00229 | 3.38537 | 3 | 9 | 104 | plasma membrane organization |
| GO:0015031 | 0.00230 | 1.48547 | 48 | 68 | 1746 | protein transport |
| GO:1903506 | 0.00230 | 1.38954 | 77 | 101 | 2792 | regulation of nucleic acid-templated transcription |
| GO:0050678 | 0.00231 | 2.12884 | 10 | 20 | 358 | regulation of epithelial cell proliferation |
| GO:0044057 | 0.00232 | 1.84807 | 16 | 29 | 596 | regulation of system process |
| GO:0042094 | 0.00233 | 8.37076 | 1 | 4 | 21 | interleukin-2 biosynthetic process |
| GO:2001224 | 0.00233 | 8.37076 | 1 | 4 | 21 | positive regulation of neuron migration |
| GO:0048738 | 0.00238 | 2.35391 | 7 | 16 | 260 | cardiac muscle tissue development |
| GO:0051223 | 0.00239 | 1.76945 | 19 | 33 | 708 | regulation of protein transport |
| GO:0001885 | 0.00239 | 4.16228 | 2 | 7 | 67 | endothelial cell development |
| GO:0042491 | 0.00240 | 4.86076 | 1 | 6 | 50 | inner ear auditory receptor cell differentiation |
| GO:0045124 | 0.00240 | 4.86076 | 1 | 6 | 50 | regulation of bone resorption |
| GO:0050891 | 0.00240 | 4.86076 | 1 | 6 | 50 | multicellular organismal water homeostasis |
| GO:0071622 | 0.00240 | 4.86076 | 1 | 6 | 50 | regulation of granulocyte chemotaxis |
| GO:0033993 | 0.00243 | 1.70866 | 23 | 37 | 822 | response to lipid |
| GO:0019219 | 0.00246 | 1.35691 | 92 | 118 | 3352 | regulation of nucleobase-containing compound metabolic process |
| GO:0050773 | 0.00250 | 2.61683 | 5 | 13 | 191 | regulation of dendrite development |
| GO:0008610 | 0.00252 | 1.88140 | 15 | 27 | 545 | lipid biosynthetic process |
| GO:2000249 | 0.00253 | 5.93523 | 1 | 5 | 35 | regulation of actin cytoskeleton reorganization |
| GO:0006873 | 0.00254 | 1.79632 | 18 | 31 | 655 | cellular ion homeostasis |
| GO:0045444 | 0.00256 | 2.41300 | 7 | 15 | 238 | fat cell differentiation |
| GO:0022898 | 0.00257 | 2.33456 | 7 | 16 | 262 | regulation of transmembrane transporter activity |
| GO:0070201 | 0.00260 | 1.74344 | 20 | 34 | 740 | regulation of establishment of protein localization |
| GO:0046474 | 0.00261 | 3.31528 | 3 | 9 | 106 | glycerophospholipid biosynthetic process |
| GO:0009890 | 0.00262 | 1.51325 | 41 | 60 | 1509 | negative regulation of biosynthetic process |
| GO:0045912 | 0.00265 | 4.75253 | 1 | 6 | 51 | negative regulation of carbohydrate metabolic process |
| GO:0003231 | 0.00266 | 2.87297 | 4 | 11 | 148 | cardiac ventricle development |
| GO:0090257 | 0.00266 | 2.40212 | 7 | 15 | 239 | regulation of muscle system process |
| GO:0001890 | 0.00267 | 2.71938 | 5 | 12 | 170 | placenta development |
| GO:0010811 | 0.00270 | 3.05610 | 3 | 10 | 127 | positive regulation of cell-substrate adhesion |
| GO:0014065 | 0.00270 | 3.05610 | 3 | 10 | 127 | phosphatidylinositol 3-kinase signaling |
| GO:0061387 | 0.00270 | 3.05610 | 3 | 10 | 127 | regulation of extent of cell growth |
| GO:0002690 | 0.00271 | 3.61551 | 2 | 8 | 87 | positive regulation of leukocyte chemotaxis |
| GO:0010717 | 0.00271 | 3.61551 | 2 | 8 | 87 | regulation of epithelial to mesenchymal transition |
| GO:0048762 | 0.00272 | 2.48461 | 6 | 14 | 216 | mesenchymal cell differentiation |
| GO:0002834 | 0.00279 | 7.90536 | 1 | 4 | 22 | regulation of response to tumor cell |
| GO:0002837 | 0.00279 | 7.90536 | 1 | 4 | 22 | regulation of immune response to tumor cell |
| GO:0036314 | 0.00279 | 7.90536 | 1 | 4 | 22 | response to sterol |
| GO:0006766 | 0.00283 | 4.02766 | 2 | 7 | 69 | vitamin metabolic process |
| GO:0043299 | 0.00283 | 4.02766 | 2 | 7 | 69 | leukocyte degranulation |
| GO:0043547 | 0.00284 | 2.47226 | 6 | 14 | 217 | positive regulation of GTPase activity |
| GO:0034097 | 0.00285 | 1.62519 | 28 | 43 | 1004 | response to cytokine |
| GO:0051254 | 0.00286 | 1.48745 | 45 | 64 | 1638 | positive regulation of RNA metabolic process |
| GO:0002923 | 0.00289 | 13.32520 | 0 | 3 | 11 | regulation of humoral immune response mediated by circulating immunoglobulin |
| GO:0035739 | 0.00289 | 13.32520 | 0 | 3 | 11 | CD4-positive, alpha-beta T cell proliferation |
| GO:0086016 | 0.00289 | 13.32520 | 0 | 3 | 11 | AV node cell action potential |
| GO:0086027 | 0.00289 | 13.32520 | 0 | 3 | 11 | AV node cell to bundle of His cell signaling |
| GO:2000561 | 0.00289 | 13.32520 | 0 | 3 | 11 | regulation of CD4-positive, alpha-beta T cell proliferation |
| GO:0032642 | 0.00291 | 3.57016 | 2 | 8 | 88 | regulation of chemokine production |
| GO:1901570 | 0.00293 | 4.64901 | 1 | 6 | 52 | fatty acid derivative biosynthetic process |
| GO:2001222 | 0.00293 | 4.64901 | 1 | 6 | 52 | regulation of neuron migration |
| GO:0007420 | 0.00297 | 1.79461 | 17 | 30 | 634 | brain development |
| GO:0007605 | 0.00298 | 2.29680 | 7 | 16 | 266 | sensory perception of sound |
| GO:0007266 | 0.00299 | 2.55886 | 5 | 13 | 195 | Rho protein signal transduction |
| GO:0050778 | 0.00301 | 1.72577 | 21 | 34 | 747 | positive regulation of immune response |
| GO:0045664 | 0.00305 | 1.71004 | 21 | 35 | 776 | regulation of neuron differentiation |
| GO:0002090 | 0.00308 | 3.96355 | 2 | 7 | 70 | regulation of receptor internalization |
| GO:0060537 | 0.00308 | 1.93032 | 13 | 24 | 472 | muscle tissue development |
| GO:0050878 | 0.00312 | 2.11432 | 9 | 19 | 342 | regulation of body fluid levels |
| GO:0007229 | 0.00312 | 3.52593 | 2 | 8 | 89 | integrin-mediated signaling pathway |
| GO:0060415 | 0.00312 | 3.52593 | 2 | 8 | 89 | muscle tissue morphogenesis |
| GO:1904063 | 0.00312 | 3.52593 | 2 | 8 | 89 | negative regulation of cation transmembrane transport |
| GO:1905954 | 0.00312 | 3.52593 | 2 | 8 | 89 | positive regulation of lipid localization |
| GO:0032649 | 0.00315 | 3.21539 | 3 | 9 | 109 | regulation of interferon-gamma production |
| GO:0048259 | 0.00315 | 3.21539 | 3 | 9 | 109 | regulation of receptor-mediated endocytosis |
| GO:0006874 | 0.00316 | 1.92593 | 13 | 24 | 473 | cellular calcium ion homeostasis |
| GO:0045935 | 0.00321 | 1.45462 | 50 | 70 | 1833 | positive regulation of nucleobase-containing compound metabolic process |
| GO:0098815 | 0.00323 | 4.54989 | 1 | 6 | 53 | modulation of excitatory postsynaptic potential |
| GO:0032633 | 0.00325 | 5.56378 | 1 | 5 | 37 | interleukin-4 production |
| GO:0046470 | 0.00325 | 5.56378 | 1 | 5 | 37 | phosphatidylcholine metabolic process |
| GO:0046640 | 0.00325 | 5.56378 | 1 | 5 | 37 | regulation of alpha-beta T cell proliferation |
| GO:0071158 | 0.00325 | 5.56378 | 1 | 5 | 37 | positive regulation of cell cycle arrest |
| GO:0086065 | 0.00325 | 5.56378 | 1 | 5 | 37 | cell communication involved in cardiac conduction |
| GO:2000463 | 0.00325 | 5.56378 | 1 | 5 | 37 | positive regulation of excitatory postsynaptic potential |
| GO:0048562 | 0.00325 | 2.15535 | 9 | 18 | 318 | embryonic organ morphogenesis |
| GO:0002093 | 0.00330 | 7.48896 | 1 | 4 | 23 | auditory receptor cell morphogenesis |
| GO:0035743 | 0.00330 | 7.48896 | 1 | 4 | 23 | CD4-positive, alpha-beta T cell cytokine production |
| GO:2000316 | 0.00330 | 7.48896 | 1 | 4 | 23 | regulation of T-helper 17 type immune response |
| GO:0032413 | 0.00333 | 3.90145 | 2 | 7 | 71 | negative regulation of ion transmembrane transporter activity |
| GO:0006357 | 0.00334 | 1.43453 | 55 | 75 | 1993 | regulation of transcription by RNA polymerase II |
| GO:0001843 | 0.00335 | 3.18341 | 3 | 9 | 110 | neural tube closure |
| GO:0007156 | 0.00335 | 3.18341 | 3 | 9 | 110 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0010876 | 0.00336 | 2.05474 | 10 | 20 | 370 | lipid localization |
| GO:0014706 | 0.00340 | 1.94419 | 12 | 23 | 449 | striated muscle tissue development |
| GO:0031334 | 0.00349 | 2.32859 | 7 | 15 | 246 | positive regulation of protein complex assembly |
| GO:0032774 | 0.00351 | 1.36338 | 80 | 103 | 2896 | RNA biosynthetic process |
| GO:0035148 | 0.00355 | 2.61918 | 5 | 12 | 176 | tube formation |
| GO:0050922 | 0.00355 | 4.45491 | 1 | 6 | 54 | negative regulation of chemotaxis |
| GO:0086001 | 0.00355 | 4.45491 | 1 | 6 | 54 | cardiac muscle cell action potential |
| GO:0044242 | 0.00355 | 2.50338 | 5 | 13 | 199 | cellular lipid catabolic process |
| GO:0021782 | 0.00356 | 3.15206 | 3 | 9 | 111 | glial cell development |
| GO:0060606 | 0.00356 | 3.15206 | 3 | 9 | 111 | tube closure |
| GO:0090287 | 0.00358 | 2.25126 | 7 | 16 | 271 | regulation of cellular response to growth factor stimulus |
| GO:0002028 | 0.00358 | 3.44066 | 3 | 8 | 91 | regulation of sodium ion transport |
| GO:0032652 | 0.00358 | 3.44066 | 3 | 8 | 91 | regulation of interleukin-1 production |
| GO:0045944 | 0.00359 | 1.54710 | 34 | 50 | 1226 | positive regulation of transcription by RNA polymerase II |
| GO:0050954 | 0.00361 | 2.18737 | 8 | 17 | 296 | sensory perception of mechanical stimulus |
| GO:0001838 | 0.00361 | 2.75169 | 4 | 11 | 154 | embryonic epithelial tube formation |
| GO:0010506 | 0.00363 | 2.31845 | 7 | 15 | 247 | regulation of autophagy |
| GO:0006636 | 0.00366 | 5.39494 | 1 | 5 | 38 | unsaturated fatty acid biosynthetic process |
| GO:0016339 | 0.00366 | 5.39494 | 1 | 5 | 38 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0099590 | 0.00366 | 5.39494 | 1 | 5 | 38 | neurotransmitter receptor internalization |
| GO:0031327 | 0.00368 | 1.49745 | 40 | 58 | 1471 | negative regulation of cellular biosynthetic process |
| GO:0061564 | 0.00370 | 1.87305 | 14 | 25 | 506 | axon development |
| GO:0051235 | 0.00371 | 2.12661 | 9 | 18 | 322 | maintenance of location |
| GO:0032026 | 0.00378 | 11.84409 | 0 | 3 | 12 | response to magnesium ion |
| GO:0043312 | 0.00378 | 11.84409 | 0 | 3 | 12 | neutrophil degranulation |
| GO:0045086 | 0.00378 | 11.84409 | 0 | 3 | 12 | positive regulation of interleukin-2 biosynthetic process |
| GO:0060430 | 0.00378 | 11.84409 | 0 | 3 | 12 | lung saccule development |
| GO:0016525 | 0.00378 | 3.12132 | 3 | 9 | 112 | negative regulation of angiogenesis |
| GO:0030516 | 0.00378 | 3.12132 | 3 | 9 | 112 | regulation of axon extension |
| GO:0032602 | 0.00383 | 3.39955 | 3 | 8 | 92 | chemokine production |
| GO:0002418 | 0.00388 | 7.11420 | 1 | 4 | 24 | immune response to tumor cell |
| GO:0019048 | 0.00388 | 7.11420 | 1 | 4 | 24 | modulation by virus of host morphology or physiology |
| GO:0032753 | 0.00388 | 7.11420 | 1 | 4 | 24 | positive regulation of interleukin-4 production |
| GO:0034104 | 0.00388 | 7.11420 | 1 | 4 | 24 | negative regulation of tissue remodeling |
| GO:0097186 | 0.00388 | 7.11420 | 1 | 4 | 24 | amelogenesis |
| GO:0035315 | 0.00390 | 4.36379 | 2 | 6 | 55 | hair cell differentiation |
| GO:0050732 | 0.00390 | 4.36379 | 2 | 6 | 55 | negative regulation of peptidyl-tyrosine phosphorylation |
| GO:0051851 | 0.00390 | 3.78288 | 2 | 7 | 73 | modification by host of symbiont morphology or physiology |
| GO:0051704 | 0.00394 | 1.39032 | 66 | 87 | 2389 | multi-organism process |
| GO:0006351 | 0.00396 | 1.35872 | 79 | 102 | 2875 | transcription, DNA-templated |
| GO:0051707 | 0.00396 | 1.55242 | 32 | 48 | 1172 | response to other organism |
| GO:0055123 | 0.00397 | 2.88268 | 4 | 10 | 134 | digestive system development |
| GO:0010605 | 0.00401 | 1.37562 | 71 | 93 | 2584 | negative regulation of macromolecule metabolic process |
| GO:0043207 | 0.00409 | 1.54952 | 32 | 48 | 1174 | response to external biotic stimulus |
| GO:0009620 | 0.00411 | 5.23604 | 1 | 5 | 39 | response to fungus |
| GO:0046885 | 0.00411 | 5.23604 | 1 | 5 | 39 | regulation of hormone biosynthetic process |
| GO:0010594 | 0.00418 | 2.69478 | 4 | 11 | 157 | regulation of endothelial cell migration |
| GO:0002066 | 0.00420 | 3.72626 | 2 | 7 | 74 | columnar/cuboidal epithelial cell development |
| GO:0097327 | 0.00420 | 3.72626 | 2 | 7 | 74 | response to antineoplastic agent |
| GO:0030104 | 0.00426 | 4.27633 | 2 | 6 | 56 | water homeostasis |
| GO:0008202 | 0.00426 | 2.14837 | 8 | 17 | 301 | steroid metabolic process |
| GO:0090596 | 0.00426 | 2.14837 | 8 | 17 | 301 | sensory organ morphogenesis |
| GO:0050803 | 0.00427 | 2.20747 | 8 | 16 | 276 | regulation of synapse structure or activity |
| GO:0097659 | 0.00430 | 1.35426 | 79 | 102 | 2883 | nucleic acid-templated transcription |
| GO:0002924 | 0.00436 | 35.48742 | 0 | 2 | 4 | negative regulation of humoral immune response mediated by circulating immunoglobulin |
| GO:0033326 | 0.00436 | 35.48742 | 0 | 2 | 4 | cerebrospinal fluid secretion |
| GO:0060214 | 0.00436 | 35.48742 | 0 | 2 | 4 | endocardium formation |
| GO:0061218 | 0.00436 | 35.48742 | 0 | 2 | 4 | negative regulation of mesonephros development |
| GO:0061884 | 0.00436 | 35.48742 | 0 | 2 | 4 | regulation of mini excitatory postsynaptic potential |
| GO:0071896 | 0.00436 | 35.48742 | 0 | 2 | 4 | protein localization to adherens junction |
| GO:0098816 | 0.00436 | 35.48742 | 0 | 2 | 4 | mini excitatory postsynaptic potential |
| GO:0098904 | 0.00436 | 35.48742 | 0 | 2 | 4 | regulation of AV node cell action potential |
| GO:1900126 | 0.00436 | 35.48742 | 0 | 2 | 4 | negative regulation of hyaluronan biosynthetic process |
| GO:1903903 | 0.00436 | 35.48742 | 0 | 2 | 4 | regulation of establishment of T cell polarity |
| GO:1903936 | 0.00436 | 35.48742 | 0 | 2 | 4 | cellular response to sodium arsenite |
| GO:2000520 | 0.00436 | 35.48742 | 0 | 2 | 4 | regulation of immunological synapse formation |
| GO:2000667 | 0.00436 | 35.48742 | 0 | 2 | 4 | positive regulation of interleukin-13 secretion |
| GO:0051051 | 0.00436 | 1.82316 | 15 | 26 | 540 | negative regulation of transport |
| GO:0002709 | 0.00437 | 3.32019 | 3 | 8 | 94 | regulation of T cell mediated immunity |
| GO:1904018 | 0.00438 | 2.43730 | 6 | 13 | 204 | positive regulation of vasculature development |
| GO:0006941 | 0.00439 | 2.67633 | 4 | 11 | 158 | striated muscle contraction |
| GO:1903707 | 0.00439 | 2.67633 | 4 | 11 | 158 | negative regulation of hemopoiesis |
| GO:0046578 | 0.00441 | 2.34403 | 6 | 14 | 228 | regulation of Ras protein signal transduction |
| GO:0048863 | 0.00441 | 2.34403 | 6 | 14 | 228 | stem cell differentiation |
| GO:0001516 | 0.00452 | 6.77512 | 1 | 4 | 25 | prostaglandin biosynthetic process |
| GO:0031629 | 0.00452 | 6.77512 | 1 | 4 | 25 | synaptic vesicle fusion to presynaptic active zone membrane |
| GO:0032703 | 0.00452 | 6.77512 | 1 | 4 | 25 | negative regulation of interleukin-2 production |
| GO:0046457 | 0.00452 | 6.77512 | 1 | 4 | 25 | prostanoid biosynthetic process |
| GO:0050832 | 0.00452 | 6.77512 | 1 | 4 | 25 | defense response to fungus |
| GO:0086019 | 0.00452 | 6.77512 | 1 | 4 | 25 | cell-cell signaling involved in cardiac conduction |
| GO:0060563 | 0.00453 | 3.67130 | 2 | 7 | 75 | neuroepithelial cell differentiation |
| GO:0030225 | 0.00459 | 5.08621 | 1 | 5 | 40 | macrophage differentiation |
| GO:0045911 | 0.00459 | 5.08621 | 1 | 5 | 40 | positive regulation of DNA recombination |
| GO:0046633 | 0.00459 | 5.08621 | 1 | 5 | 40 | alpha-beta T cell proliferation |
| GO:0110111 | 0.00459 | 5.08621 | 1 | 5 | 40 | negative regulation of animal organ morphogenesis |
| GO:0033043 | 0.00461 | 1.52519 | 34 | 50 | 1242 | regulation of organelle organization |
| GO:0002456 | 0.00464 | 2.81421 | 4 | 10 | 137 | T cell mediated immunity |
| GO:2000112 | 0.00465 | 1.33397 | 88 | 112 | 3219 | regulation of cellular macromolecule biosynthetic process |
| GO:2000181 | 0.00477 | 3.00410 | 3 | 9 | 116 | negative regulation of blood vessel morphogenesis |
| GO:0000122 | 0.00479 | 1.63310 | 24 | 37 | 857 | negative regulation of transcription by RNA polymerase II |
| GO:0003157 | 0.00481 | 10.65921 | 0 | 3 | 13 | endocardium development |
| GO:0033280 | 0.00481 | 10.65921 | 0 | 3 | 13 | response to vitamin D |
| GO:0042482 | 0.00481 | 10.65921 | 0 | 3 | 13 | positive regulation of odontogenesis |
| GO:0086067 | 0.00481 | 10.65921 | 0 | 3 | 13 | AV node cell to bundle of His cell communication |
| GO:1904181 | 0.00481 | 10.65921 | 0 | 3 | 13 | positive regulation of membrane depolarization |
| GO:2001054 | 0.00481 | 10.65921 | 0 | 3 | 13 | negative regulation of mesenchymal cell apoptotic process |
| GO:0035821 | 0.00482 | 2.64017 | 4 | 11 | 160 | modification of morphology or physiology of other organism |
| GO:1902533 | 0.00485 | 1.58129 | 28 | 42 | 1005 | positive regulation of intracellular signal transduction |
| GO:0048844 | 0.00487 | 3.61793 | 2 | 7 | 76 | artery morphogenesis |
| GO:0070228 | 0.00487 | 3.61793 | 2 | 7 | 76 | regulation of lymphocyte apoptotic process |
| GO:0014020 | 0.00504 | 2.97615 | 3 | 9 | 117 | primary neural tube formation |
| GO:0045055 | 0.00504 | 2.23097 | 7 | 15 | 256 | regulated exocytosis |
| GO:0072175 | 0.00505 | 2.62246 | 4 | 11 | 161 | epithelial tube formation |
| GO:0098900 | 0.00508 | 4.11149 | 2 | 6 | 58 | regulation of action potential |
| GO:0002832 | 0.00511 | 4.94471 | 1 | 5 | 41 | negative regulation of response to biotic stimulus |
| GO:0060122 | 0.00511 | 4.94471 | 1 | 5 | 41 | inner ear receptor cell stereocilium organization |
| GO:0010975 | 0.00518 | 1.75600 | 17 | 28 | 603 | regulation of neuron projection development |
| GO:1901700 | 0.00522 | 1.45599 | 44 | 61 | 1589 | response to oxygen-containing compound |
| GO:0050927 | 0.00523 | 6.46688 | 1 | 4 | 26 | positive regulation of positive chemotaxis |
| GO:0070233 | 0.00523 | 6.46688 | 1 | 4 | 26 | negative regulation of T cell apoptotic process |
| GO:0072574 | 0.00523 | 6.46688 | 1 | 4 | 26 | hepatocyte proliferation |
| GO:0072575 | 0.00523 | 6.46688 | 1 | 4 | 26 | epithelial cell proliferation involved in liver morphogenesis |
| GO:0099500 | 0.00523 | 6.46688 | 1 | 4 | 26 | vesicle fusion to plasma membrane |
| GO:1903010 | 0.00523 | 6.46688 | 1 | 4 | 26 | regulation of bone development |
| GO:0072332 | 0.00524 | 3.56609 | 2 | 7 | 77 | intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:0045638 | 0.00529 | 3.20785 | 3 | 8 | 97 | negative regulation of myeloid cell differentiation |
| GO:0048644 | 0.00529 | 3.20785 | 3 | 8 | 97 | muscle organ morphogenesis |
| GO:0051248 | 0.00530 | 1.55556 | 29 | 44 | 1070 | negative regulation of protein metabolic process |
| GO:0045927 | 0.00535 | 2.09604 | 8 | 17 | 308 | positive regulation of growth |
| GO:0008361 | 0.00536 | 2.37460 | 6 | 13 | 209 | regulation of cell size |
| GO:0042060 | 0.00540 | 2.00109 | 10 | 19 | 360 | wound healing |
| GO:0006109 | 0.00550 | 2.46756 | 5 | 12 | 186 | regulation of carbohydrate metabolic process |
| GO:0045806 | 0.00552 | 4.03374 | 2 | 6 | 59 | negative regulation of endocytosis |
| GO:0006813 | 0.00553 | 2.27949 | 6 | 14 | 234 | potassium ion transport |
| GO:0009611 | 0.00554 | 1.83415 | 14 | 24 | 495 | response to wounding |
| GO:0002699 | 0.00560 | 2.20325 | 7 | 15 | 259 | positive regulation of immune effector process |
| GO:0061515 | 0.00562 | 3.51570 | 2 | 7 | 78 | myeloid cell development |
| GO:1902742 | 0.00567 | 4.81085 | 1 | 5 | 42 | apoptotic process involved in development |
| GO:0035637 | 0.00568 | 2.72779 | 4 | 10 | 141 | multicellular organismal signaling |
| GO:0015711 | 0.00572 | 1.91584 | 11 | 21 | 415 | organic anion transport |
| GO:0010976 | 0.00572 | 1.98925 | 10 | 19 | 362 | positive regulation of neuron projection development |
| GO:0032102 | 0.00573 | 2.03171 | 9 | 18 | 336 | negative regulation of response to external stimulus |
| GO:0007409 | 0.00586 | 1.85109 | 13 | 23 | 470 | axonogenesis |
| GO:0055082 | 0.00591 | 1.63247 | 22 | 35 | 810 | cellular chemical homeostasis |
| GO:0050680 | 0.00596 | 2.70701 | 4 | 10 | 142 | negative regulation of epithelial cell proliferation |
| GO:0062014 | 0.00597 | 3.13707 | 3 | 8 | 99 | negative regulation of small molecule metabolic process |
| GO:0060341 | 0.00599 | 1.57781 | 26 | 40 | 958 | regulation of cellular localization |
| GO:0060324 | 0.00600 | 3.95886 | 2 | 6 | 60 | face development |
| GO:0071156 | 0.00600 | 3.95886 | 2 | 6 | 60 | regulation of cell cycle arrest |
| GO:0035745 | 0.00600 | 9.68976 | 0 | 3 | 14 | T-helper 2 cell cytokine production |
| GO:0048537 | 0.00600 | 9.68976 | 0 | 3 | 14 | mucosal-associated lymphoid tissue development |
| GO:0048541 | 0.00600 | 9.68976 | 0 | 3 | 14 | Peyer's patch development |
| GO:0070486 | 0.00600 | 9.68976 | 0 | 3 | 14 | leukocyte aggregation |
| GO:0072537 | 0.00600 | 9.68976 | 0 | 3 | 14 | fibroblast activation |
| GO:0086069 | 0.00600 | 9.68976 | 0 | 3 | 14 | bundle of His cell to Purkinje myocyte communication |
| GO:0097066 | 0.00600 | 9.68976 | 0 | 3 | 14 | response to thyroid hormone |
| GO:0002335 | 0.00600 | 6.18543 | 1 | 4 | 27 | mature B cell differentiation |
| GO:0045830 | 0.00600 | 6.18543 | 1 | 4 | 27 | positive regulation of isotype switching |
| GO:0048843 | 0.00600 | 6.18543 | 1 | 4 | 27 | negative regulation of axon extension involved in axon guidance |
| GO:0050926 | 0.00600 | 6.18543 | 1 | 4 | 27 | regulation of positive chemotaxis |
| GO:0051702 | 0.00602 | 3.46672 | 2 | 7 | 79 | interaction with symbiont |
| GO:0006875 | 0.00605 | 1.75302 | 16 | 27 | 582 | cellular metal ion homeostasis |
| GO:0010647 | 0.00622 | 1.41218 | 51 | 69 | 1854 | positive regulation of cell communication |
| GO:0009267 | 0.00626 | 2.68653 | 4 | 10 | 143 | cellular response to starvation |
| GO:0048565 | 0.00627 | 2.86935 | 3 | 9 | 121 | digestive tract development |
| GO:0051129 | 0.00627 | 1.65072 | 21 | 33 | 755 | negative regulation of cellular component organization |
| GO:0031670 | 0.00628 | 4.68404 | 1 | 5 | 43 | cellular response to nutrient |
| GO:0002312 | 0.00645 | 3.41908 | 2 | 7 | 80 | B cell activation involved in immune response |
| GO:0030500 | 0.00645 | 3.41908 | 2 | 7 | 80 | regulation of bone mineralization |
| GO:0032410 | 0.00645 | 3.41908 | 2 | 7 | 80 | negative regulation of transporter activity |
| GO:0050805 | 0.00645 | 3.41908 | 2 | 7 | 80 | negative regulation of synaptic transmission |
| GO:0060113 | 0.00645 | 3.41908 | 2 | 7 | 80 | inner ear receptor cell differentiation |
| GO:0048639 | 0.00650 | 2.31501 | 6 | 13 | 214 | positive regulation of developmental growth |
| GO:0006366 | 0.00652 | 1.39005 | 56 | 75 | 2049 | transcription by RNA polymerase II |
| GO:0002708 | 0.00656 | 2.66637 | 4 | 10 | 144 | positive regulation of lymphocyte mediated immunity |
| GO:0006936 | 0.00658 | 2.10113 | 8 | 16 | 289 | muscle contraction |
| GO:0001501 | 0.00659 | 1.78210 | 15 | 25 | 530 | skeletal system development |
| GO:0032609 | 0.00660 | 2.84383 | 3 | 9 | 122 | interferon-gamma production |
| GO:0023056 | 0.00668 | 1.40704 | 51 | 69 | 1860 | positive regulation of signaling |
| GO:0035265 | 0.00675 | 2.30345 | 6 | 13 | 215 | organ growth |
| GO:0002507 | 0.00685 | 5.92744 | 1 | 4 | 28 | tolerance induction |
| GO:0006929 | 0.00685 | 5.92744 | 1 | 4 | 28 | substrate-dependent cell migration |
| GO:0010719 | 0.00685 | 5.92744 | 1 | 4 | 28 | negative regulation of epithelial to mesenchymal transition |
| GO:0044003 | 0.00685 | 5.92744 | 1 | 4 | 28 | modification by symbiont of host morphology or physiology |
| GO:0072576 | 0.00685 | 5.92744 | 1 | 4 | 28 | liver morphogenesis |
| GO:0086005 | 0.00685 | 5.92744 | 1 | 4 | 28 | ventricular cardiac muscle cell action potential |
| GO:0098698 | 0.00685 | 5.92744 | 1 | 4 | 28 | postsynaptic specialization assembly |
| GO:1902668 | 0.00685 | 5.92744 | 1 | 4 | 28 | negative regulation of axon guidance |
| GO:1904861 | 0.00685 | 5.92744 | 1 | 4 | 28 | excitatory synapse assembly |
| GO:0031646 | 0.00690 | 3.37272 | 2 | 7 | 81 | positive regulation of neurological system process |
| GO:0050918 | 0.00693 | 4.56374 | 1 | 5 | 44 | positive chemotaxis |
| GO:0050807 | 0.00710 | 2.14113 | 7 | 15 | 266 | regulation of synapse organization |
| GO:0002367 | 0.00713 | 3.03654 | 3 | 8 | 102 | cytokine production involved in immune response |
| GO:1905477 | 0.00713 | 3.03654 | 3 | 8 | 102 | positive regulation of protein localization to membrane |
| GO:0003006 | 0.00713 | 1.62219 | 22 | 34 | 791 | developmental process involved in reproduction |
| GO:0001915 | 0.00714 | 23.65723 | 0 | 2 | 5 | negative regulation of T cell mediated cytotoxicity |
| GO:0006701 | 0.00714 | 23.65723 | 0 | 2 | 5 | progesterone biosynthetic process |
| GO:0006742 | 0.00714 | 23.65723 | 0 | 2 | 5 | NADP catabolic process |
| GO:0010641 | 0.00714 | 23.65723 | 0 | 2 | 5 | positive regulation of platelet-derived growth factor receptor signaling pathway |
| GO:0010693 | 0.00714 | 23.65723 | 0 | 2 | 5 | negative regulation of alkaline phosphatase activity |
| GO:0032696 | 0.00714 | 23.65723 | 0 | 2 | 5 | negative regulation of interleukin-13 production |
| GO:0038145 | 0.00714 | 23.65723 | 0 | 2 | 5 | macrophage colony-stimulating factor signaling pathway |
| GO:0086029 | 0.00714 | 23.65723 | 0 | 2 | 5 | Purkinje myocyte to ventricular cardiac muscle cell signaling |
| GO:0086068 | 0.00714 | 23.65723 | 0 | 2 | 5 | Purkinje myocyte to ventricular cardiac muscle cell communication |
| GO:0098910 | 0.00714 | 23.65723 | 0 | 2 | 5 | regulation of atrial cardiac muscle cell action potential |
| GO:1900425 | 0.00714 | 23.65723 | 0 | 2 | 5 | negative regulation of defense response to bacterium |
| GO:1904347 | 0.00714 | 23.65723 | 0 | 2 | 5 | regulation of small intestine smooth muscle contraction |
| GO:1904502 | 0.00714 | 23.65723 | 0 | 2 | 5 | regulation of lipophagy |
| GO:1904504 | 0.00714 | 23.65723 | 0 | 2 | 5 | positive regulation of lipophagy |
| GO:1990770 | 0.00714 | 23.65723 | 0 | 2 | 5 | small intestine smooth muscle contraction |
| GO:0043254 | 0.00720 | 1.84341 | 12 | 22 | 451 | regulation of protein complex assembly |
| GO:1990778 | 0.00725 | 1.98114 | 9 | 18 | 344 | protein localization to cell periphery |
| GO:0001771 | 0.00735 | 8.88189 | 0 | 3 | 15 | immunological synapse formation |
| GO:0070234 | 0.00735 | 8.88189 | 0 | 3 | 15 | positive regulation of T cell apoptotic process |
| GO:0072413 | 0.00735 | 8.88189 | 0 | 3 | 15 | signal transduction involved in mitotic cell cycle checkpoint |
| GO:0090197 | 0.00735 | 8.88189 | 0 | 3 | 15 | positive regulation of chemokine secretion |
| GO:1900029 | 0.00735 | 8.88189 | 0 | 3 | 15 | positive regulation of ruffle assembly |
| GO:1902402 | 0.00735 | 8.88189 | 0 | 3 | 15 | signal transduction involved in mitotic DNA damage checkpoint |
| GO:1902403 | 0.00735 | 8.88189 | 0 | 3 | 15 | signal transduction involved in mitotic DNA integrity checkpoint |
| GO:0043583 | 0.00736 | 2.19872 | 7 | 14 | 242 | ear development |
| GO:0090630 | 0.00736 | 3.32761 | 2 | 7 | 82 | activation of GTPase activity |
| GO:0043588 | 0.00746 | 2.07041 | 8 | 16 | 293 | skin development |
| GO:0060401 | 0.00752 | 2.47302 | 5 | 11 | 170 | cytosolic calcium ion transport |
| GO:0000018 | 0.00755 | 3.00444 | 3 | 8 | 103 | regulation of DNA recombination |
| GO:0030258 | 0.00755 | 2.26943 | 6 | 13 | 218 | lipid modification |
| GO:0042445 | 0.00755 | 2.26943 | 6 | 13 | 218 | hormone metabolic process |
| GO:0030308 | 0.00762 | 2.35825 | 5 | 12 | 194 | negative regulation of cell growth |
| GO:0032965 | 0.00762 | 4.44945 | 1 | 5 | 45 | regulation of collagen biosynthetic process |
| GO:0060135 | 0.00762 | 4.44945 | 1 | 5 | 45 | maternal process involved in female pregnancy |
| GO:0018130 | 0.00778 | 1.30305 | 93 | 115 | 3374 | heterocycle biosynthetic process |
| GO:0042119 | 0.00778 | 5.69009 | 1 | 4 | 29 | neutrophil activation |
| GO:0060117 | 0.00778 | 5.69009 | 1 | 4 | 29 | auditory receptor cell development |
| GO:0072395 | 0.00778 | 5.69009 | 1 | 4 | 29 | signal transduction involved in cell cycle checkpoint |
| GO:0072401 | 0.00778 | 5.69009 | 1 | 4 | 29 | signal transduction involved in DNA integrity checkpoint |
| GO:0072422 | 0.00778 | 5.69009 | 1 | 4 | 29 | signal transduction involved in DNA damage checkpoint |
| GO:0071900 | 0.00780 | 1.85821 | 12 | 21 | 427 | regulation of protein serine/threonine kinase activity |
| GO:0006942 | 0.00786 | 3.28368 | 2 | 7 | 83 | regulation of striated muscle contraction |
| GO:0002700 | 0.00791 | 2.58862 | 4 | 10 | 148 | regulation of production of molecular mediator of immune response |
| GO:0034654 | 0.00796 | 1.30442 | 91 | 113 | 3310 | nucleobase-containing compound biosynthetic process |
| GO:0032612 | 0.00798 | 2.97302 | 3 | 8 | 104 | interleukin-1 production |
| GO:0043406 | 0.00812 | 2.24730 | 6 | 13 | 220 | positive regulation of MAP kinase activity |
| GO:1902903 | 0.00812 | 1.95677 | 10 | 18 | 348 | regulation of supramolecular fiber organization |
| GO:0043086 | 0.00818 | 1.65886 | 19 | 30 | 682 | negative regulation of catalytic activity |
| GO:0008015 | 0.00821 | 1.79374 | 13 | 23 | 484 | blood circulation |
| GO:0030517 | 0.00836 | 4.34073 | 1 | 5 | 46 | negative regulation of axon extension |
| GO:0032007 | 0.00836 | 4.34073 | 1 | 5 | 46 | negative regulation of TOR signaling |
| GO:0034766 | 0.00844 | 2.94224 | 3 | 8 | 105 | negative regulation of ion transmembrane transport |
| GO:0000724 | 0.00852 | 2.72272 | 3 | 9 | 127 | double-strand break repair via homologous recombination |
| GO:0000725 | 0.00852 | 2.72272 | 3 | 9 | 127 | recombinational repair |
| GO:0051592 | 0.00852 | 2.72272 | 3 | 9 | 127 | response to calcium ion |
| GO:0007267 | 0.00856 | 1.42166 | 44 | 60 | 1596 | cell-cell signaling |
| GO:0051924 | 0.00863 | 2.09058 | 7 | 15 | 272 | regulation of calcium ion transport |
| GO:0019438 | 0.00865 | 1.29746 | 93 | 115 | 3386 | aromatic compound biosynthetic process |
| GO:0031297 | 0.00879 | 5.47100 | 1 | 4 | 30 | replication fork processing |
| GO:0042481 | 0.00879 | 5.47100 | 1 | 4 | 30 | regulation of odontogenesis |
| GO:0016445 | 0.00882 | 3.62256 | 2 | 6 | 65 | somatic diversification of immunoglobulins |
| GO:0045123 | 0.00882 | 3.62256 | 2 | 6 | 65 | cellular extravasation |
| GO:0060425 | 0.00882 | 3.62256 | 2 | 6 | 65 | lung morphogenesis |
| GO:0001886 | 0.00886 | 8.19830 | 0 | 3 | 16 | endothelial cell morphogenesis |
| GO:0002283 | 0.00886 | 8.19830 | 0 | 3 | 16 | neutrophil activation involved in immune response |
| GO:0002467 | 0.00886 | 8.19830 | 0 | 3 | 16 | germinal center formation |
| GO:0007512 | 0.00886 | 8.19830 | 0 | 3 | 16 | adult heart development |
| GO:0045779 | 0.00886 | 8.19830 | 0 | 3 | 16 | negative regulation of bone resorption |
| GO:0090196 | 0.00886 | 8.19830 | 0 | 3 | 16 | regulation of chemokine secretion |
| GO:0097284 | 0.00886 | 8.19830 | 0 | 3 | 16 | hepatocyte apoptotic process |
| GO:1902414 | 0.00886 | 8.19830 | 0 | 3 | 16 | protein localization to cell junction |
| GO:1903779 | 0.00886 | 8.19830 | 0 | 3 | 16 | regulation of cardiac conduction |
| GO:2001053 | 0.00886 | 8.19830 | 0 | 3 | 16 | regulation of mesenchymal cell apoptotic process |
| GO:0030041 | 0.00889 | 2.41190 | 5 | 11 | 174 | actin filament polymerization |
| GO:0043542 | 0.00889 | 2.30712 | 5 | 12 | 198 | endothelial cell migration |
| GO:0098659 | 0.00892 | 3.19920 | 2 | 7 | 85 | inorganic cation import across plasma membrane |
| GO:0099587 | 0.00892 | 3.19920 | 2 | 7 | 85 | inorganic ion import across plasma membrane |
| GO:1901863 | 0.00892 | 3.19920 | 2 | 7 | 85 | positive regulation of muscle tissue development |
| GO:1901343 | 0.00894 | 2.69972 | 4 | 9 | 128 | negative regulation of vasculature development |
| GO:0030162 | 0.00900 | 1.63181 | 20 | 31 | 716 | regulation of proteolysis |
| GO:0002639 | 0.00915 | 4.23719 | 1 | 5 | 47 | positive regulation of immunoglobulin production |
| GO:0010563 | 0.00941 | 1.72612 | 15 | 25 | 546 | negative regulation of phosphorus metabolic process |
| GO:0045936 | 0.00941 | 1.72612 | 15 | 25 | 546 | negative regulation of phosphate metabolic process |
| GO:0014074 | 0.00941 | 2.88254 | 3 | 8 | 107 | response to purine-containing compound |
| GO:0042490 | 0.00948 | 3.15856 | 2 | 7 | 86 | mechanoreceptor differentiation |
| GO:0050804 | 0.00953 | 1.65310 | 18 | 29 | 661 | modulation of chemical synaptic transmission |
| GO:0050727 | 0.00958 | 1.92131 | 10 | 18 | 354 | regulation of inflammatory response |
| GO:0002705 | 0.00964 | 2.38246 | 5 | 11 | 176 | positive regulation of leukocyte mediated immunity |
| GO:0099177 | 0.00972 | 1.65042 | 18 | 29 | 662 | regulation of trans-synaptic signaling |
| GO:0032967 | 0.00987 | 5.26814 | 1 | 4 | 31 | positive regulation of collagen biosynthetic process |
| GO:0042036 | 0.00987 | 5.26814 | 1 | 4 | 31 | negative regulation of cytokine biosynthetic process |
| GO:0048011 | 0.00987 | 5.26814 | 1 | 4 | 31 | neurotrophin TRK receptor signaling pathway |
| GO:0030316 | 0.00993 | 2.85359 | 3 | 8 | 108 | osteoclast differentiation |
| GO:0002714 | 0.00999 | 4.13847 | 1 | 5 | 48 | positive regulation of B cell mediated immunity |
| GO:0002891 | 0.00999 | 4.13847 | 1 | 5 | 48 | positive regulation of immunoglobulin mediated immune response |
| GO:0090311 | 0.00999 | 4.13847 | 1 | 5 | 48 | regulation of protein deacetylation |
| GO:0007219 | 0.01003 | 2.36800 | 5 | 11 | 177 | Notch signaling pathway |
| GO:0006820 | 0.01003 | 1.71600 | 15 | 25 | 549 | anion transport |
| GO:0072091 | 0.01008 | 3.11894 | 2 | 7 | 87 | regulation of stem cell proliferation |
| GO:0006801 | 0.01018 | 3.50348 | 2 | 6 | 67 | superoxide metabolic process |
| GO:0006940 | 0.01018 | 3.50348 | 2 | 6 | 67 | regulation of smooth muscle contraction |
| GO:0050771 | 0.01018 | 3.50348 | 2 | 6 | 67 | negative regulation of axonogenesis |
| GO:0010469 | 0.01033 | 2.63298 | 4 | 9 | 131 | regulation of signaling receptor activity |
| GO:0045087 | 0.01041 | 1.56544 | 23 | 35 | 842 | innate immune response |
| GO:0001705 | 0.01051 | 17.74214 | 0 | 2 | 6 | ectoderm formation |
| GO:0002461 | 0.01051 | 17.74214 | 0 | 2 | 6 | tolerance induction dependent upon immune response |
| GO:0014004 | 0.01051 | 17.74214 | 0 | 2 | 6 | microglia differentiation |
| GO:0019364 | 0.01051 | 17.74214 | 0 | 2 | 6 | pyridine nucleotide catabolic process |
| GO:0034316 | 0.01051 | 17.74214 | 0 | 2 | 6 | negative regulation of Arp2/3 complex-mediated actin nucleation |
| GO:0042695 | 0.01051 | 17.74214 | 0 | 2 | 6 | thelarche |
| GO:0045588 | 0.01051 | 17.74214 | 0 | 2 | 6 | positive regulation of gamma-delta T cell differentiation |
| GO:0046645 | 0.01051 | 17.74214 | 0 | 2 | 6 | positive regulation of gamma-delta T cell activation |
| GO:0051005 | 0.01051 | 17.74214 | 0 | 2 | 6 | negative regulation of lipoprotein lipase activity |
| GO:0051182 | 0.01051 | 17.74214 | 0 | 2 | 6 | coenzyme transport |
| GO:0060744 | 0.01051 | 17.74214 | 0 | 2 | 6 | mammary gland branching involved in thelarche |
| GO:0060751 | 0.01051 | 17.74214 | 0 | 2 | 6 | branch elongation involved in mammary gland duct branching |
| GO:0061724 | 0.01051 | 17.74214 | 0 | 2 | 6 | lipophagy |
| GO:0072177 | 0.01051 | 17.74214 | 0 | 2 | 6 | mesonephric duct development |
| GO:0086073 | 0.01051 | 17.74214 | 0 | 2 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
| GO:0090258 | 0.01051 | 17.74214 | 0 | 2 | 6 | negative regulation of mitochondrial fission |
| GO:0099576 | 0.01051 | 17.74214 | 0 | 2 | 6 | regulation of protein catabolic process at postsynapse, modulating synaptic transmission |
| GO:1900028 | 0.01051 | 17.74214 | 0 | 2 | 6 | negative regulation of ruffle assembly |
| GO:1901552 | 0.01051 | 17.74214 | 0 | 2 | 6 | positive regulation of endothelial cell development |
| GO:1902075 | 0.01051 | 17.74214 | 0 | 2 | 6 | cellular response to salt |
| GO:1903142 | 0.01051 | 17.74214 | 0 | 2 | 6 | positive regulation of establishment of endothelial barrier |
| GO:1903935 | 0.01051 | 17.74214 | 0 | 2 | 6 | response to sodium arsenite |
| GO:2000405 | 0.01051 | 17.74214 | 0 | 2 | 6 | negative regulation of T cell migration |
| GO:2001181 | 0.01051 | 17.74214 | 0 | 2 | 6 | positive regulation of interleukin-10 secretion |
| GO:0007288 | 0.01054 | 7.61237 | 0 | 3 | 17 | sperm axoneme assembly |
| GO:0045579 | 0.01054 | 7.61237 | 0 | 3 | 17 | positive regulation of B cell differentiation |
| GO:0070243 | 0.01054 | 7.61237 | 0 | 3 | 17 | regulation of thymocyte apoptotic process |
| GO:0070886 | 0.01054 | 7.61237 | 0 | 3 | 17 | positive regulation of calcineurin-NFAT signaling cascade |
| GO:0090185 | 0.01054 | 7.61237 | 0 | 3 | 17 | negative regulation of kidney development |
| GO:0090195 | 0.01054 | 7.61237 | 0 | 3 | 17 | chemokine secretion |
| GO:0097152 | 0.01054 | 7.61237 | 0 | 3 | 17 | mesenchymal cell apoptotic process |
| GO:0106058 | 0.01054 | 7.61237 | 0 | 3 | 17 | positive regulation of calcineurin-mediated signaling |
| GO:2001185 | 0.01054 | 7.61237 | 0 | 3 | 17 | regulation of CD8-positive, alpha-beta T cell activation |
| GO:0003013 | 0.01056 | 1.75107 | 14 | 23 | 495 | circulatory system process |
| GO:1901362 | 0.01060 | 1.28313 | 96 | 118 | 3510 | organic cyclic compound biosynthetic process |
| GO:0033077 | 0.01069 | 3.08030 | 2 | 7 | 88 | T cell differentiation in thymus |
| GO:0051149 | 0.01069 | 3.08030 | 2 | 7 | 88 | positive regulation of muscle cell differentiation |
| GO:0001508 | 0.01082 | 2.61146 | 4 | 9 | 132 | action potential |
| GO:0001841 | 0.01082 | 2.61146 | 4 | 9 | 132 | neural tube formation |
| GO:0001906 | 0.01085 | 2.33960 | 5 | 11 | 179 | cell killing |
| GO:0034109 | 0.01092 | 3.44682 | 2 | 6 | 68 | homotypic cell-cell adhesion |
| GO:0006914 | 0.01094 | 1.85715 | 11 | 19 | 386 | autophagy |
| GO:0061919 | 0.01094 | 1.85715 | 11 | 19 | 386 | process utilizing autophagic mechanism |
| GO:0006690 | 0.01102 | 2.79739 | 3 | 8 | 110 | icosanoid metabolic process |
| GO:0002446 | 0.01104 | 5.07977 | 1 | 4 | 32 | neutrophil mediated immunity |
| GO:0032743 | 0.01104 | 5.07977 | 1 | 4 | 32 | positive regulation of interleukin-2 production |
| GO:0045577 | 0.01104 | 5.07977 | 1 | 4 | 32 | regulation of B cell differentiation |
| GO:0051180 | 0.01104 | 5.07977 | 1 | 4 | 32 | vitamin transport |
| GO:0060706 | 0.01104 | 5.07977 | 1 | 4 | 32 | cell differentiation involved in embryonic placenta development |
| GO:0031032 | 0.01110 | 2.23442 | 6 | 12 | 204 | actomyosin structure organization |
| GO:0030003 | 0.01133 | 1.64430 | 18 | 28 | 641 | cellular cation homeostasis |
| GO:0001837 | 0.01133 | 2.59029 | 4 | 9 | 133 | epithelial to mesenchymal transition |
| GO:0043112 | 0.01150 | 2.22275 | 6 | 12 | 205 | receptor metabolic process |
| GO:0009628 | 0.01168 | 1.49874 | 28 | 41 | 1030 | response to abiotic stimulus |
| GO:0032370 | 0.01169 | 3.39195 | 2 | 6 | 69 | positive regulation of lipid transport |
| GO:0061035 | 0.01169 | 3.39195 | 2 | 6 | 69 | regulation of cartilage development |
| GO:0060402 | 0.01170 | 2.42916 | 4 | 10 | 157 | calcium ion transport into cytosol |
| GO:0010332 | 0.01182 | 3.95419 | 1 | 5 | 50 | response to gamma radiation |
| GO:0051055 | 0.01182 | 3.95419 | 1 | 5 | 50 | negative regulation of lipid biosynthetic process |
| GO:0002698 | 0.01186 | 2.56945 | 4 | 9 | 134 | negative regulation of immune effector process |
| GO:0060348 | 0.01190 | 2.13286 | 6 | 13 | 231 | bone development |
| GO:0032526 | 0.01201 | 3.00580 | 2 | 7 | 90 | response to retinoic acid |
| GO:0045833 | 0.01201 | 3.00580 | 2 | 7 | 90 | negative regulation of lipid metabolic process |
| GO:0008654 | 0.01220 | 2.41264 | 4 | 10 | 158 | phospholipid biosynthetic process |
| GO:0006775 | 0.01230 | 4.90438 | 1 | 4 | 33 | fat-soluble vitamin metabolic process |
| GO:0048841 | 0.01230 | 4.90438 | 1 | 4 | 33 | regulation of axon extension involved in axon guidance |
| GO:0032269 | 0.01230 | 1.50095 | 28 | 40 | 1003 | negative regulation of cellular protein metabolic process |
| GO:0010801 | 0.01240 | 7.10457 | 0 | 3 | 18 | negative regulation of peptidyl-threonine phosphorylation |
| GO:0030002 | 0.01240 | 7.10457 | 0 | 3 | 18 | cellular anion homeostasis |
| GO:0030320 | 0.01240 | 7.10457 | 0 | 3 | 18 | cellular monovalent inorganic anion homeostasis |
| GO:0032700 | 0.01240 | 7.10457 | 0 | 3 | 18 | negative regulation of interleukin-17 production |
| GO:0046851 | 0.01240 | 7.10457 | 0 | 3 | 18 | negative regulation of bone remodeling |
| GO:0019915 | 0.01249 | 3.33881 | 2 | 6 | 70 | lipid storage |
| GO:0046907 | 0.01271 | 1.40577 | 41 | 56 | 1502 | intracellular transport |
| GO:0046683 | 0.01272 | 2.96989 | 3 | 7 | 91 | response to organophosphorus |
| GO:0060428 | 0.01281 | 3.86805 | 1 | 5 | 51 | lung epithelium development |
| GO:0016064 | 0.01286 | 2.04460 | 7 | 14 | 259 | immunoglobulin mediated immune response |
| GO:0042471 | 0.01298 | 2.52876 | 4 | 9 | 136 | ear morphogenesis |
| GO:0097553 | 0.01298 | 2.52876 | 4 | 9 | 136 | calcium ion transmembrane import into cytosol |
| GO:0007268 | 0.01312 | 1.53775 | 24 | 35 | 856 | chemical synaptic transmission |
| GO:0098916 | 0.01312 | 1.53775 | 24 | 35 | 856 | anterograde trans-synaptic signaling |
| GO:1903169 | 0.01323 | 2.38025 | 4 | 10 | 160 | regulation of calcium ion transmembrane transport |
| GO:2000027 | 0.01324 | 2.17723 | 6 | 12 | 209 | regulation of animal organ morphogenesis |
| GO:0048814 | 0.01348 | 2.69134 | 3 | 8 | 114 | regulation of dendrite morphogenesis |
| GO:0048675 | 0.01356 | 2.50889 | 4 | 9 | 137 | axon extension |
| GO:0045766 | 0.01363 | 2.25832 | 5 | 11 | 185 | positive regulation of angiogenesis |
| GO:0001773 | 0.01364 | 4.74069 | 1 | 4 | 34 | myeloid dendritic cell activation |
| GO:0006739 | 0.01364 | 4.74069 | 1 | 4 | 34 | NADP metabolic process |
| GO:0010714 | 0.01364 | 4.74069 | 1 | 4 | 34 | positive regulation of collagen metabolic process |
| GO:0050869 | 0.01364 | 4.74069 | 1 | 4 | 34 | negative regulation of B cell activation |
| GO:0099068 | 0.01364 | 4.74069 | 1 | 4 | 34 | postsynapse assembly |
| GO:0031400 | 0.01367 | 1.66711 | 16 | 25 | 564 | negative regulation of protein modification process |
| GO:0010558 | 0.01378 | 1.41196 | 39 | 53 | 1414 | negative regulation of macromolecule biosynthetic process |
| GO:0010712 | 0.01387 | 3.78559 | 1 | 5 | 52 | regulation of collagen metabolic process |
| GO:0007517 | 0.01412 | 1.77577 | 12 | 20 | 424 | muscle organ development |
| GO:0042326 | 0.01414 | 1.74845 | 12 | 21 | 452 | negative regulation of phosphorylation |
| GO:0043062 | 0.01419 | 1.91618 | 9 | 16 | 315 | extracellular structure organization |
| GO:0048872 | 0.01419 | 1.91618 | 9 | 16 | 315 | homeostasis of number of cells |
| GO:0048839 | 0.01419 | 2.15515 | 6 | 12 | 211 | inner ear development |
| GO:0002027 | 0.01421 | 2.90056 | 3 | 7 | 93 | regulation of heart rate |
| GO:0042116 | 0.01421 | 2.90056 | 3 | 7 | 93 | macrophage activation |
| GO:0030239 | 0.01422 | 3.23734 | 2 | 6 | 72 | myofibril assembly |
| GO:0044237 | 0.01439 | 1.19768 | 258 | 285 | 9374 | cellular metabolic process |
| GO:0002643 | 0.01443 | 6.66024 | 1 | 3 | 19 | regulation of tolerance induction |
| GO:0030889 | 0.01443 | 6.66024 | 1 | 3 | 19 | negative regulation of B cell proliferation |
| GO:0045953 | 0.01443 | 6.66024 | 1 | 3 | 19 | negative regulation of natural killer cell mediated cytotoxicity |
| GO:0070723 | 0.01443 | 6.66024 | 1 | 3 | 19 | response to cholesterol |
| GO:0001955 | 0.01445 | 14.19308 | 0 | 2 | 7 | blood vessel maturation |
| GO:0002291 | 0.01445 | 14.19308 | 0 | 2 | 7 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0003160 | 0.01445 | 14.19308 | 0 | 2 | 7 | endocardium morphogenesis |
| GO:0009635 | 0.01445 | 14.19308 | 0 | 2 | 7 | response to herbicide |
| GO:0010760 | 0.01445 | 14.19308 | 0 | 2 | 7 | negative regulation of macrophage chemotaxis |
| GO:0035701 | 0.01445 | 14.19308 | 0 | 2 | 7 | hematopoietic stem cell migration |
| GO:0044828 | 0.01445 | 14.19308 | 0 | 2 | 7 | negative regulation by host of viral genome replication |
| GO:0045630 | 0.01445 | 14.19308 | 0 | 2 | 7 | positive regulation of T-helper 2 cell differentiation |
| GO:0048170 | 0.01445 | 14.19308 | 0 | 2 | 7 | positive regulation of long-term neuronal synaptic plasticity |
| GO:0060385 | 0.01445 | 14.19308 | 0 | 2 | 7 | axonogenesis involved in innervation |
| GO:0060558 | 0.01445 | 14.19308 | 0 | 2 | 7 | regulation of calcidiol 1-monooxygenase activity |
| GO:0061517 | 0.01445 | 14.19308 | 0 | 2 | 7 | macrophage proliferation |
| GO:0061518 | 0.01445 | 14.19308 | 0 | 2 | 7 | microglial cell proliferation |
| GO:0150094 | 0.01445 | 14.19308 | 0 | 2 | 7 | amyloid-beta clearance by cellular catabolic process |
| GO:2000048 | 0.01445 | 14.19308 | 0 | 2 | 7 | negative regulation of cell-cell adhesion mediated by cadherin |
| GO:2000553 | 0.01445 | 14.19308 | 0 | 2 | 7 | positive regulation of T-helper 2 cell cytokine production |
| GO:0019724 | 0.01452 | 2.01139 | 7 | 14 | 263 | B cell mediated immunity |
| GO:0051640 | 0.01453 | 1.63987 | 16 | 26 | 596 | organelle localization |
| GO:0030216 | 0.01479 | 2.47007 | 4 | 9 | 139 | keratinocyte differentiation |
| GO:0030282 | 0.01484 | 2.64127 | 3 | 8 | 116 | bone mineralization |
| GO:0060041 | 0.01491 | 2.33327 | 4 | 10 | 163 | retina development in camera-type eye |
| GO:0002204 | 0.01497 | 3.70656 | 1 | 5 | 53 | somatic recombination of immunoglobulin genes involved in immune response |
| GO:0002208 | 0.01497 | 3.70656 | 1 | 5 | 53 | somatic diversification of immunoglobulins involved in immune response |
| GO:0045190 | 0.01497 | 3.70656 | 1 | 5 | 53 | isotype switching |
| GO:0045214 | 0.01497 | 3.70656 | 1 | 5 | 53 | sarcomere organization |
| GO:0001570 | 0.01500 | 2.86710 | 3 | 7 | 94 | vasculogenesis |
| GO:0035909 | 0.01508 | 4.58756 | 1 | 4 | 35 | aorta morphogenesis |
| GO:0036230 | 0.01508 | 4.58756 | 1 | 4 | 35 | granulocyte activation |
| GO:0055090 | 0.01508 | 4.58756 | 1 | 4 | 35 | acylglycerol homeostasis |
| GO:0060441 | 0.01508 | 4.58756 | 1 | 4 | 35 | epithelial tube branching involved in lung morphogenesis |
| GO:0070328 | 0.01508 | 4.58756 | 1 | 4 | 35 | triglyceride homeostasis |
| GO:0099537 | 0.01514 | 1.52045 | 24 | 35 | 865 | trans-synaptic signaling |
| GO:0045670 | 0.01515 | 3.18888 | 2 | 6 | 73 | regulation of osteoclast differentiation |
| GO:0050810 | 0.01515 | 3.18888 | 2 | 6 | 73 | regulation of steroid biosynthetic process |
| GO:0051155 | 0.01515 | 3.18888 | 2 | 6 | 73 | positive regulation of striated muscle cell differentiation |
| GO:0006464 | 0.01518 | 1.26701 | 95 | 115 | 3453 | cellular protein modification process |
| GO:0036211 | 0.01518 | 1.26701 | 95 | 115 | 3453 | protein modification process |
| GO:0150063 | 0.01542 | 1.78778 | 11 | 19 | 400 | visual system development |
| GO:0072089 | 0.01544 | 2.45111 | 4 | 9 | 140 | stem cell proliferation |
| GO:0051701 | 0.01556 | 2.61692 | 3 | 8 | 117 | interaction with host |
| GO:0001655 | 0.01577 | 1.85078 | 10 | 17 | 346 | urogenital system development |
| GO:0046777 | 0.01590 | 2.04747 | 7 | 13 | 240 | protein autophosphorylation |
| GO:0045017 | 0.01611 | 2.43243 | 4 | 9 | 141 | glycerolipid biosynthetic process |
| GO:0061041 | 0.01611 | 2.43243 | 4 | 9 | 141 | regulation of wound healing |
| GO:0006919 | 0.01611 | 3.14185 | 2 | 6 | 74 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0032651 | 0.01611 | 3.14185 | 2 | 6 | 74 | regulation of interleukin-1 beta production |
| GO:0032964 | 0.01614 | 3.63075 | 1 | 5 | 54 | collagen biosynthetic process |
| GO:0051346 | 0.01616 | 1.77829 | 11 | 19 | 402 | negative regulation of hydrolase activity |
| GO:0042476 | 0.01631 | 2.59302 | 3 | 8 | 118 | odontogenesis |
| GO:0071695 | 0.01633 | 2.19475 | 5 | 11 | 190 | anatomical structure maturation |
| GO:1901576 | 0.01641 | 1.22688 | 138 | 161 | 5031 | organic substance biosynthetic process |
| GO:0061024 | 0.01646 | 1.54067 | 21 | 32 | 780 | membrane organization |
| GO:0048880 | 0.01654 | 1.77358 | 11 | 19 | 403 | sensory system development |
| GO:0016358 | 0.01659 | 1.92383 | 8 | 15 | 294 | dendrite development |
| GO:0032735 | 0.01660 | 4.44401 | 1 | 4 | 36 | positive regulation of interleukin-12 production |
| GO:0045601 | 0.01660 | 4.44401 | 1 | 4 | 36 | regulation of endothelial cell differentiation |
| GO:0051181 | 0.01660 | 4.44401 | 1 | 4 | 36 | cofactor transport |
| GO:0060969 | 0.01660 | 4.44401 | 1 | 4 | 36 | negative regulation of gene silencing |
| GO:0098751 | 0.01660 | 4.44401 | 1 | 4 | 36 | bone cell development |
| GO:1904037 | 0.01660 | 4.44401 | 1 | 4 | 36 | positive regulation of epithelial cell apoptotic process |
| GO:0002523 | 0.01663 | 6.26818 | 1 | 3 | 20 | leukocyte migration involved in inflammatory response |
| GO:0002716 | 0.01663 | 6.26818 | 1 | 3 | 20 | negative regulation of natural killer cell mediated immunity |
| GO:0006691 | 0.01663 | 6.26818 | 1 | 3 | 20 | leukotriene metabolic process |
| GO:0035584 | 0.01663 | 6.26818 | 1 | 3 | 20 | calcium-mediated signaling using intracellular calcium source |
| GO:0035855 | 0.01663 | 6.26818 | 1 | 3 | 20 | megakaryocyte development |
| GO:0043011 | 0.01663 | 6.26818 | 1 | 3 | 20 | myeloid dendritic cell differentiation |
| GO:0045649 | 0.01663 | 6.26818 | 1 | 3 | 20 | regulation of macrophage differentiation |
| GO:0045986 | 0.01663 | 6.26818 | 1 | 3 | 20 | negative regulation of smooth muscle contraction |
| GO:0099565 | 0.01668 | 2.80242 | 3 | 7 | 96 | chemical synaptic transmission, postsynaptic |
| GO:0140029 | 0.01668 | 2.80242 | 3 | 7 | 96 | exocytic process |
| GO:0042594 | 0.01673 | 2.28809 | 5 | 10 | 166 | response to starvation |
| GO:0050729 | 0.01679 | 2.41404 | 4 | 9 | 142 | positive regulation of inflammatory response |
| GO:0021915 | 0.01691 | 2.18246 | 5 | 11 | 191 | neural tube development |
| GO:0043280 | 0.01708 | 2.56954 | 3 | 8 | 119 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0080134 | 0.01710 | 1.40633 | 37 | 50 | 1337 | regulation of response to stress |
| GO:0002200 | 0.01712 | 3.09618 | 2 | 6 | 75 | somatic diversification of immune receptors |
| GO:0035019 | 0.01736 | 3.55798 | 2 | 5 | 55 | somatic stem cell population maintenance |
| GO:0045058 | 0.01736 | 3.55798 | 2 | 5 | 55 | T cell selection |
| GO:0099536 | 0.01741 | 1.50352 | 24 | 35 | 874 | synaptic signaling |
| GO:0010634 | 0.01750 | 2.39591 | 4 | 9 | 143 | positive regulation of epithelial cell migration |
| GO:0055007 | 0.01750 | 2.39591 | 4 | 9 | 143 | cardiac muscle cell differentiation |
| GO:0072073 | 0.01750 | 2.39591 | 4 | 9 | 143 | kidney epithelium development |
| GO:0043410 | 0.01756 | 1.66453 | 14 | 23 | 519 | positive regulation of MAPK cascade |
| GO:0044249 | 0.01761 | 1.22522 | 136 | 158 | 4938 | cellular biosynthetic process |
| GO:0051208 | 0.01787 | 2.54649 | 3 | 8 | 120 | sequestering of calcium ion |
| GO:0051495 | 0.01789 | 2.08127 | 6 | 12 | 218 | positive regulation of cytoskeleton organization |
| GO:0070374 | 0.01789 | 2.08127 | 6 | 12 | 218 | positive regulation of ERK1 and ERK2 cascade |
| GO:2001257 | 0.01804 | 2.25893 | 5 | 10 | 168 | regulation of cation channel activity |
| GO:0033260 | 0.01822 | 4.30915 | 1 | 4 | 37 | nuclear DNA replication |
| GO:0042092 | 0.01822 | 4.30915 | 1 | 4 | 37 | type 2 immune response |
| GO:0045191 | 0.01822 | 4.30915 | 1 | 4 | 37 | regulation of isotype switching |
| GO:0048846 | 0.01822 | 4.30915 | 1 | 4 | 37 | axon extension involved in axon guidance |
| GO:0060674 | 0.01822 | 4.30915 | 1 | 4 | 37 | placenta blood vessel development |
| GO:0097028 | 0.01822 | 4.30915 | 1 | 4 | 37 | dendritic cell differentiation |
| GO:1902284 | 0.01822 | 4.30915 | 1 | 4 | 37 | neuron projection extension involved in neuron projection guidance |
| GO:0030198 | 0.01835 | 1.94808 | 7 | 14 | 271 | extracellular matrix organization |
| GO:0070227 | 0.01848 | 2.74058 | 3 | 7 | 98 | lymphocyte apoptotic process |
| GO:0032732 | 0.01865 | 3.48806 | 2 | 5 | 56 | positive regulation of interleukin-1 production |
| GO:1900449 | 0.01865 | 3.48806 | 2 | 5 | 56 | regulation of glutamate receptor signaling pathway |
| GO:0001889 | 0.01869 | 2.52384 | 3 | 8 | 121 | liver development |
| GO:0030643 | 0.01892 | 11.82704 | 0 | 2 | 8 | cellular phosphate ion homeostasis |
| GO:0032287 | 0.01892 | 11.82704 | 0 | 2 | 8 | peripheral nervous system myelin maintenance |
| GO:0032627 | 0.01892 | 11.82704 | 0 | 2 | 8 | interleukin-23 production |
| GO:0032667 | 0.01892 | 11.82704 | 0 | 2 | 8 | regulation of interleukin-23 production |
| GO:0035425 | 0.01892 | 11.82704 | 0 | 2 | 8 | autocrine signaling |
| GO:0042363 | 0.01892 | 11.82704 | 0 | 2 | 8 | fat-soluble vitamin catabolic process |
| GO:0051126 | 0.01892 | 11.82704 | 0 | 2 | 8 | negative regulation of actin nucleation |
| GO:0051136 | 0.01892 | 11.82704 | 0 | 2 | 8 | regulation of NK T cell differentiation |
| GO:0060836 | 0.01892 | 11.82704 | 0 | 2 | 8 | lymphatic endothelial cell differentiation |
| GO:0070314 | 0.01892 | 11.82704 | 0 | 2 | 8 | G1 to G0 transition |
| GO:0070561 | 0.01892 | 11.82704 | 0 | 2 | 8 | vitamin D receptor signaling pathway |
| GO:0071493 | 0.01892 | 11.82704 | 0 | 2 | 8 | cellular response to UV-B |
| GO:0071578 | 0.01892 | 11.82704 | 0 | 2 | 8 | zinc ion import across plasma membrane |
| GO:0072501 | 0.01892 | 11.82704 | 0 | 2 | 8 | cellular divalent inorganic anion homeostasis |
| GO:0072502 | 0.01892 | 11.82704 | 0 | 2 | 8 | cellular trivalent inorganic anion homeostasis |
| GO:0072526 | 0.01892 | 11.82704 | 0 | 2 | 8 | pyridine-containing compound catabolic process |
| GO:0098883 | 0.01892 | 11.82704 | 0 | 2 | 8 | synapse pruning |
| GO:2000562 | 0.01892 | 11.82704 | 0 | 2 | 8 | negative regulation of CD4-positive, alpha-beta T cell proliferation |
| GO:0031579 | 0.01902 | 5.91969 | 1 | 3 | 21 | membrane raft organization |
| GO:0032930 | 0.01902 | 5.91969 | 1 | 3 | 21 | positive regulation of superoxide anion generation |
| GO:0046339 | 0.01902 | 5.91969 | 1 | 3 | 21 | diacylglycerol metabolic process |
| GO:0070230 | 0.01902 | 5.91969 | 1 | 3 | 21 | positive regulation of lymphocyte apoptotic process |
| GO:0097107 | 0.01902 | 5.91969 | 1 | 3 | 21 | postsynaptic density assembly |
| GO:1901522 | 0.01902 | 5.91969 | 1 | 3 | 21 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus |
| GO:0099003 | 0.01908 | 1.99421 | 7 | 13 | 246 | vesicle-mediated transport in synapse |
| GO:0031347 | 0.01909 | 1.58298 | 18 | 27 | 640 | regulation of defense response |
| GO:0030193 | 0.01927 | 3.00869 | 2 | 6 | 77 | regulation of blood coagulation |
| GO:0032088 | 0.01927 | 3.00869 | 2 | 6 | 77 | negative regulation of NF-kappaB transcription factor activity |
| GO:0061180 | 0.01927 | 3.00869 | 2 | 6 | 77 | mammary gland epithelium development |
| GO:0003205 | 0.01941 | 2.13463 | 5 | 11 | 195 | cardiac chamber development |
| GO:1902905 | 0.01941 | 2.13463 | 5 | 11 | 195 | positive regulation of supramolecular fiber organization |
| GO:0010771 | 0.01943 | 2.71067 | 3 | 7 | 99 | negative regulation of cell morphogenesis involved in differentiation |
| GO:0009894 | 0.01959 | 1.50789 | 23 | 33 | 821 | regulation of catabolic process |
| GO:0061061 | 0.01965 | 1.55187 | 19 | 29 | 701 | muscle structure development |
| GO:0007568 | 0.01966 | 1.98560 | 7 | 13 | 247 | aging |
| GO:0072006 | 0.01975 | 2.34314 | 4 | 9 | 146 | nephron development |
| GO:0014002 | 0.01993 | 4.18222 | 1 | 4 | 38 | astrocyte development |
| GO:0042149 | 0.01993 | 4.18222 | 1 | 4 | 38 | cellular response to glucose starvation |
| GO:0043267 | 0.01993 | 4.18222 | 1 | 4 | 38 | negative regulation of potassium ion transport |
| GO:0045005 | 0.01993 | 4.18222 | 1 | 4 | 38 | DNA-dependent DNA replication maintenance of fidelity |
| GO:1904645 | 0.01993 | 4.18222 | 1 | 4 | 38 | response to amyloid-beta |
| GO:0048260 | 0.01999 | 3.42083 | 2 | 5 | 57 | positive regulation of receptor-mediated endocytosis |
| GO:0072577 | 0.01999 | 3.42083 | 2 | 5 | 57 | endothelial cell apoptotic process |
| GO:0043271 | 0.02014 | 2.21654 | 5 | 10 | 171 | negative regulation of ion transport |
| GO:0043507 | 0.02040 | 2.96677 | 2 | 6 | 78 | positive regulation of JUN kinase activity |
| GO:1900046 | 0.02040 | 2.96677 | 2 | 6 | 78 | regulation of hemostasis |
| GO:0051153 | 0.02042 | 2.47972 | 3 | 8 | 123 | regulation of striated muscle cell differentiation |
| GO:0055013 | 0.02042 | 2.68141 | 3 | 7 | 100 | cardiac muscle cell development |
| GO:0030856 | 0.02055 | 2.32605 | 4 | 9 | 147 | regulation of epithelial cell differentiation |
| GO:0072001 | 0.02058 | 1.86954 | 8 | 15 | 302 | renal system development |
| GO:0061008 | 0.02132 | 2.45824 | 3 | 8 | 124 | hepaticobiliary system development |
| GO:0016447 | 0.02140 | 3.35614 | 2 | 5 | 58 | somatic recombination of immunoglobulin gene segments |
| GO:0043954 | 0.02140 | 3.35614 | 2 | 5 | 58 | cellular component maintenance |
| GO:0061337 | 0.02140 | 3.35614 | 2 | 5 | 58 | cardiac conduction |
| GO:0072678 | 0.02140 | 3.35614 | 2 | 5 | 58 | T cell migration |
| GO:0043903 | 0.02145 | 2.10010 | 5 | 11 | 198 | regulation of symbiosis, encompassing mutualism through parasitism |
| GO:0032042 | 0.02158 | 5.60787 | 1 | 3 | 22 | mitochondrial DNA metabolic process |
| GO:0046641 | 0.02158 | 5.60787 | 1 | 3 | 22 | positive regulation of alpha-beta T cell proliferation |
| GO:0048857 | 0.02158 | 5.60787 | 1 | 3 | 22 | neural nucleus development |
| GO:0060602 | 0.02158 | 5.60787 | 1 | 3 | 22 | branch elongation of an epithelium |
| GO:0070242 | 0.02158 | 5.60787 | 1 | 3 | 22 | thymocyte apoptotic process |
| GO:2000353 | 0.02158 | 5.60787 | 1 | 3 | 22 | positive regulation of endothelial cell apoptotic process |
| GO:0031644 | 0.02164 | 2.18915 | 5 | 10 | 173 | regulation of neurological system process |
| GO:0032496 | 0.02171 | 1.77939 | 10 | 17 | 359 | response to lipopolysaccharide |
| GO:0062012 | 0.02171 | 1.77939 | 10 | 17 | 359 | regulation of small molecule metabolic process |
| GO:0044331 | 0.02174 | 4.06255 | 1 | 4 | 39 | cell-cell adhesion mediated by cadherin |
| GO:0010721 | 0.02176 | 1.74689 | 11 | 18 | 387 | negative regulation of cell development |
| GO:0051656 | 0.02215 | 1.66564 | 13 | 21 | 473 | establishment of organelle localization |
| GO:0044283 | 0.02273 | 1.55686 | 18 | 27 | 650 | small molecule biosynthetic process |
| GO:0043154 | 0.02281 | 2.88633 | 2 | 6 | 80 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0072078 | 0.02281 | 2.88633 | 2 | 6 | 80 | nephron tubule morphogenesis |
| GO:0006661 | 0.02287 | 3.29384 | 2 | 5 | 59 | phosphatidylinositol biosynthetic process |
| GO:0060119 | 0.02287 | 3.29384 | 2 | 5 | 59 | inner ear receptor cell development |
| GO:1903078 | 0.02287 | 3.29384 | 2 | 5 | 59 | positive regulation of protein localization to plasma membrane |
| GO:2000401 | 0.02287 | 3.29384 | 2 | 5 | 59 | regulation of lymphocyte migration |
| GO:0031623 | 0.02321 | 2.41636 | 3 | 8 | 126 | receptor internalization |
| GO:0034332 | 0.02321 | 2.41636 | 3 | 8 | 126 | adherens junction organization |
| GO:0045934 | 0.02342 | 1.37228 | 38 | 51 | 1395 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0006310 | 0.02351 | 1.88141 | 8 | 14 | 280 | DNA recombination |
| GO:0017015 | 0.02358 | 2.59727 | 3 | 7 | 103 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0008154 | 0.02365 | 2.06667 | 6 | 11 | 201 | actin polymerization or depolymerization |
| GO:0002686 | 0.02365 | 3.94953 | 1 | 4 | 40 | negative regulation of leukocyte migration |
| GO:0003009 | 0.02365 | 3.94953 | 1 | 4 | 40 | skeletal muscle contraction |
| GO:0006692 | 0.02365 | 3.94953 | 1 | 4 | 40 | prostanoid metabolic process |
| GO:0006693 | 0.02365 | 3.94953 | 1 | 4 | 40 | prostaglandin metabolic process |
| GO:0032620 | 0.02365 | 3.94953 | 1 | 4 | 40 | interleukin-17 production |
| GO:0038179 | 0.02365 | 3.94953 | 1 | 4 | 40 | neurotrophin signaling pathway |
| GO:0050706 | 0.02365 | 3.94953 | 1 | 4 | 40 | regulation of interleukin-1 beta secretion |
| GO:0060603 | 0.02365 | 3.94953 | 1 | 4 | 40 | mammary gland duct morphogenesis |
| GO:0086004 | 0.02365 | 3.94953 | 1 | 4 | 40 | regulation of cardiac muscle cell contraction |
| GO:2000273 | 0.02365 | 3.94953 | 1 | 4 | 40 | positive regulation of signaling receptor activity |
| GO:1901701 | 0.02371 | 1.39947 | 33 | 45 | 1206 | cellular response to oxygen-containing compound |
| GO:0002713 | 0.02389 | 10.13702 | 0 | 2 | 9 | negative regulation of B cell mediated immunity |
| GO:0002890 | 0.02389 | 10.13702 | 0 | 2 | 9 | negative regulation of immunoglobulin mediated immune response |
| GO:0003223 | 0.02389 | 10.13702 | 0 | 2 | 9 | ventricular compact myocardium morphogenesis |
| GO:0014827 | 0.02389 | 10.13702 | 0 | 2 | 9 | intestine smooth muscle contraction |
| GO:0016338 | 0.02389 | 10.13702 | 0 | 2 | 9 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0030223 | 0.02389 | 10.13702 | 0 | 2 | 9 | neutrophil differentiation |
| GO:0043320 | 0.02389 | 10.13702 | 0 | 2 | 9 | natural killer cell degranulation |
| GO:0045988 | 0.02389 | 10.13702 | 0 | 2 | 9 | negative regulation of striated muscle contraction |
| GO:0050713 | 0.02389 | 10.13702 | 0 | 2 | 9 | negative regulation of interleukin-1 beta secretion |
| GO:0060040 | 0.02389 | 10.13702 | 0 | 2 | 9 | retinal bipolar neuron differentiation |
| GO:0060556 | 0.02389 | 10.13702 | 0 | 2 | 9 | regulation of vitamin D biosynthetic process |
| GO:0071372 | 0.02389 | 10.13702 | 0 | 2 | 9 | cellular response to follicle-stimulating hormone stimulus |
| GO:0090286 | 0.02389 | 10.13702 | 0 | 2 | 9 | cytoskeletal anchoring at nuclear membrane |
| GO:0097067 | 0.02389 | 10.13702 | 0 | 2 | 9 | cellular response to thyroid hormone stimulus |
| GO:0099612 | 0.02389 | 10.13702 | 0 | 2 | 9 | protein localization to axon |
| GO:1900125 | 0.02389 | 10.13702 | 0 | 2 | 9 | regulation of hyaluronan biosynthetic process |
| GO:1904304 | 0.02389 | 10.13702 | 0 | 2 | 9 | regulation of gastro-intestinal system smooth muscle contraction |
| GO:2000969 | 0.02389 | 10.13702 | 0 | 2 | 9 | positive regulation of AMPA receptor activity |
| GO:2001138 | 0.02389 | 10.13702 | 0 | 2 | 9 | regulation of phospholipid transport |
| GO:2001140 | 0.02389 | 10.13702 | 0 | 2 | 9 | positive regulation of phospholipid transport |
| GO:2001187 | 0.02389 | 10.13702 | 0 | 2 | 9 | positive regulation of CD8-positive, alpha-beta T cell activation |
| GO:2001214 | 0.02389 | 10.13702 | 0 | 2 | 9 | positive regulation of vasculogenesis |
| GO:0050818 | 0.02408 | 2.84772 | 2 | 6 | 81 | regulation of coagulation |
| GO:0001822 | 0.02415 | 1.87428 | 8 | 14 | 281 | kidney development |
| GO:0032959 | 0.02432 | 5.32724 | 1 | 3 | 23 | inositol trisphosphate biosynthetic process |
| GO:0050765 | 0.02432 | 5.32724 | 1 | 3 | 23 | negative regulation of phagocytosis |
| GO:0060261 | 0.02432 | 5.32724 | 1 | 3 | 23 | positive regulation of transcription initiation from RNA polymerase II promoter |
| GO:0003012 | 0.02434 | 1.72315 | 11 | 18 | 392 | muscle system process |
| GO:0001101 | 0.02439 | 1.75335 | 10 | 17 | 364 | response to acid chemical |
| GO:0033209 | 0.02440 | 3.23381 | 2 | 5 | 60 | tumor necrosis factor-mediated signaling pathway |
| GO:0050982 | 0.02440 | 3.23381 | 2 | 5 | 60 | detection of mechanical stimulus |
| GO:0044281 | 0.02457 | 1.32916 | 48 | 62 | 1753 | small molecule metabolic process |
| GO:0001657 | 0.02471 | 2.57038 | 3 | 7 | 104 | ureteric bud development |
| GO:0030101 | 0.02471 | 2.57038 | 3 | 7 | 104 | natural killer cell activation |
| GO:0072163 | 0.02471 | 2.57038 | 3 | 7 | 104 | mesonephric epithelium development |
| GO:0072164 | 0.02471 | 2.57038 | 3 | 7 | 104 | mesonephric tubule development |
| GO:0008016 | 0.02487 | 2.13633 | 5 | 10 | 177 | regulation of heart contraction |
| GO:0010675 | 0.02488 | 2.24422 | 4 | 9 | 152 | regulation of cellular carbohydrate metabolic process |
| GO:0050709 | 0.02488 | 2.24422 | 4 | 9 | 152 | negative regulation of protein secretion |
| GO:0019725 | 0.02525 | 1.45007 | 26 | 36 | 930 | cellular homeostasis |
| GO:0002718 | 0.02540 | 2.81013 | 2 | 6 | 82 | regulation of cytokine production involved in immune response |
| GO:0051899 | 0.02540 | 2.81013 | 2 | 6 | 82 | membrane depolarization |
| GO:0072088 | 0.02540 | 2.81013 | 2 | 6 | 82 | nephron epithelium morphogenesis |
| GO:0038083 | 0.02565 | 3.84261 | 1 | 4 | 41 | peptidyl-tyrosine autophosphorylation |
| GO:0045197 | 0.02565 | 3.84261 | 1 | 4 | 41 | establishment or maintenance of epithelial cell apical/basal polarity |
| GO:0099084 | 0.02565 | 3.84261 | 1 | 4 | 41 | postsynaptic specialization organization |
| GO:1905521 | 0.02565 | 3.84261 | 1 | 4 | 41 | regulation of macrophage migration |
| GO:2001258 | 0.02565 | 3.84261 | 1 | 4 | 41 | negative regulation of cation channel activity |
| GO:0000075 | 0.02573 | 2.12352 | 5 | 10 | 178 | cell cycle checkpoint |
| GO:0048813 | 0.02573 | 2.12352 | 5 | 10 | 178 | dendrite morphogenesis |
| GO:1903844 | 0.02587 | 2.54403 | 3 | 7 | 105 | regulation of cellular response to transforming growth factor beta stimulus |
| GO:0010812 | 0.02600 | 3.17592 | 2 | 5 | 61 | negative regulation of cell-substrate adhesion |
| GO:0048286 | 0.02600 | 3.17592 | 2 | 5 | 61 | lung alveolus development |
| GO:0051591 | 0.02600 | 3.17592 | 2 | 5 | 61 | response to cAMP |
| GO:1902305 | 0.02600 | 3.17592 | 2 | 5 | 61 | regulation of sodium ion transmembrane transport |
| GO:0071560 | 0.02600 | 2.03427 | 6 | 11 | 204 | cellular response to transforming growth factor beta stimulus |
| GO:0044262 | 0.02613 | 1.85321 | 8 | 14 | 284 | cellular carbohydrate metabolic process |
| GO:0001936 | 0.02626 | 2.35613 | 4 | 8 | 129 | regulation of endothelial cell proliferation |
| GO:0046488 | 0.02626 | 2.35613 | 4 | 8 | 129 | phosphatidylinositol metabolic process |
| GO:0050830 | 0.02626 | 2.35613 | 4 | 8 | 129 | defense response to Gram-positive bacterium |
| GO:1903034 | 0.02661 | 2.11086 | 5 | 10 | 179 | regulation of response to wounding |
| GO:0072028 | 0.02677 | 2.77351 | 2 | 6 | 83 | nephron morphogenesis |
| GO:0071248 | 0.02678 | 2.21307 | 4 | 9 | 154 | cellular response to metal ion |
| GO:0061448 | 0.02682 | 1.84628 | 8 | 14 | 285 | connective tissue development |
| GO:0031345 | 0.02683 | 2.02369 | 6 | 11 | 205 | negative regulation of cell projection organization |
| GO:0055006 | 0.02707 | 2.51823 | 3 | 7 | 106 | cardiac cell development |
| GO:0060840 | 0.02707 | 2.51823 | 3 | 7 | 106 | artery development |
| GO:0001654 | 0.02715 | 1.70003 | 11 | 18 | 397 | eye development |
| GO:0002693 | 0.02724 | 5.07334 | 1 | 3 | 24 | positive regulation of cellular extravasation |
| GO:0006882 | 0.02724 | 5.07334 | 1 | 3 | 24 | cellular zinc ion homeostasis |
| GO:0032928 | 0.02724 | 5.07334 | 1 | 3 | 24 | regulation of superoxide anion generation |
| GO:0000085 | 0.02749 | Inf | 0 | 1 | 1 | mitotic G2 phase |
| GO:0001100 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of exit from mitosis |
| GO:0002194 | 0.02749 | Inf | 0 | 1 | 1 | hepatocyte cell migration |
| GO:0002280 | 0.02749 | Inf | 0 | 1 | 1 | monocyte activation involved in immune response |
| GO:0002316 | 0.02749 | Inf | 0 | 1 | 1 | follicular B cell differentiation |
| GO:0002413 | 0.02749 | Inf | 0 | 1 | 1 | tolerance induction to tumor cell |
| GO:0002419 | 0.02749 | Inf | 0 | 1 | 1 | T cell mediated cytotoxicity directed against tumor cell target |
| GO:0002510 | 0.02749 | Inf | 0 | 1 | 1 | central B cell tolerance induction |
| GO:0002646 | 0.02749 | Inf | 0 | 1 | 1 | regulation of central tolerance induction |
| GO:0002648 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of central tolerance induction |
| GO:0002841 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of T cell mediated immune response to tumor cell |
| GO:0002843 | 0.02749 | Inf | 0 | 1 | 1 | regulation of tolerance induction to tumor cell |
| GO:0002845 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of tolerance induction to tumor cell |
| GO:0002852 | 0.02749 | Inf | 0 | 1 | 1 | regulation of T cell mediated cytotoxicity directed against tumor cell target |
| GO:0002853 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of T cell mediated cytotoxicity directed against tumor cell target |
| GO:0002895 | 0.02749 | Inf | 0 | 1 | 1 | regulation of central B cell tolerance induction |
| GO:0002897 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of central B cell tolerance induction |
| GO:0003059 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of the force of heart contraction by epinephrine |
| GO:0003226 | 0.02749 | Inf | 0 | 1 | 1 | right ventricular compact myocardium morphogenesis |
| GO:0006580 | 0.02749 | Inf | 0 | 1 | 1 | ethanolamine metabolic process |
| GO:0006653 | 0.02749 | Inf | 0 | 1 | 1 | 1,2-diacyl-sn-glycero-3-phosphocholine metabolic process |
| GO:0009817 | 0.02749 | Inf | 0 | 1 | 1 | defense response to fungus, incompatible interaction |
| GO:0010650 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of cell communication by electrical coupling |
| GO:0014006 | 0.02749 | Inf | 0 | 1 | 1 | regulation of microglia differentiation |
| GO:0014008 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of microglia differentiation |
| GO:0014828 | 0.02749 | Inf | 0 | 1 | 1 | distal stomach smooth muscle contraction |
| GO:0015680 | 0.02749 | Inf | 0 | 1 | 1 | protein maturation by copper ion transfer |
| GO:0016024 | 0.02749 | Inf | 0 | 1 | 1 | CDP-diacylglycerol biosynthetic process |
| GO:0031619 | 0.02749 | Inf | 0 | 1 | 1 | homologous chromosome orientation involved in meiotic metaphase I plate congression |
| GO:0032254 | 0.02749 | Inf | 0 | 1 | 1 | establishment of secretory granule localization |
| GO:0032658 | 0.02749 | Inf | 0 | 1 | 1 | regulation of interleukin-15 production |
| GO:0032712 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of interleukin-3 production |
| GO:0032738 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of interleukin-15 production |
| GO:0033343 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of collagen binding |
| GO:0034465 | 0.02749 | Inf | 0 | 1 | 1 | response to carbon monoxide |
| GO:0035565 | 0.02749 | Inf | 0 | 1 | 1 | regulation of pronephros size |
| GO:0035664 | 0.02749 | Inf | 0 | 1 | 1 | TIRAP-dependent toll-like receptor signaling pathway |
| GO:0035665 | 0.02749 | Inf | 0 | 1 | 1 | TIRAP-dependent toll-like receptor 4 signaling pathway |
| GO:0036268 | 0.02749 | Inf | 0 | 1 | 1 | swimming |
| GO:0042313 | 0.02749 | Inf | 0 | 1 | 1 | protein kinase C deactivation |
| GO:0042441 | 0.02749 | Inf | 0 | 1 | 1 | eye pigment metabolic process |
| GO:0042696 | 0.02749 | Inf | 0 | 1 | 1 | menarche |
| GO:0043056 | 0.02749 | Inf | 0 | 1 | 1 | forward locomotion |
| GO:0043324 | 0.02749 | Inf | 0 | 1 | 1 | pigment metabolic process involved in developmental pigmentation |
| GO:0043474 | 0.02749 | Inf | 0 | 1 | 1 | pigment metabolic process involved in pigmentation |
| GO:0044651 | 0.02749 | Inf | 0 | 1 | 1 | adhesion of symbiont to host epithelial cell |
| GO:0045660 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of neutrophil differentiation |
| GO:0045959 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of complement activation, classical pathway |
| GO:0046154 | 0.02749 | Inf | 0 | 1 | 1 | rhodopsin metabolic process |
| GO:0046449 | 0.02749 | Inf | 0 | 1 | 1 | creatinine metabolic process |
| GO:0046551 | 0.02749 | Inf | 0 | 1 | 1 | retinal cone cell fate commitment |
| GO:0060082 | 0.02749 | Inf | 0 | 1 | 1 | eye blink reflex |
| GO:0060222 | 0.02749 | Inf | 0 | 1 | 1 | regulation of retinal cone cell fate commitment |
| GO:0060223 | 0.02749 | Inf | 0 | 1 | 1 | retinal rod cell fate commitment |
| GO:0060226 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of retinal cone cell fate commitment |
| GO:0060234 | 0.02749 | Inf | 0 | 1 | 1 | neuroblast delamination |
| GO:0061114 | 0.02749 | Inf | 0 | 1 | 1 | branching involved in pancreas morphogenesis |
| GO:0061163 | 0.02749 | Inf | 0 | 1 | 1 | endoplasmic reticulum polarization |
| GO:0061206 | 0.02749 | Inf | 0 | 1 | 1 | mesonephros morphogenesis |
| GO:0061215 | 0.02749 | Inf | 0 | 1 | 1 | mesonephric nephron development |
| GO:0061228 | 0.02749 | Inf | 0 | 1 | 1 | mesonephric nephron morphogenesis |
| GO:0061235 | 0.02749 | Inf | 0 | 1 | 1 | mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis |
| GO:0061295 | 0.02749 | Inf | 0 | 1 | 1 | regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis |
| GO:0061296 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis |
| GO:0061485 | 0.02749 | Inf | 0 | 1 | 1 | memory T cell proliferation |
| GO:0061573 | 0.02749 | Inf | 0 | 1 | 1 | actin filament bundle retrograde transport |
| GO:0061737 | 0.02749 | Inf | 0 | 1 | 1 | leukotriene signaling pathway |
| GO:0061837 | 0.02749 | Inf | 0 | 1 | 1 | neuropeptide processing |
| GO:0061886 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of mini excitatory postsynaptic potential |
| GO:0061914 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of growth plate cartilage chondrocyte proliferation |
| GO:0061921 | 0.02749 | Inf | 0 | 1 | 1 | peptidyl-lysine propionylation |
| GO:0061976 | 0.02749 | Inf | 0 | 1 | 1 | temporomandibular joint articular cartilage development |
| GO:0061978 | 0.02749 | Inf | 0 | 1 | 1 | mandibular condyle articular cartilage development |
| GO:0061986 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of transcription by glucose |
| GO:0061987 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of transcription from RNA polymerase II promoter by glucose |
| GO:0071228 | 0.02749 | Inf | 0 | 1 | 1 | cellular response to tumor cell |
| GO:0071606 | 0.02749 | Inf | 0 | 1 | 1 | chemokine (C-C motif) ligand 4 production |
| GO:0071629 | 0.02749 | Inf | 0 | 1 | 1 | cytoplasm protein quality control by the ubiquitin-proteasome system |
| GO:0071643 | 0.02749 | Inf | 0 | 1 | 1 | regulation of chemokine (C-C motif) ligand 4 production |
| GO:0071644 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of chemokine (C-C motif) ligand 4 production |
| GO:0071656 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of granulocyte colony-stimulating factor production |
| GO:0071932 | 0.02749 | Inf | 0 | 1 | 1 | replication fork reversal |
| GO:0072428 | 0.02749 | Inf | 0 | 1 | 1 | signal transduction involved in intra-S DNA damage checkpoint |
| GO:0072709 | 0.02749 | Inf | 0 | 1 | 1 | cellular response to sorbitol |
| GO:0072740 | 0.02749 | Inf | 0 | 1 | 1 | cellular response to anisomycin |
| GO:0086072 | 0.02749 | Inf | 0 | 1 | 1 | AV node cell-bundle of His cell adhesion involved in cell communication |
| GO:0090251 | 0.02749 | Inf | 0 | 1 | 1 | protein localization involved in establishment of planar polarity |
| GO:0090425 | 0.02749 | Inf | 0 | 1 | 1 | acinar cell differentiation |
| GO:0097291 | 0.02749 | Inf | 0 | 1 | 1 | renal phosphate ion absorption |
| GO:0097326 | 0.02749 | Inf | 0 | 1 | 1 | melanocyte adhesion |
| GO:0097510 | 0.02749 | Inf | 0 | 1 | 1 | base-excision repair, AP site formation via deaminated base removal |
| GO:0098737 | 0.02749 | Inf | 0 | 1 | 1 | protein insertion into plasma membrane |
| GO:0106088 | 0.02749 | Inf | 0 | 1 | 1 | regulation of cell adhesion involved in sprouting angiogenesis |
| GO:0106089 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of cell adhesion involved in sprouting angiogenesis |
| GO:0120064 | 0.02749 | Inf | 0 | 1 | 1 | stomach pylorus smooth muscle contraction |
| GO:0120065 | 0.02749 | Inf | 0 | 1 | 1 | pyloric antrum smooth muscle contraction |
| GO:0120071 | 0.02749 | Inf | 0 | 1 | 1 | regulation of pyloric antrum smooth muscle contraction |
| GO:0120072 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of pyloric antrum smooth muscle contraction |
| GO:0140067 | 0.02749 | Inf | 0 | 1 | 1 | peptidyl-lysine butyrylation |
| GO:1900827 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of membrane depolarization during cardiac muscle cell action potential |
| GO:1901146 | 0.02749 | Inf | 0 | 1 | 1 | mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis |
| GO:1901148 | 0.02749 | Inf | 0 | 1 | 1 | gene expression involved in extracellular matrix organization |
| GO:1901246 | 0.02749 | Inf | 0 | 1 | 1 | regulation of lung ciliated cell differentiation |
| GO:1901248 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of lung ciliated cell differentiation |
| GO:1901257 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of macrophage colony-stimulating factor production |
| GO:1902076 | 0.02749 | Inf | 0 | 1 | 1 | regulation of lateral motor column neuron migration |
| GO:1902078 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of lateral motor column neuron migration |
| GO:1902576 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of nuclear cell cycle DNA replication |
| GO:1902691 | 0.02749 | Inf | 0 | 1 | 1 | respiratory basal cell differentiation |
| GO:1903210 | 0.02749 | Inf | 0 | 1 | 1 | glomerular visceral epithelial cell apoptotic process |
| GO:1903450 | 0.02749 | Inf | 0 | 1 | 1 | regulation of G1 to G0 transition |
| GO:1903452 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of G1 to G0 transition |
| GO:1903464 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of mitotic cell cycle DNA replication |
| GO:1903781 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of cardiac conduction |
| GO:1903904 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of establishment of T cell polarity |
| GO:1903949 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of atrial cardiac muscle cell action potential |
| GO:1904140 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of microglial cell migration |
| GO:1904199 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization |
| GO:1904274 | 0.02749 | Inf | 0 | 1 | 1 | tricellular tight junction assembly |
| GO:1904472 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of endothelin secretion |
| GO:1904596 | 0.02749 | Inf | 0 | 1 | 1 | regulation of connective tissue replacement involved in inflammatory response wound healing |
| GO:1904597 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of connective tissue replacement involved in inflammatory response wound healing |
| GO:1904603 | 0.02749 | Inf | 0 | 1 | 1 | regulation of advanced glycation end-product receptor activity |
| GO:1904604 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of advanced glycation end-product receptor activity |
| GO:1904605 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of advanced glycation end-product receptor activity |
| GO:1904633 | 0.02749 | Inf | 0 | 1 | 1 | regulation of glomerular visceral epithelial cell apoptotic process |
| GO:1904635 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of glomerular visceral epithelial cell apoptotic process |
| GO:1905217 | 0.02749 | Inf | 0 | 1 | 1 | response to astaxanthin |
| GO:1905226 | 0.02749 | Inf | 0 | 1 | 1 | regulation of adhesion of symbiont to host epithelial cell |
| GO:1905239 | 0.02749 | Inf | 0 | 1 | 1 | regulation of canonical Wnt signaling pathway involved in osteoblast differentiation |
| GO:1905240 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation |
| GO:1905313 | 0.02749 | Inf | 0 | 1 | 1 | transforming growth factor beta receptor signaling pathway involved in heart development |
| GO:1905403 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process |
| GO:1905404 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process |
| GO:1905483 | 0.02749 | Inf | 0 | 1 | 1 | regulation of motor neuron migration |
| GO:1905485 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of motor neuron migration |
| GO:1905535 | 0.02749 | Inf | 0 | 1 | 1 | regulation of eukaryotic translation initiation factor 4F complex assembly |
| GO:1905537 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of eukaryotic translation initiation factor 4F complex assembly |
| GO:1905610 | 0.02749 | Inf | 0 | 1 | 1 | regulation of mRNA cap binding |
| GO:1905612 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of mRNA cap binding |
| GO:1905872 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of protein localization to cell leading edge |
| GO:1990134 | 0.02749 | Inf | 0 | 1 | 1 | epithelial cell apoptotic process involved in palatal shelf morphogenesis |
| GO:1990402 | 0.02749 | Inf | 0 | 1 | 1 | embryonic liver development |
| GO:1990654 | 0.02749 | Inf | 0 | 1 | 1 | sebum secreting cell proliferation |
| GO:1990736 | 0.02749 | Inf | 0 | 1 | 1 | regulation of vascular smooth muscle cell membrane depolarization |
| GO:1990771 | 0.02749 | Inf | 0 | 1 | 1 | clathrin-dependent extracellular exosome endocytosis |
| GO:2000184 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of progesterone biosynthetic process |
| GO:2000266 | 0.02749 | Inf | 0 | 1 | 1 | regulation of blood coagulation, intrinsic pathway |
| GO:2000970 | 0.02749 | Inf | 0 | 1 | 1 | regulation of detection of glucose |
| GO:2000971 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of detection of glucose |
| GO:2000979 | 0.02749 | Inf | 0 | 1 | 1 | positive regulation of forebrain neuron differentiation |
| GO:2001246 | 0.02749 | Inf | 0 | 1 | 1 | negative regulation of phosphatidylcholine biosynthetic process |
| GO:2001295 | 0.02749 | Inf | 0 | 1 | 1 | malonyl-CoA biosynthetic process |
| GO:1902115 | 0.02767 | 2.01323 | 6 | 11 | 206 | regulation of organelle assembly |
| GO:0030858 | 0.02767 | 3.12006 | 2 | 5 | 62 | positive regulation of epithelial cell differentiation |
| GO:0034308 | 0.02767 | 3.12006 | 2 | 5 | 62 | primary alcohol metabolic process |
| GO:0043966 | 0.02767 | 3.12006 | 2 | 5 | 62 | histone H3 acetylation |
| GO:0048008 | 0.02767 | 3.12006 | 2 | 5 | 62 | platelet-derived growth factor receptor signaling pathway |
| GO:0071363 | 0.02769 | 1.55463 | 17 | 25 | 602 | cellular response to growth factor stimulus |
| GO:0006687 | 0.02775 | 3.74132 | 1 | 4 | 42 | glycosphingolipid metabolic process |
| GO:0030866 | 0.02775 | 3.74132 | 1 | 4 | 42 | cortical actin cytoskeleton organization |
| GO:0032768 | 0.02775 | 3.74132 | 1 | 4 | 42 | regulation of monooxygenase activity |
| GO:0034198 | 0.02775 | 3.74132 | 1 | 4 | 42 | cellular response to amino acid starvation |
| GO:0009617 | 0.02818 | 1.44442 | 25 | 35 | 907 | response to bacterium |
| GO:0045844 | 0.02819 | 2.73783 | 2 | 6 | 84 | positive regulation of striated muscle tissue development |
| GO:0048524 | 0.02819 | 2.73783 | 2 | 6 | 84 | positive regulation of viral process |
| GO:0048636 | 0.02819 | 2.73783 | 2 | 6 | 84 | positive regulation of muscle organ development |
| GO:0030278 | 0.02821 | 1.93870 | 6 | 12 | 233 | regulation of ossification |
| GO:0001823 | 0.02831 | 2.49293 | 3 | 7 | 107 | mesonephros development |
| GO:0003014 | 0.02831 | 2.49293 | 3 | 7 | 107 | renal system process |
| GO:0030218 | 0.02844 | 2.31762 | 4 | 8 | 131 | erythrocyte differentiation |
| GO:1901564 | 0.02883 | 1.18683 | 171 | 193 | 6234 | organonitrogen compound metabolic process |
| GO:0072593 | 0.02896 | 1.82582 | 8 | 14 | 288 | reactive oxygen species metabolic process |
| GO:0002420 | 0.02933 | 8.86950 | 0 | 2 | 10 | natural killer cell mediated cytotoxicity directed against tumor cell target |
| GO:0002634 | 0.02933 | 8.86950 | 0 | 2 | 10 | regulation of germinal center formation |
| GO:0002645 | 0.02933 | 8.86950 | 0 | 2 | 10 | positive regulation of tolerance induction |
| GO:0002858 | 0.02933 | 8.86950 | 0 | 2 | 10 | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
| GO:0032354 | 0.02933 | 8.86950 | 0 | 2 | 10 | response to follicle-stimulating hormone |
| GO:0033085 | 0.02933 | 8.86950 | 0 | 2 | 10 | negative regulation of T cell differentiation in thymus |
| GO:0043201 | 0.02933 | 8.86950 | 0 | 2 | 10 | response to leucine |
| GO:0044793 | 0.02933 | 8.86950 | 0 | 2 | 10 | negative regulation by host of viral process |
| GO:0046543 | 0.02933 | 8.86950 | 0 | 2 | 10 | development of secondary female sexual characteristics |
| GO:0051601 | 0.02933 | 8.86950 | 0 | 2 | 10 | exocyst localization |
| GO:0051639 | 0.02933 | 8.86950 | 0 | 2 | 10 | actin filament network formation |
| GO:0070244 | 0.02933 | 8.86950 | 0 | 2 | 10 | negative regulation of thymocyte apoptotic process |
| GO:0070673 | 0.02933 | 8.86950 | 0 | 2 | 10 | response to interleukin-18 |
| GO:0071233 | 0.02933 | 8.86950 | 0 | 2 | 10 | cellular response to leucine |
| GO:0071305 | 0.02933 | 8.86950 | 0 | 2 | 10 | cellular response to vitamin D |
| GO:1902074 | 0.02933 | 8.86950 | 0 | 2 | 10 | response to salt |
| GO:1904468 | 0.02933 | 8.86950 | 0 | 2 | 10 | negative regulation of tumor necrosis factor secretion |
| GO:1990253 | 0.02933 | 8.86950 | 0 | 2 | 10 | cellular response to leucine starvation |
| GO:2000551 | 0.02933 | 8.86950 | 0 | 2 | 10 | regulation of T-helper 2 cell cytokine production |
| GO:2001179 | 0.02933 | 8.86950 | 0 | 2 | 10 | regulation of interleukin-10 secretion |
| GO:0005975 | 0.02933 | 1.57667 | 15 | 23 | 546 | carbohydrate metabolic process |
| GO:0035051 | 0.02938 | 2.07377 | 5 | 10 | 182 | cardiocyte differentiation |
| GO:0120032 | 0.02938 | 2.07377 | 5 | 10 | 182 | regulation of plasma membrane bounded cell projection assembly |
| GO:0035904 | 0.02940 | 3.06613 | 2 | 5 | 63 | aorta development |
| GO:0043388 | 0.02940 | 3.06613 | 2 | 5 | 63 | positive regulation of DNA binding |
| GO:0043967 | 0.02940 | 3.06613 | 2 | 5 | 63 | histone H4 acetylation |
| GO:0099601 | 0.02940 | 3.06613 | 2 | 5 | 63 | regulation of neurotransmitter receptor activity |
| GO:2000756 | 0.02940 | 3.06613 | 2 | 5 | 63 | regulation of peptidyl-lysine acetylation |
| GO:0071559 | 0.02940 | 1.99261 | 6 | 11 | 208 | response to transforming growth factor beta |
| GO:0030048 | 0.02958 | 2.46814 | 3 | 7 | 108 | actin filament-based movement |
| GO:2000106 | 0.02958 | 2.46814 | 3 | 7 | 108 | regulation of leukocyte apoptotic process |
| GO:0003002 | 0.02985 | 1.70834 | 10 | 17 | 373 | regionalization |
| GO:0003416 | 0.02996 | 3.64523 | 1 | 4 | 43 | endochondral bone growth |
| GO:0038202 | 0.02996 | 3.64523 | 1 | 4 | 43 | TORC1 signaling |
| GO:0042307 | 0.02996 | 3.64523 | 1 | 4 | 43 | positive regulation of protein import into nucleus |
| GO:0045823 | 0.02996 | 3.64523 | 1 | 4 | 43 | positive regulation of heart contraction |
| GO:0048854 | 0.02996 | 3.64523 | 1 | 4 | 43 | brain morphogenesis |
| GO:0086002 | 0.02996 | 3.64523 | 1 | 4 | 43 | cardiac muscle cell action potential involved in contraction |
| GO:1901031 | 0.02996 | 3.64523 | 1 | 4 | 43 | regulation of response to reactive oxygen species |
| GO:0002440 | 0.03000 | 1.73911 | 9 | 16 | 345 | production of molecular mediator of immune response |
| GO:0098542 | 0.03013 | 1.51433 | 18 | 27 | 667 | defense response to other organism |
| GO:0009058 | 0.03014 | 1.19725 | 141 | 161 | 5125 | biosynthetic process |
| GO:0019722 | 0.03030 | 1.98246 | 6 | 11 | 209 | calcium-mediated signaling |
| GO:0008152 | 0.03033 | 1.16647 | 288 | 312 | 10485 | metabolic process |
| GO:0010640 | 0.03034 | 4.84252 | 1 | 3 | 25 | regulation of platelet-derived growth factor receptor signaling pathway |
| GO:0010894 | 0.03034 | 4.84252 | 1 | 3 | 25 | negative regulation of steroid biosynthetic process |
| GO:0014821 | 0.03034 | 4.84252 | 1 | 3 | 25 | phasic smooth muscle contraction |
| GO:0045939 | 0.03034 | 4.84252 | 1 | 3 | 25 | negative regulation of steroid metabolic process |
| GO:0055069 | 0.03034 | 4.84252 | 1 | 3 | 25 | zinc ion homeostasis |
| GO:0085029 | 0.03034 | 4.84252 | 1 | 3 | 25 | extracellular matrix assembly |
| GO:0090140 | 0.03034 | 4.84252 | 1 | 3 | 25 | regulation of mitochondrial fission |
| GO:0120033 | 0.03034 | 4.84252 | 1 | 3 | 25 | negative regulation of plasma membrane bounded cell projection assembly |
| GO:0050792 | 0.03035 | 2.06169 | 5 | 10 | 183 | regulation of viral process |
| GO:0034763 | 0.03075 | 2.28033 | 4 | 8 | 133 | negative regulation of transmembrane transport |
| GO:1901568 | 0.03075 | 2.28033 | 4 | 8 | 133 | fatty acid derivative metabolic process |
| GO:0044238 | 0.03085 | 1.16723 | 260 | 283 | 9443 | primary metabolic process |
| GO:0001910 | 0.03089 | 2.44383 | 3 | 7 | 109 | regulation of leukocyte mediated cytotoxicity |
| GO:0072009 | 0.03089 | 2.44383 | 3 | 7 | 109 | nephron epithelium development |
| GO:2000379 | 0.03089 | 2.44383 | 3 | 7 | 109 | positive regulation of reactive oxygen species metabolic process |
| GO:0032611 | 0.03116 | 2.66915 | 2 | 6 | 86 | interleukin-1 beta production |
| GO:0060079 | 0.03116 | 2.66915 | 2 | 6 | 86 | excitatory postsynaptic potential |
| GO:0061333 | 0.03116 | 2.66915 | 2 | 6 | 86 | renal tubule morphogenesis |
| GO:0001658 | 0.03119 | 3.01403 | 2 | 5 | 64 | branching involved in ureteric bud morphogenesis |
| GO:0042267 | 0.03119 | 3.01403 | 2 | 5 | 64 | natural killer cell mediated cytotoxicity |
| GO:0046434 | 0.03122 | 1.97241 | 6 | 11 | 210 | organophosphate catabolic process |
| GO:0060491 | 0.03134 | 2.04975 | 5 | 10 | 184 | regulation of cell projection assembly |
| GO:0050864 | 0.03154 | 1.84971 | 7 | 13 | 264 | regulation of B cell activation |
| GO:0030833 | 0.03197 | 2.13882 | 4 | 9 | 159 | regulation of actin filament polymerization |
| GO:0042552 | 0.03197 | 2.13882 | 4 | 9 | 159 | myelination |
| GO:0007611 | 0.03200 | 1.79923 | 8 | 14 | 292 | learning or memory |
| GO:0043010 | 0.03211 | 1.72316 | 10 | 16 | 348 | camera-type eye development |
| GO:0060047 | 0.03216 | 1.96246 | 6 | 11 | 211 | heart contraction |
| GO:0090100 | 0.03224 | 2.42000 | 3 | 7 | 110 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0010569 | 0.03226 | 3.55394 | 1 | 4 | 44 | regulation of double-strand break repair via homologous recombination |
| GO:0050919 | 0.03226 | 3.55394 | 1 | 4 | 44 | negative chemotaxis |
| GO:0010770 | 0.03235 | 2.03794 | 5 | 10 | 185 | positive regulation of cell morphogenesis involved in differentiation |
| GO:0002237 | 0.03255 | 1.68905 | 10 | 17 | 377 | response to molecule of bacterial origin |
| GO:0042475 | 0.03273 | 2.63608 | 2 | 6 | 87 | odontogenesis of dentin-containing tooth |
| GO:0070252 | 0.03273 | 2.63608 | 2 | 6 | 87 | actin-mediated cell contraction |
| GO:2000117 | 0.03273 | 2.63608 | 2 | 6 | 87 | negative regulation of cysteine-type endopeptidase activity |
| GO:0071396 | 0.03277 | 1.52745 | 17 | 25 | 612 | cellular response to lipid |
| GO:0043647 | 0.03306 | 2.96367 | 2 | 5 | 65 | inositol phosphate metabolic process |
| GO:0150076 | 0.03306 | 2.96367 | 2 | 5 | 65 | neuroinflammatory response |
| GO:1903522 | 0.03336 | 1.88695 | 7 | 12 | 239 | regulation of blood circulation |
| GO:1905475 | 0.03338 | 2.02627 | 5 | 10 | 186 | regulation of protein localization to membrane |
| GO:0045742 | 0.03362 | 4.63177 | 1 | 3 | 26 | positive regulation of epidermal growth factor receptor signaling pathway |
| GO:0051570 | 0.03362 | 4.63177 | 1 | 3 | 26 | regulation of histone H3-K9 methylation |
| GO:0055003 | 0.03362 | 4.63177 | 1 | 3 | 26 | cardiac myofibril assembly |
| GO:0060716 | 0.03362 | 4.63177 | 1 | 3 | 26 | labyrinthine layer blood vessel development |
| GO:0090189 | 0.03362 | 4.63177 | 1 | 3 | 26 | regulation of branching involved in ureteric bud morphogenesis |
| GO:2000311 | 0.03362 | 4.63177 | 1 | 3 | 26 | regulation of AMPA receptor activity |
| GO:0016054 | 0.03409 | 1.94285 | 6 | 11 | 213 | organic acid catabolic process |
| GO:0046395 | 0.03409 | 1.94285 | 6 | 11 | 213 | carboxylic acid catabolic process |
| GO:0051147 | 0.03423 | 2.11049 | 4 | 9 | 161 | regulation of muscle cell differentiation |
| GO:0070848 | 0.03443 | 1.51948 | 17 | 25 | 615 | response to growth factor |
| GO:0001774 | 0.03466 | 3.46711 | 1 | 4 | 45 | microglial cell activation |
| GO:0002063 | 0.03466 | 3.46711 | 1 | 4 | 45 | chondrocyte development |
| GO:0002269 | 0.03466 | 3.46711 | 1 | 4 | 45 | leukocyte activation involved in inflammatory response |
| GO:0060421 | 0.03466 | 3.46711 | 1 | 4 | 45 | positive regulation of heart growth |
| GO:0061028 | 0.03466 | 3.46711 | 1 | 4 | 45 | establishment of endothelial barrier |
| GO:0071526 | 0.03466 | 3.46711 | 1 | 4 | 45 | semaphorin-plexin signaling pathway |
| GO:0002253 | 0.03479 | 1.56378 | 14 | 22 | 526 | activation of immune response |
| GO:0019637 | 0.03488 | 1.41059 | 26 | 36 | 954 | organophosphate metabolic process |
| GO:0071704 | 0.03498 | 1.16099 | 275 | 298 | 10008 | organic substance metabolic process |
| GO:0002228 | 0.03499 | 2.91495 | 2 | 5 | 66 | natural killer cell mediated immunity |
| GO:1904377 | 0.03499 | 2.91495 | 2 | 5 | 66 | positive regulation of protein localization to cell periphery |
| GO:0060078 | 0.03506 | 2.37369 | 3 | 7 | 112 | regulation of postsynaptic membrane potential |
| GO:0072329 | 0.03506 | 2.37369 | 3 | 7 | 112 | monocarboxylic acid catabolic process |
| GO:0001574 | 0.03520 | 7.88365 | 0 | 2 | 11 | ganglioside biosynthetic process |
| GO:0001865 | 0.03520 | 7.88365 | 0 | 2 | 11 | NK T cell differentiation |
| GO:0002423 | 0.03520 | 7.88365 | 0 | 2 | 11 | natural killer cell mediated immune response to tumor cell |
| GO:0002855 | 0.03520 | 7.88365 | 0 | 2 | 11 | regulation of natural killer cell mediated immune response to tumor cell |
| GO:0006977 | 0.03520 | 7.88365 | 0 | 2 | 11 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest |
| GO:0009111 | 0.03520 | 7.88365 | 0 | 2 | 11 | vitamin catabolic process |
| GO:0017085 | 0.03520 | 7.88365 | 0 | 2 | 11 | response to insecticide |
| GO:0031630 | 0.03520 | 7.88365 | 0 | 2 | 11 | regulation of synaptic vesicle fusion to presynaptic active zone membrane |
| GO:0033327 | 0.03520 | 7.88365 | 0 | 2 | 11 | Leydig cell differentiation |
| GO:0035881 | 0.03520 | 7.88365 | 0 | 2 | 11 | amacrine cell differentiation |
| GO:0036005 | 0.03520 | 7.88365 | 0 | 2 | 11 | response to macrophage colony-stimulating factor |
| GO:0036006 | 0.03520 | 7.88365 | 0 | 2 | 11 | cellular response to macrophage colony-stimulating factor stimulus |
| GO:0042368 | 0.03520 | 7.88365 | 0 | 2 | 11 | vitamin D biosynthetic process |
| GO:0043619 | 0.03520 | 7.88365 | 0 | 2 | 11 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress |
| GO:0048845 | 0.03520 | 7.88365 | 0 | 2 | 11 | venous blood vessel morphogenesis |
| GO:0051574 | 0.03520 | 7.88365 | 0 | 2 | 11 | positive regulation of histone H3-K9 methylation |
| GO:0060600 | 0.03520 | 7.88365 | 0 | 2 | 11 | dichotomous subdivision of an epithelial terminal unit |
| GO:1901894 | 0.03520 | 7.88365 | 0 | 2 | 11 | regulation of calcium-transporting ATPase activity |
| GO:1902260 | 0.03520 | 7.88365 | 0 | 2 | 11 | negative regulation of delayed rectifier potassium channel activity |
| GO:1903799 | 0.03520 | 7.88365 | 0 | 2 | 11 | negative regulation of production of miRNAs involved in gene silencing by miRNA |
| GO:1904862 | 0.03520 | 7.88365 | 0 | 2 | 11 | inhibitory synapse assembly |
| GO:2000343 | 0.03520 | 7.88365 | 0 | 2 | 11 | positive regulation of chemokine (C-X-C motif) ligand 2 production |
| GO:0043412 | 0.03524 | 1.21670 | 100 | 117 | 3634 | macromolecule modification |
| GO:0002792 | 0.03540 | 2.09661 | 4 | 9 | 162 | negative regulation of peptide secretion |
| GO:0007272 | 0.03540 | 2.09661 | 4 | 9 | 162 | ensheathment of neurons |
| GO:0008366 | 0.03540 | 2.09661 | 4 | 9 | 162 | axon ensheathment |
| GO:0007389 | 0.03541 | 1.59819 | 13 | 20 | 468 | pattern specification process |
| GO:0051259 | 0.03556 | 1.51421 | 17 | 25 | 617 | protein complex oligomerization |
| GO:0000041 | 0.03600 | 2.57233 | 2 | 6 | 89 | transition metal ion transport |
| GO:0032271 | 0.03610 | 1.92363 | 6 | 11 | 215 | regulation of protein polymerization |
| GO:0050871 | 0.03610 | 1.92363 | 6 | 11 | 215 | positive regulation of B cell activation |
| GO:0001952 | 0.03653 | 2.35119 | 3 | 7 | 113 | regulation of cell-matrix adhesion |
| GO:0050890 | 0.03693 | 1.72341 | 9 | 15 | 326 | cognition |
| GO:0009059 | 0.03698 | 1.20332 | 113 | 131 | 4121 | macromolecule biosynthetic process |
| GO:0002562 | 0.03699 | 2.86781 | 2 | 5 | 67 | somatic diversification of immune receptors via germline recombination within a single locus |
| GO:0016239 | 0.03699 | 2.86781 | 2 | 5 | 67 | positive regulation of macroautophagy |
| GO:0016444 | 0.03699 | 2.86781 | 2 | 5 | 67 | somatic cell DNA recombination |
| GO:0050710 | 0.03699 | 2.86781 | 2 | 5 | 67 | negative regulation of cytokine secretion |
| GO:0007050 | 0.03706 | 2.19214 | 4 | 8 | 138 | cell cycle arrest |
| GO:0010460 | 0.03707 | 4.43858 | 1 | 3 | 27 | positive regulation of heart rate |
| GO:0030212 | 0.03707 | 4.43858 | 1 | 3 | 27 | hyaluronan metabolic process |
| GO:0032801 | 0.03707 | 4.43858 | 1 | 3 | 27 | receptor catabolic process |
| GO:0032957 | 0.03707 | 4.43858 | 1 | 3 | 27 | inositol trisphosphate metabolic process |
| GO:0036037 | 0.03707 | 4.43858 | 1 | 3 | 27 | CD8-positive, alpha-beta T cell activation |
| GO:0045061 | 0.03707 | 4.43858 | 1 | 3 | 27 | thymic T cell selection |
| GO:0045332 | 0.03707 | 4.43858 | 1 | 3 | 27 | phospholipid translocation |
| GO:0045730 | 0.03707 | 4.43858 | 1 | 3 | 27 | respiratory burst |
| GO:0048305 | 0.03707 | 4.43858 | 1 | 3 | 27 | immunoglobulin secretion |
| GO:0050901 | 0.03707 | 4.43858 | 1 | 3 | 27 | leukocyte tethering or rolling |
| GO:0060008 | 0.03707 | 4.43858 | 1 | 3 | 27 | Sertoli cell differentiation |
| GO:0061099 | 0.03707 | 4.43858 | 1 | 3 | 27 | negative regulation of protein tyrosine kinase activity |
| GO:2000272 | 0.03707 | 4.43858 | 1 | 3 | 27 | negative regulation of signaling receptor activity |
| GO:2000727 | 0.03707 | 4.43858 | 1 | 3 | 27 | positive regulation of cardiac muscle cell differentiation |
| GO:0010677 | 0.03717 | 3.38441 | 1 | 4 | 46 | negative regulation of cellular carbohydrate metabolic process |
| GO:0010799 | 0.03717 | 3.38441 | 1 | 4 | 46 | regulation of peptidyl-threonine phosphorylation |
| GO:0072604 | 0.03717 | 3.38441 | 1 | 4 | 46 | interleukin-6 secretion |
| GO:0098868 | 0.03717 | 3.38441 | 1 | 4 | 46 | bone growth |
| GO:1902667 | 0.03717 | 3.38441 | 1 | 4 | 46 | regulation of axon guidance |
| GO:1990928 | 0.03717 | 3.38441 | 1 | 4 | 46 | response to amino acid starvation |
| GO:2000404 | 0.03717 | 3.38441 | 1 | 4 | 46 | regulation of T cell migration |
| GO:0007204 | 0.03777 | 1.71780 | 9 | 15 | 327 | positive regulation of cytosolic calcium ion concentration |
| GO:0022414 | 0.03777 | 1.32280 | 40 | 52 | 1471 | reproductive process |
| GO:0006643 | 0.03782 | 2.06937 | 5 | 9 | 164 | membrane lipid metabolic process |
| GO:0042472 | 0.03804 | 2.32912 | 3 | 7 | 114 | inner ear morphogenesis |
| GO:0060419 | 0.03804 | 2.32912 | 3 | 7 | 114 | heart growth |
| GO:0000003 | 0.03816 | 1.32181 | 40 | 52 | 1472 | reproduction |
| GO:0051604 | 0.03877 | 1.74827 | 8 | 14 | 300 | protein maturation |
| GO:0007179 | 0.03907 | 2.05601 | 5 | 9 | 165 | transforming growth factor beta receptor signaling pathway |
| GO:0007411 | 0.03914 | 1.83787 | 7 | 12 | 245 | axon guidance |
| GO:0044271 | 0.03932 | 1.20255 | 110 | 127 | 3993 | cellular nitrogen compound biosynthetic process |
| GO:0019538 | 0.03939 | 1.18142 | 147 | 166 | 5344 | protein metabolic process |
| GO:0001938 | 0.03948 | 2.51158 | 3 | 6 | 91 | positive regulation of endothelial cell proliferation |
| GO:0048864 | 0.03948 | 2.51158 | 3 | 6 | 91 | stem cell development |
| GO:0051209 | 0.03958 | 2.30745 | 3 | 7 | 115 | release of sequestered calcium ion into cytosol |
| GO:0048010 | 0.03978 | 3.30555 | 1 | 4 | 47 | vascular endothelial growth factor receptor signaling pathway |
| GO:0050702 | 0.03978 | 3.30555 | 1 | 4 | 47 | interleukin-1 beta secretion |
| GO:0050704 | 0.03978 | 3.30555 | 1 | 4 | 47 | regulation of interleukin-1 secretion |
| GO:0071300 | 0.03978 | 3.30555 | 1 | 4 | 47 | cellular response to retinoic acid |
| GO:2000113 | 0.03979 | 1.32869 | 38 | 49 | 1379 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0019752 | 0.04001 | 1.40754 | 25 | 34 | 902 | carboxylic acid metabolic process |
| GO:0097485 | 0.04017 | 1.82993 | 7 | 12 | 246 | neuron projection guidance |
| GO:0051258 | 0.04058 | 1.77804 | 8 | 13 | 274 | protein polymerization |
| GO:0001945 | 0.04069 | 4.26085 | 1 | 3 | 28 | lymph vessel development |
| GO:0030511 | 0.04069 | 4.26085 | 1 | 3 | 28 | positive regulation of transforming growth factor beta receptor signaling pathway |
| GO:0033198 | 0.04069 | 4.26085 | 1 | 3 | 28 | response to ATP |
| GO:0034204 | 0.04069 | 4.26085 | 1 | 3 | 28 | lipid translocation |
| GO:0044788 | 0.04069 | 4.26085 | 1 | 3 | 28 | modulation by host of viral process |
| GO:0060384 | 0.04069 | 4.26085 | 1 | 3 | 28 | innervation |
| GO:0060444 | 0.04069 | 4.26085 | 1 | 3 | 28 | branching involved in mammary gland duct morphogenesis |
| GO:0061217 | 0.04069 | 4.26085 | 1 | 3 | 28 | regulation of mesonephros development |
| GO:1900745 | 0.04069 | 4.26085 | 1 | 3 | 28 | positive regulation of p38MAPK cascade |
| GO:1901186 | 0.04069 | 4.26085 | 1 | 3 | 28 | positive regulation of ERBB signaling pathway |
| GO:1903846 | 0.04069 | 4.26085 | 1 | 3 | 28 | positive regulation of cellular response to transforming growth factor beta stimulus |
| GO:2000310 | 0.04069 | 4.26085 | 1 | 3 | 28 | regulation of NMDA receptor activity |
| GO:0002040 | 0.04117 | 2.28618 | 3 | 7 | 116 | sprouting angiogenesis |
| GO:0010927 | 0.04117 | 2.28618 | 3 | 7 | 116 | cellular component assembly involved in morphogenesis |
| GO:0098739 | 0.04117 | 2.28618 | 3 | 7 | 116 | import across plasma membrane |
| GO:0010633 | 0.04120 | 2.77794 | 2 | 5 | 69 | negative regulation of epithelial cell migration |
| GO:0045576 | 0.04120 | 2.77794 | 2 | 5 | 69 | mast cell activation |
| GO:0055117 | 0.04120 | 2.77794 | 2 | 5 | 69 | regulation of cardiac muscle contraction |
| GO:1903670 | 0.04120 | 2.77794 | 2 | 5 | 69 | regulation of sprouting angiogenesis |
| GO:0046165 | 0.04124 | 2.14240 | 4 | 8 | 141 | alcohol biosynthetic process |
| GO:0007249 | 0.04128 | 1.94816 | 5 | 10 | 193 | I-kappaB kinase/NF-kappaB signaling |
| GO:0055002 | 0.04128 | 1.94816 | 5 | 10 | 193 | striated muscle cell development |
| GO:0002921 | 0.04149 | 7.09497 | 0 | 2 | 12 | negative regulation of humoral immune response |
| GO:0006098 | 0.04149 | 7.09497 | 0 | 2 | 12 | pentose-phosphate shunt |
| GO:0006957 | 0.04149 | 7.09497 | 0 | 2 | 12 | complement activation, alternative pathway |
| GO:0021670 | 0.04149 | 7.09497 | 0 | 2 | 12 | lateral ventricle development |
| GO:0032353 | 0.04149 | 7.09497 | 0 | 2 | 12 | negative regulation of hormone biosynthetic process |
| GO:0045078 | 0.04149 | 7.09497 | 0 | 2 | 12 | positive regulation of interferon-gamma biosynthetic process |
| GO:0072176 | 0.04149 | 7.09497 | 0 | 2 | 12 | nephric duct development |
| GO:0072431 | 0.04149 | 7.09497 | 0 | 2 | 12 | signal transduction involved in mitotic G1 DNA damage checkpoint |
| GO:0072540 | 0.04149 | 7.09497 | 0 | 2 | 12 | T-helper 17 cell lineage commitment |
| GO:0072608 | 0.04149 | 7.09497 | 0 | 2 | 12 | interleukin-10 secretion |
| GO:0072615 | 0.04149 | 7.09497 | 0 | 2 | 12 | interleukin-17 secretion |
| GO:0099639 | 0.04149 | 7.09497 | 0 | 2 | 12 | neurotransmitter receptor transport, endosome to plasma membrane |
| GO:1900165 | 0.04149 | 7.09497 | 0 | 2 | 12 | negative regulation of interleukin-6 secretion |
| GO:1902400 | 0.04149 | 7.09497 | 0 | 2 | 12 | intracellular signal transduction involved in G1 DNA damage checkpoint |
| GO:1904251 | 0.04149 | 7.09497 | 0 | 2 | 12 | regulation of bile acid metabolic process |
| GO:2000402 | 0.04149 | 7.09497 | 0 | 2 | 12 | negative regulation of lymphocyte migration |
| GO:0006302 | 0.04150 | 1.87719 | 6 | 11 | 220 | double-strand break repair |
| GO:0031348 | 0.04150 | 1.87719 | 6 | 11 | 220 | negative regulation of defense response |
| GO:0032731 | 0.04249 | 3.23028 | 1 | 4 | 48 | positive regulation of interleukin-1 beta production |
| GO:0043303 | 0.04249 | 3.23028 | 1 | 4 | 48 | mast cell degranulation |
| GO:0044786 | 0.04249 | 3.23028 | 1 | 4 | 48 | cell cycle DNA replication |
| GO:0045104 | 0.04249 | 3.23028 | 1 | 4 | 48 | intermediate filament cytoskeleton organization |
| GO:0045910 | 0.04249 | 3.23028 | 1 | 4 | 48 | negative regulation of DNA recombination |
| GO:0050850 | 0.04249 | 3.23028 | 1 | 4 | 48 | positive regulation of calcium-mediated signaling |
| GO:1903115 | 0.04249 | 3.23028 | 1 | 4 | 48 | regulation of actin filament-based movement |
| GO:1904591 | 0.04249 | 3.23028 | 1 | 4 | 48 | positive regulation of protein import |
| GO:2000725 | 0.04249 | 3.23028 | 1 | 4 | 48 | regulation of cardiac muscle cell differentiation |
| GO:0051961 | 0.04249 | 1.65726 | 10 | 16 | 361 | negative regulation of nervous system development |
| GO:0003015 | 0.04264 | 1.86817 | 6 | 11 | 221 | heart process |
| GO:0071345 | 0.04268 | 1.39916 | 25 | 34 | 907 | cellular response to cytokine stimulus |
| GO:0034101 | 0.04270 | 2.12632 | 4 | 8 | 142 | erythrocyte homeostasis |
| GO:0051283 | 0.04280 | 2.26529 | 3 | 7 | 117 | negative regulation of sequestering of calcium ion |
| GO:0061572 | 0.04300 | 2.01695 | 5 | 9 | 168 | actin filament bundle organization |
| GO:0097164 | 0.04300 | 2.01695 | 5 | 9 | 168 | ammonium ion metabolic process |
| GO:0009062 | 0.04316 | 2.45362 | 3 | 6 | 93 | fatty acid catabolic process |
| GO:0043506 | 0.04316 | 2.45362 | 3 | 6 | 93 | regulation of JUN kinase activity |
| GO:0046173 | 0.04341 | 2.73508 | 2 | 5 | 70 | polyol biosynthetic process |
| GO:1903725 | 0.04341 | 2.73508 | 2 | 5 | 70 | regulation of phospholipid metabolic process |
| GO:0030307 | 0.04375 | 1.92692 | 5 | 10 | 195 | positive regulation of cell growth |
| GO:0043436 | 0.04408 | 1.38804 | 26 | 35 | 941 | oxoacid metabolic process |
| GO:0001935 | 0.04419 | 2.11048 | 4 | 8 | 143 | endothelial cell proliferation |
| GO:0046330 | 0.04419 | 2.11048 | 4 | 8 | 143 | positive regulation of JNK cascade |
| GO:0046620 | 0.04447 | 2.24479 | 3 | 7 | 118 | regulation of organ growth |
| GO:0070372 | 0.04449 | 1.71189 | 8 | 14 | 306 | regulation of ERK1 and ERK2 cascade |
| GO:0031295 | 0.04449 | 4.09679 | 1 | 3 | 29 | T cell costimulation |
| GO:0033273 | 0.04449 | 4.09679 | 1 | 3 | 29 | response to vitamin |
| GO:0060260 | 0.04449 | 4.09679 | 1 | 3 | 29 | regulation of transcription initiation from RNA polymerase II promoter |
| GO:0071480 | 0.04449 | 4.09679 | 1 | 3 | 29 | cellular response to gamma radiation |
| GO:0071548 | 0.04449 | 4.09679 | 1 | 3 | 29 | response to dexamethasone |
| GO:0002279 | 0.04530 | 3.15836 | 1 | 4 | 49 | mast cell activation involved in immune response |
| GO:0002448 | 0.04530 | 3.15836 | 1 | 4 | 49 | mast cell mediated immunity |
| GO:0045103 | 0.04530 | 3.15836 | 1 | 4 | 49 | intermediate filament-based process |
| GO:0046834 | 0.04530 | 3.15836 | 1 | 4 | 49 | lipid phosphorylation |
| GO:0070229 | 0.04530 | 3.15836 | 1 | 4 | 49 | negative regulation of lymphocyte apoptotic process |
| GO:0044267 | 0.04553 | 1.18441 | 126 | 143 | 4569 | cellular protein metabolic process |
| GO:0002711 | 0.04568 | 2.69352 | 2 | 5 | 71 | positive regulation of T cell mediated immunity |
| GO:0014068 | 0.04568 | 2.69352 | 2 | 5 | 71 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0060675 | 0.04568 | 2.69352 | 2 | 5 | 71 | ureteric bud morphogenesis |
| GO:0061045 | 0.04568 | 2.69352 | 2 | 5 | 71 | negative regulation of wound healing |
| GO:0046890 | 0.04576 | 1.99172 | 5 | 9 | 170 | regulation of lipid biosynthetic process |
| GO:0006909 | 0.04596 | 1.66897 | 9 | 15 | 336 | phagocytosis |
| GO:0010467 | 0.04607 | 1.18021 | 132 | 150 | 4814 | gene expression |
| GO:0051282 | 0.04619 | 2.22464 | 3 | 7 | 119 | regulation of sequestering of calcium ion |
| GO:1902275 | 0.04633 | 1.90614 | 5 | 10 | 197 | regulation of chromatin organization |
| GO:0050768 | 0.04694 | 1.66371 | 9 | 15 | 337 | negative regulation of neurogenesis |
| GO:0042692 | 0.04696 | 1.60732 | 11 | 17 | 395 | muscle cell differentiation |
| GO:0032874 | 0.04718 | 1.97933 | 5 | 9 | 171 | positive regulation of stress-activated MAPK cascade |
| GO:1905952 | 0.04728 | 2.07948 | 4 | 8 | 145 | regulation of lipid localization |
| GO:0097190 | 0.04750 | 1.47949 | 17 | 24 | 605 | apoptotic signaling pathway |
| GO:0010508 | 0.04794 | 2.20486 | 3 | 7 | 120 | positive regulation of autophagy |
| GO:1901216 | 0.04794 | 2.20486 | 3 | 7 | 120 | positive regulation of neuron death |
| GO:0000079 | 0.04803 | 2.65320 | 2 | 5 | 72 | regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:0072171 | 0.04803 | 2.65320 | 2 | 5 | 72 | mesonephric tubule morphogenesis |
| GO:0006670 | 0.04816 | 6.44969 | 0 | 2 | 13 | sphingosine metabolic process |
| GO:0006857 | 0.04816 | 6.44969 | 0 | 2 | 13 | oligopeptide transport |
| GO:0019054 | 0.04816 | 6.44969 | 0 | 2 | 13 | modulation by virus of host process |
| GO:0019370 | 0.04816 | 6.44969 | 0 | 2 | 13 | leukotriene biosynthetic process |
| GO:0030240 | 0.04816 | 6.44969 | 0 | 2 | 13 | skeletal muscle thin filament assembly |
| GO:0030948 | 0.04816 | 6.44969 | 0 | 2 | 13 | negative regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:0032351 | 0.04816 | 6.44969 | 0 | 2 | 13 | negative regulation of hormone metabolic process |
| GO:0038065 | 0.04816 | 6.44969 | 0 | 2 | 13 | collagen-activated signaling pathway |
| GO:0045072 | 0.04816 | 6.44969 | 0 | 2 | 13 | regulation of interferon-gamma biosynthetic process |
| GO:0045136 | 0.04816 | 6.44969 | 0 | 2 | 13 | development of secondary sexual characteristics |
| GO:0045628 | 0.04816 | 6.44969 | 0 | 2 | 13 | regulation of T-helper 2 cell differentiation |
| GO:0045820 | 0.04816 | 6.44969 | 0 | 2 | 13 | negative regulation of glycolytic process |
| GO:0046642 | 0.04816 | 6.44969 | 0 | 2 | 13 | negative regulation of alpha-beta T cell proliferation |
| GO:0048304 | 0.04816 | 6.44969 | 0 | 2 | 13 | positive regulation of isotype switching to IgG isotypes |
| GO:0050711 | 0.04816 | 6.44969 | 0 | 2 | 13 | negative regulation of interleukin-1 secretion |
| GO:0071295 | 0.04816 | 6.44969 | 0 | 2 | 13 | cellular response to vitamin |
| GO:0097202 | 0.04816 | 6.44969 | 0 | 2 | 13 | activation of cysteine-type endopeptidase activity |
| GO:0099159 | 0.04816 | 6.44969 | 0 | 2 | 13 | regulation of modification of postsynaptic structure |
| GO:1903817 | 0.04816 | 6.44969 | 0 | 2 | 13 | negative regulation of voltage-gated potassium channel activity |
| GO:2000650 | 0.04816 | 6.44969 | 0 | 2 | 13 | negative regulation of sodium ion transmembrane transporter activity |
| GO:0010596 | 0.04821 | 3.08956 | 1 | 4 | 50 | negative regulation of endothelial cell migration |
| GO:0030865 | 0.04821 | 3.08956 | 1 | 4 | 50 | cortical cytoskeleton organization |
| GO:0032330 | 0.04821 | 3.08956 | 1 | 4 | 50 | regulation of chondrocyte differentiation |
| GO:1902930 | 0.04821 | 3.08956 | 1 | 4 | 50 | regulation of alcohol biosynthetic process |
| GO:0032692 | 0.04846 | 3.94488 | 1 | 3 | 30 | negative regulation of interleukin-1 production |
| GO:0034110 | 0.04846 | 3.94488 | 1 | 3 | 30 | regulation of homotypic cell-cell adhesion |
| GO:0061037 | 0.04846 | 3.94488 | 1 | 3 | 30 | negative regulation of cartilage development |
| GO:0070306 | 0.04846 | 3.94488 | 1 | 3 | 30 | lens fiber cell differentiation |
| GO:0070304 | 0.04864 | 1.96710 | 5 | 9 | 172 | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0051253 | 0.04868 | 1.32353 | 35 | 45 | 1269 | negative regulation of RNA metabolic process |
| GO:0050679 | 0.04900 | 1.88581 | 5 | 10 | 199 | positive regulation of epithelial cell proliferation |
| GO:0014066 | 0.04908 | 2.37152 | 3 | 6 | 96 | regulation of phosphatidylinositol 3-kinase signaling |
| GO:0099072 | 0.04908 | 2.37152 | 3 | 6 | 96 | regulation of postsynaptic membrane neurotransmitter receptor levels |
| GO:0120162 | 0.04908 | 2.37152 | 3 | 6 | 96 | positive regulation of cold-induced thermogenesis |
| GO:0032411 | 0.04974 | 2.18542 | 3 | 7 | 121 | positive regulation of transporter activity |